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Abstract 
 
Sonic hedgehog (Shh) plays an important role in embryogenesis. It acts as a 
morphogen that diffuses to form a concentration gradient and works in a temporally 
and spatially controlled manner. Shh not only regulates organogenesis, such as 
formation of digits on limbs and organization of the brain, but also controls cell 
division of stem cells. Perturbations in Shh signaling have been implicated in 
developmental disorders and development of some cancers. However, owing to the 
dynamic in vivo environment and the high degree of complexity of the molecular 
processes and transports, there are challenges of investigating the cell-Shh 
interactions. 
 
Controlled immobilization of proteins like cell adhesion proteins, immunoglobulins, 
hormones, morphogens, including Shh, is an essential step for a large set of 
applications in biology, medicine and biotechnology ranging from developmental 
biology to tissue engineering and biosensing. Reliable attachment of biomolecules on 
solid man-made substrates opens routes for many new key experiments, allowing 
studies of the biomolecules in simplified and thus controllable conditions. 
 
By taking advantage of the immobilization models for studying complicated 
biological events, the objective of the current project was to organize Shh in vitro in a 
way mimicking the in vivo microenvironment, in which the morphogen is distributed 
with a concentration gradient extracellularly. The immobilization processes have to 
show selective binding chemistry, provide control of the positioning and orientation 
of Shh on the substrate, and need to allow access of Shh to its receptor. 
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In the presented project, biologically active Shh protein variants were synthesised in 
vitro. Plasmids of Shh with different tags or linker groups for immobilization were 
made. Production of sufficient amount of Shh for immobilization and surface analysis 
was performed in the E. coli expression system; while the determination of biological 
activity of Shh was carried out with the proteins obtained from the HEK293 cell 
culture system. The C3H10T1/2 clone 8 and the Shh LIGHT II cells demonstrated 
that the in vitro expressed Shh proteins are biologically active. The Shh induced 
cellular responses are dosage dependent.  
 
Adsorption or immobilization of Shh on substrates by a variety of physical and 
chemical interactions was then developed and tested. These interactions include 
collagen matrix networking; nickel(II)/poly(6)histidine affinity; biotin/streptavidin 
affinity; and benzylguanine (BG)/SNAPTM covalent binding. Each of them exhibits 
different binding strength. Surface analysis illustrated that all of the applied systems 
are capable of immobilizing Shh by physisorption or chemical binding. Collagen 
permits motility of the adsorbed Shh. The biological activity of the protein is 
maintained to induce Shh signal specific cellular responses. The 
nickel(II)/poly(6)histidine and biotin/streptavidine systems facilitate Shh binding with 
high selectivity. The BG/SNAPTM approach promotes specific and irreversible 
immobilization of Shh. Further experiments are under progression for the 
establishment of a tailor-made platform for the in vitro investigation of the interaction 
of irreversibly bound Shh with the responsive cells.
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Zusammenfassung 
 
Das Signalprotein "Sonic hedgehog" (Shh) spielt eine bedeutende Rolle in der 
Embryogenese. Es fungiert als Morphogen: Das von einer lokalen Quelle aus 
diffundierende Molekül bildet einen Konzentrationsgradienten aus, dessen räumliche 
und zeitliche Ausprägung die Zellentwicklung steuert. Shh steuert nicht nur die 
Organentwicklung wie beispielsweise das Ausbildung von Gliedmaßen und die 
Organisation des Gehirns, sondern auch die Zellteilung von Stammzellen. Störungen 
des Sonic hedgehog Signalwegs führen zu Fehlbildungen in der 
Embryonalentwicklung und werden mit dem Auftreten bestimmter Krebsarten in 
Zusammenhang gebracht. Aufgrund der großen Dynamik im lebenden Organismus 
und der hohen Komplexität der Prozesse auf molekularer Ebene, ist die Untersuchung 
der Wechselwirkung zwischen Zellen und Shh oft schwierig. 
 
Die kontrollierte Immobilisierung von Proteinen wie Zelladhäsionsproteine, 
Immunoglobuline, Hormone, Morphogene wie Shh ist ein essentieller Schritt in 
zahlreichen und ganz verschiedenen biologischen, medizinischen oder 
biotechnologischen Anwendungen wie beispielsweise Entwicklungsbiologie, Tissue 
Engineering und Biosensorik. Eine gezielte Anbindung von Biomolekülen an feste, 
künstliche Substrate ermöglicht viele neue Schlüsselexperimente, die es erlauben 
Biomoleküle unter einfachen – und daher kontrollierbaren – Bedingungen zu 
untersuchen. Gemäß diesem Ansatz war es das Ziel dieser Arbeit einen 
Konzentrationsgradienten wie ihn das Morphogen Shh in seiner Mikroumgebung in 
vivo ausbildet in vitro nachzubilden. Dafür muss der chemische 
Immobilisierungsprozess selektiv sein und es erlauben Position und Orientierung von 
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Shh auf dem Substrat zu steuern, so dass eine Bindung zwischen Shh und seinem 
Rezeptor möglich ist.  
 
In diesem Projekt wurde biologisch aktives Shh in vitro hergestellt. Dazu wurden 
Plasmide erzeugt, deren Sequenz Shh mit verschiedenen Tags und Linkern zur 
Immobilisierung enthält. Größere Mengen an Shh für Immobilisierungsversuche und 
Experimente zur Quantifizierung immobilisierten Proteins wurden in E. coli 
exprimiert. Versuche zur Bestimmung der biologischen Aktivität des Proteins wurden 
mit Shh durchgeführt, das mit Hilfe des HEK293 Kultursystems erhalten worden war. 
Zwei verschiedene Zellkultursysteme wurden herangezogen, um die biologische 
Aktivität des exprimierten Proteins zu verifizieren: C3H10T1/2 Klon 8 und Shh 
LIGHT II. Die durch Shh induzierten Zellantworten waren dosisabhängig. 
 
Anschließend wurden verschiedene Verfahren zur Adsorption oder Immobilisierung 
von Shh auf künstlichen Substraten mittels physikalischer bzw. chemischer Methoden 
entwickelt und getestet. Zu den untersuchten Immobilisierungsstrategien gehörte 
Adsorption an vernetzte Kollagenmatrix, Affinitätsbindung über Ni2+/Poly(6)histidin 
bzw. Biotin/Streptavidin und kovalente Bindung von Benzylguanin (BG) an 
SNAPTM-tragende Moleküle. Die Bindungsstärke variiert je nach Methode. Mittels 
Oberflächenanalyse konnte gezeigt werden, dass alle verwendeten Systeme in der 
Lage waren Shh zu adsorbieren bzw. zu binden. Die Kollagenmatrix erlaubt eine 
gewisse Mobilität des adsorbierten Shh. Die biologische Activität des Proteins blieb 
erhalten: Das Shh-Signal war in der Lage spezifische Zellantworten zu induzieren. 
Sowohl das Ni2+/Poly(6)histidin als auch das  Biotin/Streptavidin System 
ermöglichen eine hochselektive Bindung. Die Kopplung mit BG/SNAP führt zu 
spezifischer und irreversibler Immobilisierung von Shh. Weitere Experimente zielen 
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auf die Entwicklung einer maßgeschneiderten Plattform ab, welche die Grundlage für 
die in vitro Untersuchung der Wechselwirkungen von immobilisierten Shh mit 
Shh-sensitiven Zellsystemen sein wird. 
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1. Introduction 
 
Embryonic development is the result of a series of signaling events. Morphogens, 
which are represented by a number of signaling molecules, contribute to the 
developmental events and are key players of proper tissue patterning. Because of their 
significance in embryonic development, there is a large interest in studying 
morphogens in detail. While some studies focus on in vivo approaches based e.g. on 
transgenic animals etc., other aspects of morphogens functions are more conveniently 
studied in vitro using cell culture set-ups allowing for precise morphogen gradients 
and reducing the interferences with other factors present in the in vivo situation. 
 
1.1. Morphogens 
 
Morphogens are substances that govern pattern formation and growth in development 
(Ashe and Briscoe, 2006; Gallet and Therond, 2004; Mehlen et al., 2005; Torroja et 
al., 2004). Particularly, morphogens work in a dose dependent manner to determine 
locally the differentiation of cells (Ashe and Briscoe, 2006; Gallet and Therond, 2004; 
Mehlen et al., 2005; Torroja et al., 2004). Depending on the rate of production, the 
rates of the transport and self-enhanced ligand degradation, morphogens are able to 
form different slopes of concentration gradients (Torroja et al., 2004). Regarding the 
terms of transport there have been experimental studies illustrating that morphogens 
achieve gradient formation by diffusion through extracellular matrix (ECM), while 
others have proposed that morphogens spread in vesicles through repeated cycles of 
endocytosis and exocytosis. These processes ultimately shape the concentration and 
thus extent of morphogen activity (Torroja et al., 2004). Furthermore, recent studies 
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have shown that receptors of morphogens are capable of regulating endocytic 
trafficking (Han et al., 2004; Torroja et al., 2004). This lead to the hypothesis that also 
the receptors play an important role in morphogen gradient formation (Torroja et al., 
2004). 
 
The French flag model (Figure 1.1), a renowned and conceptional definition of 
morphogen spreading / gradient formation, was introduced by Lewis Wolpert in the 
1960s (Dessaud et al., 2008). In this model, the effects of different morphogen 
concentrations on cellular responses were illustrated by the different colors of the 
French flag. Morphogens are rigorously regarded as secreted signaling molecules that 
emanate from a localized source and spread through the positional fields (Mehlen et 
al., 2005). Positional values would then be specified by the local concentration of the 
morphogen, which would decrease with distance from the source. When the 
morphogen reaches its target cells, it acts directly on the cells to produce specific 
cellular activities in regard to morphogen concentration (Dessaud et al., 2008). In 
other words, morphogens affect cell states based on concentrations and these states 
are represented by the different colors of the French flag (Dessaud et al., 2008). 
Tissues are then subdivided into domains of different gene expression that correspond 
to these colors. For instance, high concentrations activate "blue" genes, lower 
concentrations activate "white" genes, with "red" serving as the default state in cells 
below the necessary concentration threshold. 
 
In this view, morphogens are defined to carry two distinctive features. On one hand, 
they act on cells at a distance from their sources, namely the signaling ranges. On the 
other hand, they induce differential gene expression in a concentration-dependent 
manner. 
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Figure 1.1. The French flag model of morphogen concentration gradient, positional cell fate 
determination, and pattern formation. The morphogen is secreted from a localized source 
of expression. After secretion, the morphogen is transported over several cell distances by 
means of diffusion and/or through interactions with carrier molecules, thereby 
establishing a concentration gradient. Cells located along the distance from the source of 
expression are exposed to different morphogen concentrations and respond by 
differentiating into corresponding cell types. (Adapted from Kerszberg and Wolpert, 
2007). 
 
The earliest and best-studied morphogens are some transcription factors that diffuse in 
early Drosophila melanogaster (fruit fly, denoted as Drosophila in the rest of the text) 
embryos. Other examples are the secreted intercellular signaling factors 
decapentaplegic (Dpp) / Transforming Growth Factor beta (TGF); hedgehog (Hh) / 
Sonic hedgehog; wingless / Wnt; Epidermal Growth Factor (EGF); and Fibroblast 
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Growth Factor (FGF) (Mehlen et al., 2005) that mediate communication between 
cells. Apart from these proteins, also small organic molecules like retinoic acid can be 
regarded as morphogens. In summary, morphogens are defined conceptually and not 
by their molecular structure (White et al., 2007). 
 
1.2. The Hedgehog / Sonic hedgehog protein 
 
The Hedgehog (Hh) signaling pathway plays a crucial role in determining cell fate 
and patterning during development. It starts with the Hedgehog gene, which was first 
discovered in Drosophila, and is required for multiple development processes such as 
embryonic segmentation, imaginal disc formation, eye and appendage development, 
and cell fate specification in wings (Heemskerk and DiNardo, 1994; Hidalgo, 1991; 
Ingham, 1993, 1995; Lee et al., 1992; Mohler, 1998; Robbins et al., 1997; Tabata et 
al., 1992). 
  
In vertebrates, three homologs of the Drosophila Hh gene have been identified to be 
expressed in a tissue specific manner and are responsible for the morphogenesis of 
various organs such as neural tube, limbs, somites and pharyngeal arches and cartilage 
and male germinal cell differentiations (Monnier et al., 2002). These three homologs 
are Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian hedgehog (Ihh) (Ågren 
et al., 2004). Among them, Shh shows the best similarity to Drosophila Hh (Chang et 
al., 1994; Chiang et al., 1996; Echelard et al., 1993; Johnson and Tabin, 1995; Krauss 
et al., 1993; Riddle et al., 1993; Robbins et al., 1997; Roelink et al., 1994). Shh is also 
the most broadly expressed member of the hedgehog family and is probably 
responsible for the major effects in the development of brain, spinal cord, axial 
skeleton and limbs (Figure 1.2; Chiang et al., 1996). 
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Figure 1.2. Shh and other Hh homologs and their roles in mouse development from an embryo to an 
adult. (Top) The embryo cartoons show aspects of expression of the Hh target gene 
patched (blue) during mouse embryonic development. (Bottom) Bars show approximate 
embryonic stages when Shh, Ihh, and/or Dhh (color code in bottom left) control 
developmental processes in the indicated tissues or cell types. The approximate 
embryonic stage is indicated by dpc and Theiler stage (TS) (Theiler 1989). (Adapted from 
Varjosalo and Taipale, 2008)  
 
1.2.1. The Hedgehog / Sonic hedgehog signaling pathway 
 
At the plasma membrane of Hh / Shh responsive cell, there is a receptor complex 
composed of Patched (Ptc) and Smoothened (Smo) proteins. Ptc is a 12-span 
transmembrane protein and binds directly to the ligand. It serves as the primary 
receptor for Hh / Shh (Martín et al., 2001). At the same time, Ptc is also a negative 
regulator of Hh / Shh signaling by suppressing the signal transmitter Smo at the cell 
membrane and the subsequent signal transduction (Ågren et al., 2004; Karpen et al., 
  
Introduction
6
2001; Martín et al., 2001). Smo is a 7-span transmembrane protein with strong 
resemblance to a G-protein coupled receptor (Ågren et al., 2004; Martin et al., 2001). 
It orchestrates the Hh / Shh pathway signaling and controls transcription factor 
activation by transducing the Hh / Shh signal via a multiprotein complex (Ayers and 
Thérond et al., 2010). The multiprotein complex, which contains the serine-threonine 
kinase Fused (Fu), Suppressor of Fused [Su(Fu)], and the zinc finger containing 
transcription factor Cubitus interruptus (Ci) in Drosophila or the vertebrate homolog 
Gli, is associated with the microtubule (Ågren et al., 2004). 
 
In the absence of Hh / Shh, Smo is suppressed by Ptc (Ågren et al., 2004; Karpen et 
al., 2001; Martín et al., 2001). No Hh / Shh signal is transmitted from Smo to the 
multiprotein complex. The transcription factor Ci / Gli is cleaved to the repressor form. 
The Su(Fu) regulated cytoplasmic-nuclear shuttling of Ci / Gli does not take place 
(Ågren et al., 2004). There is no transcription of any downstream target genes of the 
Hh / Shh signaling. 
 
Upon binding of the Hh / Shh ligand to Ptc, the suppression of Smo by Ptc is relieved 
(Robbins et al., 1997; Sisson et al., 1997). This relief of inhibition of Smo leads to the 
accumulation of Smo to the primary cilia (Corbit et al., 2005) and the dissociation of the 
multiprotein complex from microtubules (Ågren et al., 2004). Transport of the full 
length activated form of Ci / Gli into the nucleus activates transcription of the Hh / Shh 
signaling downstream target genes such as Wingless (Wg), the TGFfamily member 
Decapentaplegic (Dpp), and Ptc (Ågren et al., 2004; Lefers et al., 2001; Taipale et al., 
2000; Wang and Holmgren, 2000). In the mouse mesenchymal cells, Shh signalling 
induces the expression of alkaline phosphatase (ALP) as an early indicator of 
chondrogenic differentiation. In this project, the mouse pluripotent mesenchymal cell 
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line, C3H10T1/2 clone 8, was used for the determination of Shh biological activity. In 
addition, gene transcription driven by the Gli promoter is also an indicator of the 
activation of Shh signal transduction. The Shh LIGHT II cell line, which is stably 
transfected with the Gli-luciferase fusion DNA construct and expresses luciferase upon 
the activation of Gli promoted transcription, was also used for Shh activity analysis in 
this project. 
 
A detailed illustration of the vertebrate Shh signaling pathway is shown in figure 1.3. 
 
 
Figure 1.3. Model of vertebrate Shh signal transduction pathway. (A) In the absence of Shh, Ptc 
inhibits Smo activity at the cell membrane. No Shh signal is transferred to the 
multiprotein complex of Fu, Su(Fu) and the transcription factor Gli. Gli exists as a 
cleaved repressor form. No transcription of any downstream target genes takes place. (B) 
After the Shh ligand binds to its receptor Ptc, the suppression of Smo by Ptc is relieved. 
Smo is relocated to the microtubule. There the multiprotein complex is dissociated. Gli 
remains in the full length activator form, and is transported into the nucleus and triggers 
transcription of the target genes of Shh signaling. (Modified from Ribes and Briscoe, 
2009).  
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1.2.2. Post-translation modifications of the Hedgehog / Sonic 
hedgehog protein 
 
Shh is initially produced as a 45kDa premature precursor (Wang et al., 2007). After 
translation, like other Hedgehog homologs, Shh undergoes multiple processing steps 
in the endoplasmic reticulum (Goetz et al., 2002; Heussler and Suri, 2003; Peters et al., 
2004; Varjosalo and Taipale, 2008; Wang et al., 2007). Since the mechanisms for Hh 
processing and secretion are evolutionarily conserved (Varjosalo and Taipale, 2007, 
2008), the modification of Shh was taken as an example for all homologs in the 
family (Figure 1.4). 
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Figure 1.4. Maturation of Sonic hedgehog (Shh) signaling domain. Firstly, the full length premature 
Shh precursor is translated and transported to the endoplasmic reticulum. There the 
N-terminal signal sequence (ss), which is encoded by the first 24 amino acids of the full 
length Shh and is responsible for the release of the processed signaling domain (ShhN) 
from the expressing cell, is removed. Secondly, the autoprocessing domain (ShhC) is 
cleaved off from the C terminus of ShhN. A cholesterol modification then takes place at 
the exposed glycine residue and facilitates association of ShhN to the plasma membrane 
to get ready for ShhN secretion. With the catalysis by the acyltransferase Skinny 
hedgehog (Ski), palmitate is attached to the N terminus of ShhN. After this final 
processing step, ShhN is matured and regarded as ShhNp, where p denotes processed. 
 
After the signal sequence (or signal peptide) at the N terminus of the 45kDa Shh 
precursor is removed, an autoproteolytic cleavage is performed at the C terminus to 
generate an N-terminal fragment of Shh protein of about 19kDa (Chen et al., 2004; 
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Heussler and Suri, 2003; Miura and Treisman, 2006; Peters et al., 2004; Varjosalo and 
Taipale, 2008; Wang et al., 2007). This separation of the N- and C-terminals is 
catalyzed by the C-terminal autoprocessing domain and takes place between the 
conserved glycine and cysteine residues (Chen et al., 2004; Varjosalo and Taipale, 
2008). During the cleavage, the cholesterol modification occurs simultaneously. First, 
the peptide bond between the glycine and cysteine residues is rearranged to form a 
thioester. Subsequently, cholesterol attacks the carbonyl of the thioester, covalently 
displacing the sulfur and cleaving the Shh protein into two parts (Heussler and Suri, 
2003; Miura and Treisman, 2006; Peters et al., 2004; Varjosalo and Taipale, 2008). 
The C-terminal autoprocessing domain appears to carry no function, while the 
N-terminal Shh signaling domain (ShhN) that contains an ester-linked cholesterol at 
its C terminus is further processed to gain full protein activity (Peters et al., 2004; 
Varjosalo and Taipale, 2008). 
 
The cholesterol modification facilitates the association of ShhN with the plasma 
membrane and spatially restricts the activity zone and diffusion of ShhN from the site 
of secretion (Heussler and Suri, 2003; Peters et al., 2004; Varjosalo and Taipale, 
2008), resulting in controlled release of protein from the membrane regions of the 
producing cells to form stable gradients (Peters et al., 2004). The hydrophobicity and 
membrane anchoring ability of ShhN are further enhanced by the addition of 
palmitate, a 16-carbon saturated fatty acid that is required for ShhN activity, at its N 
terminus by the acyltransferase Skinny hedgehog (Ski) (Chen et al., 2004; Heussler 
and Suri, 2003; Miura and Treisman, 2006; Peters et al., 2004; Varjosalo and Taipale, 
2007, 2008). 
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The resulting mature and fully active form of ShhN signaling molecule is thus 
modified by cholesterol at its C terminus and palmitate at its N terminus, and is 
denoted as ShhNp, where p indicates processed (Chen et al., 2004; Varjosalo and 
Taipale, 2008). 
 
1.2.3. Secretion, transport and concentration gradient formation 
of the Hedgehog / Sonic hedgehog protein 
 
Despite its tight membrane association due to the C-terminal cholesterol modification 
and N-terminal palmitoylation, the Hh / Shh protein is able to affect patterning of 
distal tissues, acting directly over a long range of many cell diameters in a time- and 
concentration-dependent manner (Figure 1.5; Varjosalo and Taipale, 2007, 2008; 
Wang et al., 2007). The distance over which Hh has been shown to act is ~50m in 
the Drosophila wing imaginal disc formation (Varjosalo and Taipale, 2008; Zhu And 
Scott, 2004). In vertebrate limb bud formation, Shh can travel up to ~300m, which is 
up to 20 cell diameters, from its source of secretion (Saha and Schaffer, 2005; 
Varjosalo and Taipale, 2008; Zhu and Scott, 2004). The formation of the gradient of 
Hh / Shh activity emanating from the secreting cells is facilitated by multiple 
macromolecules such as heparin sulfate proteoglycans (HSPGs), which control 
release, transport and sequestration of Hh / Shh (Dierker et al., 2009a, b; Lin, 2004; 
Varjosalo and Taipale, 2007; Zhu and Scott, 2004). 
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Figure 1.5. Model illustrating the formation of Hh concentration gradients with the contribution of 
HSPG in the extracellular matrix (ECM), and the resulting signal strength of unprocessed 
(Hh-N) and processed signaling domains of Hh (Hh-Np). Processed Hh-Np associates 
with HSPG and exhibits a controlled concentration gradient in the ECM. Unprocessed 
Hh-N, on the contrary, demonstrates a more diffused pattern of morphogen distribution 
without close contact with HSPG. (Adapted from Guerrero and Chiang, 2006) 
 
In both Drosophila and vertebrates, hedgehog proteins are trafficked and anchored to 
the cell surface and released from the producing cells as lipoprotein (LP)-associated 
oligomers in a process mediated by the 12-span transmembrane protein Dispatched 
(Disp) (Saha and Schaffer, 2005; Varjosalo and Taipale, 2008). Disp, like Ptc, belongs 
to the bacterial Resistance-Nodulation-Division (RND) family of transport proteins by 
virtue of their sequence similarity (Varjosalo and Taipale, 2007, 2008; Wang et al., 
2007). Loss of Disp leads to accumulation of Hh in the producing cells and failure of 
long-range signaling in Drosophila (Burke et al., 1999; Varjosalo and Taipale, 2008). 
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After the secretion of Hh from the producing cells, several molecules and mechanisms 
are used to control the shape and size of the Hh gradient (Wang et al., 2007). For 
instance, ECM proteins have been found to regulate Shh transport. High affinity 
binding of Shh to vitronectin in the neural tube has been suggested to aid in the proper 
presentation of Shh to differentiating motoneurons (Saha and Schaffer, 2005). The 
effective transport of Drosophila Hh depends upon the activity of HSPG. Shh has also 
been shown to bind to HSPG, as indicated by the failure of Hh transport in embryos 
lacking heparan sulfate-synthesizing enzymes of the EXT/tout velu (ttv) family (Saha 
and Schaffer, 2005; Varjosalo and Taipale, 2007). There is also evidence indicating 
that Hh oligomers travel from Hh producing cells to Hh responsive cells via 
interactions with both, glypicans and megalin (Wang et al., 2007). 
 
At the plasma membrane of Hh responsive cells, Hh is capable of inducing the 
expression of its receptor Patched (Ptc). Ptc restricts the range of action of Hh in all 
species analyzed by sequestering and internalizing Hh, and targeting it to lysosomes 
for degradation (Varjosalo and Taipale, 2007, 2008). In addition to Ptc, vertebrates 
have an additional transmembrane glycoprotein, the Hh-interacting protein (Hhip), 
which is also induced by Hh signaling. It binds to Hh with high affinity, and reduces 
its range of movement by modulating Hh signaling activity (Saha and Schaffer, 2005; 
Varjosalo and Taipale, 2007, 2008). 
 
While the in vivo secretion and transportation of Hh have been widely studied in 
Drosophila, there is a growing number of works for Shh in vertebrates. Previously, 
Shh transport via diffusion was modeled in the vertebrate limb bud, using a simple 
signal transduction mechanism without consideration of any of the accessory transport 
mechanisms described above (Dillon et al., 2003; Saha and Schaffer, 2005). Based on 
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the proposed mechanism of Shh signal transduction with the active and inactive Smo, 
the model was developed to study the Ptc-Smo interaction and effects of the 
post-translationally modified and unmodified ShhN. Bead- and tissue-implant 
experiments can be monitored by using the model without postulating different 
diffusivities for the two forms of Shh; and the difference in other parameters such as the 
rate of release of Shh from the bead or transplant can explain the Shh diffusion 
mechanism equally well. 
 
1.3. Current in vitro cell culture system for the investigation 
of Sonic hedgehog function / role 
 
With reference to the significance of Shh in cell fate determination during tissue 
development and the severity of developmental defects resulting from malfunction of 
Shh or interruption of its signal transduction, many in vivo studies of Shh signaling 
were performed. However, studies of Shh function in vivo are complicated by the high 
complexity of its signaling pathway and the involvement and interactions of many 
other molecules in the signaling network. Moreover, the post-translational 
modifications that the protein undergoes in its maturation procedure in vivo hinders 
researchers from examining some Shh functions at the basic level. The establishment 
of an in vitro cell culture system would therefore be helpful in eliminating the 
contribution of other in vivo factors and provide a simplified platform for the 
investigation of the Shh modes of action. 
 
Like other morphogens, Shh can be transported by various mechanisms to generate a 
concentration gradient (Kang et al., 2007; Morales et al., 2006; Wilson and Chuang, 
2010). In an in vitro system, the formation of concentration gradient and restriction of 
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local availability of the morphogen can be achieved by immobilization of the 
morphogen on a functionalized surface. With the assumption that the Shh responsive 
cells are initially of the same type, would they react and differentiate into different 
cell types according to the sensed morphogen concentration gradient? If yes, it would 
provide information, in addition to the current knowledge on the effect of Shh on cell 
fate determination at certain levels of concentrations, on the contribution of the 
steepness of gradient slope to the definition of morphogens. 
 
In 2010, Amadi and colleagues demonstrated that the Shh gradient in a 
Resistor-Capacitor (RC) device is capable of inducing graded expression of the 
neuronal transcription factors Olig2 and Nkx2.2 in mouse embryonic stem cells 
(Figure 1.6; Amadi et al, 2010). Nevertheless, using hydrogel to "immobilize" Shh 
does not allow irreversible binding of the protein to the substrate. The work of 
Amadi’s group was thus unable to fully restrict the motility of Shh. Immobilization of 
Shh with more stringent condition, on the other hand, could raise the possibility in 
solving the problem. 
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Figure 1.6. Biomolecules inside the cells may react differently when the morphogen is applied in a 
constant concentration or is distributed in a gradient. Introduction of Shh to embryonic 
stem cells with different gradients via hydrogel triggered differentiation and graded 
expression of neural transcription factors (Adapted from Amadi et al., 2010). 
 
In the last decades, a variety of strategies have been established for surface 
modifications and patterning for organizing cell cultures and biomolecules such as 
nucleotides and proteins in a defined and controlled manner, probably by virtue of the 
expanding demand for more realistic in vitro tissue models to get closer to the in vivo 
situation (Welle et al., 2002). Taking proteins as an example, once proteins are 
adsorbed onto a biomaterial surface, they serve as mediators between the surface 
features and the biological microenvironment in touch with them (Willumeit et al., 
2007). The in vitro assemble of cellular networks offering control over positions, 
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connectivities and activities of cells by patterned culture substrates is a valuable tool 
for researches in cell biology (Chen et al., 1998; Ostuni et al., 2009). Such an 
approach not only gives the advantage of simplification of systems for fundamental 
understanding of biological metabolisms, but also enhances the resolution in viewing 
complicated cellular reactions / responses. 
 
In the case of Shh, patterning Shh in a controlled system may provide information on 
how Shh works as a morphogen: Are the absolute amounts of the protein provided 
and received governing the strength of signaling? Or are the slopes of varying protein 
concentrations more critical in modulating cellular behaviours? These questions can 
be addressed using tailor made systems for Shh immobilization and specific cell based 
assays. Taken together, substrate patterning for protein immobilization and 
investigation may reveal the most basic mechanisms of protein action. 
  
1.4. Surface functionalization and patterning for protein 
immobilization 
 
There are numerous possibilities of immobilizing proteins on functionalized surfaces 
(You et al., 2009). In the current project, immobilization of Shh was conducted by 
making use of functional group interactions such as the affinity binding between 
nickel ion and polyhistidine; biotin and streptavidin; and the benzylguanine (BG) and 
SNAPTM tag covalent bonding system. Physisorption of Shh on collagen and 
fibronectin coated surfaces were also performed to mimick Shh distribution in the 
extracellular matrix. With respect to properties of the interactions, three surface 
substrates with distinct physical properties: polystyrene (PS), glass and gold were 
used. To optimize each surface for ShhN immobilization and maximal protein activity, 
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designated methods of improving protein adsorption properties of surfaces, 
introducing active functional groups, patterning and coating of materials were tested. 
 
The following subsections provide general introduction to each of the surfaces and 
modifications employed for protein immobilization, and elucidate their advantages 
and applications. 
 
1.4.1. Physisorption of proteins on extracellular matrices 
 
The extracellular matrix (ECM) is a biological structure that provides structural 
support with their properties of forming connection networks. The well-known 
components in the ECM include collagen and fibronectin. They assist in migration of 
cells and transportation of biomaterials and information for effective protein-cell and 
cell-cell communications. Based on the results of Guerrero and Chiang (2006), also 
collagen and fibronectin should have an impact on ShhN distribution and 
bioavailability. If the ShhN/collagen or ShhN/fibronectin adsorption are fully or 
partially reversible ShhN endocytosis can take place (Jarov et al., 2003). 
 
By coating different amounts of collagen or fibronectin on glass surfaces, different 
amounts of Shh can be adsorbed. As collagen and fibronectin are ready in attaching 
themselves on glass surfaces, the two extracellular matrix substances provide a 
favorable platform for protein adsorption and cell adhesion, mimicking the in vivo 
environment. 
 
 
 
  
Introduction
19
1.4.2. Microcontact printing of proteins onto surfaces 
 
Microcontact printing (μCP) is a soft lithography method. It utilizes a 
polydimethylsiloxane (PDMS) stamp for parallel deposition of molecules on a target 
surface through conformal contact with the substrate (Figure 1.7; Thibault et al., 
2005). Cp is simple, reproducible and, cost-effective (Thibault et al., 2005). Previous 
work demonstrated that proteins and self resembled monolayers (SAMs) can be 
deposited on a substrate surface by μCP (Malaquin et al., 2003; Michel et al., 2001; 
Thibault et al., 2005). Since µCP can provide patterns at the micro- and nano-scales, it 
allows investigation of cell-protein interaction at subcellular length scales (Renault et 
al., 2003; Thaibault et al., 2005). Cp can be used to generate special patterns with 
different local densities of protein forming a protein gradient. An example of gradient 
generation by Cp is shown in figure 1.8. 
 
 
Figure 1.7. Principle of microcontact printing (Cp) of protein molecules onto a glass surface. (1) 
Inking of the stamp with the protein solution. (2) Drying of the stamp under nitrogen 
stream. (3) Manual contact between the inked PDMS stamp and the glass slide. (4) 
Protein molecules were transferred on the surface along the patterns that correspond to the 
relief structures of the PDMS stamp. (Modified from Thibault et al., 2005) 
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Figure 1.8. Substrate-bound gradient fabricated by microcontact printing of ephrin. (A) A steep 
gradient built by an array of stripes and (B) a shallow gradient built by dots. Scale bar: 50 
m. (Modified from von Philipsborn et al., 2006). 
 
1.4.3. UV assisted functionalization of polystyrene surfaces with 
nickel ions 
 
Polystyrene (PS) was originally used in the form of sterile, non-functionalized petri 
dishes for bacterial culture (Welle et al., 2002). Irradiation of polystyrene surfaces 
with ultraviolet light of = 185nm for more than 5 minutes leads to the formation of 
carboxylic groups and negative surface charges (Welle et al., 2002). The resulting 
hydrophilic surfaces favor binding of certain adhesion proteins such as collagen, 
fibronectin and laminin (Welle et al., 2002, 2005). By using chromium/quartz masks 
during UV irradiation, and different irradiation times or a proximity gap between the 
mask and substrate, one can establish different densities of carboxylic groups, hence 
different densities of adsorbed proteins on the PS surface (Figure 1.9). 
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Figure 1.9. Applications of UV irradiated polystyrene surfaces. (A) Phase contrast micrography of 
L929 cells on UV patterned polystyrene surface. Irradiation of the PS surface with 
ultraviolet light of = 185nm gives rise to the formation of a hydrophilic surface, which 
favors cell adhesion. (B, C) The change of hydrophilicity of the UV irradiated PS surfaces 
allows adsorption of fibronectin on the surfaces with sharp or graded density profiles 
along the patterns. Fibronectin was detected by immunofluorescence (IF) using the 
anti-fibronectin antibody conjugated with Cy3 (B) or green fluorescence (C) labeled 
secondary antibodies. (Courtesy of Dr. S. Engin, KIT, Karlsruhe, Germany) 
 
UV modified polystyrene is usually applied for direct cell adhesion and protein 
immobilization. In addition, the produced carboxylic acid groups at the irradiated PS 
surface can be further reacted with nickel(II)-nitrilotriacetic acid (Ni-NTA) containing 
compounds which in turn bind to poly(6)histidine tagged proteins. When six histidine 
molecules are continuously arranged, they bear a high affinity of binding to the metal 
nickel (Hochuli, 1988). The nickel-histidine binding affinity is strong and has the 
dissociation constant (Kd) of 10-13M (Schmitt et al., 1993). Such affinity is not only 
beneficial in purifying polyhistidine tagged proteins by column chromatography but 
also provides a strong and stable intermediate for protein immobilization on 
functionalized surfaces (Sigal et al., 1996). 
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1.4.4. Dip-pen nanolithography of phospholipids for protein 
immobilization 
 
Dip-pen nanolithography (DPN) is an alternative approach for biomaterial 
immobilization. It is a scanning probe lithography technique where an atomic force 
microscope (AFM) tip is used as an ultra-sharp pen for direct and micro- and 
nanoscale deposition of materials onto a surface via a water meniscus (Figure 1.10; 
Echelard et al., 1993; Ginger et al., 2004). 
 
 
Figure 1.10. Schematic diagram illustrating dip-pen nanolithography of phospholipids. On a solid 
substrate, an AFM tip is used to deliver phospholipids ink onto the surface via a water 
meniscus in an atmosphere surrounded with optimized humidity. (Courtesy of Dr. S. 
Lenhert, Florida State University, USA) 
 
DPN of phospholipids with a nickel chelating head group can be used for selective 
adsorption of polyhistidine-tagged proteins (Agarwal et al., 2003). Similarly, biotin 
terminated phospholipids can also be used to immobilize a biotinylated protein with a 
streptavidin linked between the biotin head group in the lipids and the biotin fused 
with the protein (Sekula et al.,2008). Biotin is a vitamin found in all cells while 
streptavidin, a bacterial homologous protein to avidin purified from chicken egg 
white, is isolated from the actinobacterium Streptomyces avidinii (Holmberg et al., 
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2005). The biotin/streptavidin system is the strongest non-covalent interaction known 
in nature, having a dissociation constant (Kd) of 4×10-14M (Holmberg et al., 2005; 
Livnah et al., 1993). The high affinity and specificity are due to the high shape 
complementarity as well as the extensive network of hydrogen bonds formed between 
biotin and the binding pocket of streptavidin. Biotinylation of the protein of interest 
and the phospholipids used for DPN, and connecting the two with streptavidin as the 
intermediate layer can therefore facilitate immobilization of the protein on a 
designated surface. Because of the small size of biotin, the biological activity of the 
immobilized protein is most likely unaffected. 
 
 
Figure 1.11. Schematic representation of protein-coupling strategies to spatially patterned lipid 
supports (Top), and the chemical structures of the used phospholipids (Bottom) (Adapted 
from Sekula et al., 2008) 
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1.4.5. Self assembled monolayer formation of benzylguanine 
terminated thiols on gold and immobilization of protein via 
benzylguanine/alkyltransferase covalent binding 
 
Apart from functionalized phospholipids deposited by DPN, SAMs of thiols or 
disulfides on gold are also important building blocks for surface functionalization 
used in many disciplines (Mrksich and Whitesides, 1996). For example, a thiol SAM 
on gold can be used for protein immobilization (Kim et al., 2008). A thiol group is a 
sulfhydryl (-SH) group. It is itself a head group that can form an alkanethiol with an 
alkyl chain ((CH2)n) as a backbone and a tail group, which usually is a tag for binding 
of the protein of interest (Love et al., 2005). An alkanethiol strongly binds to noble 
metal substrates, like gold and silver, by virtue of the high affinity of sulfur in the 
sulfhydryl group to the metal. The sulfur-gold interaction is semi-covalent with a 
binding energy of 50kcal/mol (Love et al., 2005). Over a long enough period of time, 
a SAM of the alkanethiol would form on the gold surface with the sulfhydryl group 
assembling together on the gold substrate and the tail group far from it for protein 
binding. Generation of SAMs of an alkanethiol with an appropriate tail group could 
therefore be applied for immobilizing proteins on gold surfaces. 
 
While different tail groups can be associated with the alkanethiol for the 
immobilization of relevantly tagged proteins on gold, the SNAPTM system was 
discovered to be appropriate for covalent immobilization of proteins (Kindermann et 
al., 2003). In nature, the human DNA repair protein O6-alkylguanine-DNA 
alkyltransferase (hAGT) transfers the alkyl group from its substrate, 
O6-alkylguanine-DNA, to one of its cysteine residues, resulting in a covalent bond at 
the site of reaction (Kindermann et al., 2003; Pegg, 2000). Previously, 
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O6-benzylguanine (BG) was found to exhibit similar properties as 
O6-alkylguanine-DNA. It could react with and form covalent bonding with hAGT, 
and thus could be used for specific labelling of hAGT fusion proteins in vivo and in 
vitro (Keppler et al., 2003; Kindermann et al., 2003). The coupling of BG and hAGT 
is covalent and is commercialized under the trade name SNAPTM. By attaching a BG 
group at the tail of an alkanethiol and substituting it, a SNAPTM tagged protein could 
be covalently immobilized on gold surface (Figure 1.12). Thus, the SNAPTM system 
can strictly control protein immobilization in vitro. 
 
 
Figure 1.12. Covalent immobilization of a hAGT (SNAPTM) fusion protein on a BG modified surface. 
(Adapted from Kindermann et al., 2003) 
 
In addition to direct protein immobilization on a BG terminated SAM on gold, 
benzylguanine terminated phospholipid pattern can be generated via DPN lithography 
on other substrates than gold, e.g. polystyrene. 
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1.5. Surface analysis techniques 
 
It is important not only to immobilize target proteins on designated surfaces, but also 
to evaluate the efficiency of protein adsorption. There are a variety of choices for 
surface analysis. The following subsections introduce the techniques used in this 
project. 
 
1.5.1. Immunofluorescence for the detection of protein adsorption  
 
Immunofluorescence (IF) is a common laboratory technique widely used for specific 
detection of proteins in cells and tissues. In IF, antibodies are chemically conjugated 
to fluorescent dyes such as fluorescein isothiocyanate (FITC) (Robinson et al., 2009) 
and bind directly or indirectly to the antigen of interest (Figure 1.13). Antigen 
detection is performed with a flow cytometer, an array scanner or automated imaging 
instrument, or by a fluorescence or confocal microscope (Robinson et al., 2009). 
 
 
Figure 1.13. Schematic depiction of direct and indirect immunofluorescence. The primary antibody 
detects the antigen or protein of interest. A secondary antibody, which is conjugated with 
a fluorophore, binds to the primary antibody and thereby indicates the presence of the 
targeted antigen or protein. (Adapted from Robinson et al., 2009) 
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1.5.2. Enzyme-linked immunosorbent assay for the detection and 
quantification of adsorbed proteins  
 
Enzyme-linked immunosorbent assay (ELISA), also known as enzyme immunoassay 
(EIA), is a biochemical technique conceptualized and developed by Engvall and 
Perlmann in 1971 at Stockholm University, Sweden (Lequin, 2005). Similar to 
immunofluorescence, ELISA is used mainly in immunology to detect the presence of 
an antibody or an antigen (or simply a protein of interest). Typically, a specific 
detection antibody is applied over the sample surface of an unknown amount of 
antigen or protein of interest affixed to the surface. The antibody forms a complex 
with the antigen or protein and is detected by a secondary antibody linked to an 
enzyme through bioconjugation. Finally an enzyme substrate is added and enzymatic 
conversion results in detectable signal, most commonly a color change in a chemical 
substrate, which indicates the quantity of the antigen or protein of interest in the 
sample (Figure 1.14). 
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Figure 1.14. Schematic diagram demonstrating the typical procedure of ELISA. (Adapted from 
http://en.wikibooks.org) 
 
By measuring the color intensity of known amounts of a protein, a standard curve can 
be plotted for quantification of the protein. In this project, ELISA was applied to 
determine the amount of Shh adsorbed on collagen surfaces. 
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1.5.3. Fluorescence recovery after photobleaching for the 
evaluation of protein motility 
 
Fluorescence recovery after photobleaching (FRAP), also termed fluorescence 
photobleaching recovery (FPR), denotes a method for measuring two-dimensional 
lateral translational dynamics of molecules based on the diffusion of fluorescent 
particles (Axelrod et al., 1976; Koppel et al., 1979; Soumpasis et al, 1983). To initiate 
FRAP, a small area of fluorescence labeled molecules on a surface is first chosen. The 
fluorescence of the moleucles is photobleached by a brief exposure to an intense 
focused laser beam (Axelrod et al., 1976; Koppel et al., 1976; Soumpasis et al., 1983). 
The subsequent recovery of the fluorescence, which occurs by replenishment of intact 
fluorophores in the bleached spot by diffusion from the surroundings, is monitored by 
fluorescence microscopy (Axelrod et al., 1976). By measuring the kinetics and the 
intensity of the fluorescence recovery, the motility of the molecules on the surface can 
be determined. Figures 1.15 and 1.16 illustrate the typical redistribution of a 
fluorescently labeled molecule on a cell surface in a FRAP experiment and an ideal 
FRAP recovery curve, respectively.
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Figure 1.15. Schematic depiction of FRAP experiment on cell surface. An intense focused laser beam 
with the corresponding wavelength of the fluorophore used for molecule labeling is 
applied to photobleach the spot of interest. While the laser intensity is always kept 
constant during the following analysis, the fluorescence intensity in the illuminated region 
changes as molecules in the unbleached surroundings move into the photobleached area. 
(Adapted from Biology 230 Tutorials, The Pennsylvania State University, USA) 
 
 
II: initial intensity
I0: intensity at timepoint t0 (first postbleach intensity)
I1/2: half recovered intensity (I1/2 = (IE - I0) / 2)
IE: endvalue of the recovered intensity
thalf: Halftime of recovery corresponding to I1/2 (t1/2 - t0)
Mobile fraction Fm = (IE - I0) / (II - I0)
Immobile fraction Fi = 1 – Fm
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Figure 1.16. An idealized plot of a FRAP recovery curve. The emitted fluorescence from the 
illuminated region is measured as a continuous function of time. Transport dynamics are 
measured by monitoring the transient behavior of an inhomogeneous distribution of 
fluorescently labeled molecules. An exposure with a high laser power bleaches the 
fluorophore within the beam, producing spatial distributions of the fluorophore. As 
molecules in the unbleached surroundings move into the photobleached area, a photo 
recovery occurs and the fluorescence intensity in the bleached area increases until 
equilibrium is reached. In ideal case, the recovered intensity (IE) should be the same as the 
initial intensity (II). Due to different association and dissociation coefficient of molecule 
binding, there can be retardation of recovery rate and the immotile fraction (Fi) cannot be 
replenished by diffusion. (Adapted from EAMNET FRAP online teaching module, 
EMBL, Germany) 
 
In this work FRAP was used to quantify the diffusion of GFP labeled Shh in collagen 
or fibrinectrin matrices. 
 
1.5.4. Quartz crystal microbalance with dissipation monitoring for 
the detection and quantification of adsorbed protein on a 
surface 
 
A quartz crystal microbalance (QCM) is an electro acoustic device for mass and 
viscoelastic analysis of adsorbed layers at a solid/liquid or solid/air interface (Chang 
and Zhao, 2008). The system consists of a megahertz piezoelectric quartz crystal 
resonator sandwiched between two gold electrodes, an oscillator, a frequency counter 
and a computer (Figure 1.17). When an alternating current (AC) is applied, the quartz 
crystal will oscillate at a certain resonance frequency (Spetz, 2006). By measuring the 
change in frequency, the mass of the adsorbed materials on the crystal can be 
determined. In this work, Shh adsorption on collagen surfaces and immobilization on 
benzylguanine thiol (BGT) SAMs were analyzed by quartz crystal microgravimetry 
with dissipation monitoring (QCM-D), which is a special kind of QCM. 
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Figure 1.17. Illustration of a QCM setup. A resonant oscillation is generated in the quartz crystal by 
the application of an AC current. The resonant frequency is then measured by the 
frequency counter (Sauerbrey, 1959). (Diagram adapted from Chang and Zhao, 2008) 
 
QCM-D is developed by Q-Sense AB, Sweden. QCM-D enables real-time, label free 
measurements of molecular adsorption and/or interactions on various surfaces. In 
addition to the adsorbed mass (ng/cm2 sensitivity) measured as changes in the 
frequency of the quartz crystal, the dissipation parameter (D) provides insights 
regarding viscoelastic properties and hydrodynamic conductivity of the adsorbed 
layers. Dissipation occurs when the driving voltage to the crystal is shut off and the 
energy from the oscillating crystal dissipates from the system. QCM-D technology 
can be used to characterize the formation of thin films (nm) such as polymers, cells 
and proteins on surfaces (Chang and Zhao, 2008). 
 
 
 
 
 
 
Quartz crystal 
Gold electrode 
Gold electrode 
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1.5.5. Time-of-flight secondary ion mass spectroscopy  
 
Time-of-flight secondary ion mass spectroscopy (ToF-SIMS) is a powerful 
surface-sensitive analytical technique. It is able to determine the composition, 
structure, orientation, and spatial distribution of molecules and chemical structures on 
a surface through both spectral analysis and direct chemical state imaging (Belu et al., 
2003). A focused, pulsed primary ion beam is scanned in a raster pattern over a 
sample surface to charge and dislodge particles from the surface of the sample. These 
secondary ions are then accelerated into a flight path and their mass is determined by 
measuring the exact time at which they reach the detector (i.e. time-of-flight) (Figure 
1.18). Because ToF-SIMS is capable of measuring the "time-of-flight" of particles on 
a scale of nanoseconds, a mass resolution down to a few ppm m/m can be achieved. 
By quasi-continuously collecting a large number of mass spectra, a "molecular map" 
of a sample area can be generated for any compound that produces a diagnostic ion in 
the spectrum. 
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Figure 1.18. Schematic diagram describing the production of secondary ions by a focused, pulsed 
primary ion beam in the ToF-SIMS system. A pulsed primary ion beam is scanned in a 
raster pattern over the sample surface to charge and dislodge the outermost particles. The 
secondary ions are then accelerated into a flight path and their mass is determined by 
measuring the exact time at which they reach the detector. (Adapted from 
http://www.geomuseum.uni-göttingen.de/people/vthiel/tof_sims.shtml) 
 
 
 
 
 
 
 
 
 
 
 
(ToF-SIMS) 
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1.6. Objectives of the thesis 
 
Sonic hedgehog (Shh) is an essential morphogen to study. However, investigation of 
the transport and signal transduction of the protein is difficult to perform in vivo. As 
mentioned in sections 1.3 and 1.4, it is necessary to eliminate the in vivo factors 
interfering with the modes of action of Shh so as to uncover the basic characters of the 
protein. Published literature provides invaluable information on the morphogenic 
property of Shh, especially on how cell fate determination is controlled by different 
concentration gradients of Shh. Nevertheless, it failed to give details on the roles of 
the tested cells regarding their sensing and recruitment of the morphogen. Whether 
endocytosis of the Shh ligand is required for proper induction of Shh signaling is 
another issue to be addressed. During molecule distribution, some portion of the 
diffusing substance would be immobilized by reversibly binding to the fixed polymer 
(Thorne et al., 2008). It therefore becomes meaningful to develop novel in vitro tools 
which mimick this in vivo situation and allow for investigations of the cellular 
responses to Shh in this advanced setup. 
 
The objectives of this project are to express the biologically active signaling domain 
of Shh (ShhN), and develop methodologies of immobilizing ShhN on defined 
functionalized surfaces making use of the advantages of several immobilization 
approaches as described afore. The thesis will stress the evaluation of the efficiency of 
the immobilization techniques, observations of the effects of immobilization on the 
accessibility and biological activity of the Shh protein, as well as the induced signal 
transduction in Shh responsive reporter cell lines. The findings may provide a 
reference for future studies of Shh in in vitro cell culture systems. 
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2. Materials and Methods 
 
2.1. Materials 
 
2.1.1. Chemicals 
 
Chemical Supplier 
1kb plus DNA ladder Fermentas, St. Leon-Rot, Germany 
Acrylamide, 30% Carl Roth, Karlsruhe, Germany 
Ammonia (28 – 30% in water) Merck, Darmstadt, Germany 
Ampicillin Sigma-Aldrich, Munich, Germany 
APS Carl Roth, Karlsruhe, Germany 
ATP Sigma-Aldrich, Munich, Germany 
Bacto-agar Carl Roth, Karlsruhe, Germany 
BCIP Roche, Mannheim, Germany 
Bromophenoblue Merck, Darmstadt, Germany 
BSA PAA, Linz, Austria 
BSA (albumin fraction V) for QCM Merck, Darmstadt, Germany 
Coelenterazin (Renilla luciferin) Biosynth AG, Staad, Switzerland 
Collagen (rat tail) Roche, Mannheim, Germany 
Complete tablets, EDTA free Roche, Mannheim, Germany 
Coomassie brilliant blue R-250 Merck, Darmstadt, Germany 
DMSO Fluka (Sigma-Aldrich), Munich, Germany
dNTPs Promega, Mannheim, Germany 
DTT Carl Roth, Karlsruhe, Germany 
EDTA Carl Roth, Karlsruhe, Germany 
EGTA Carl Roth, Karlsruhe, Germany 
Ethanol, analytical grade Sigma, Steinheim, Germany 
Ethidium bromide (EtBr) Carl Roth, Karlsruhe, Germany 
Fibronectin Sigma-Aldrich, Munich, Germany 
Firefly luciferin Biosynth AG, Staad, Switzerland 
Glycerol Carl Roth, Karlsruhe, Germany 
Glycine Carl Roth, Karlsruhe, Germany 
Heparin Sigma-Aldrich, Munich, Germany 
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HEPES Sigma-Aldrich, Munich, Germany 
Hydrogen peroxide 
(30% in water, no Sn stabilizers) 
EMSURE, Merck, Darmstadt, Germany 
Imidazole Carl Roth, Karlsruhe, Germany 
IPTG Carl Roth, Karlsruhe, Germany 
Lysozyme Sigma-Aldrich, Munich, Germany 
NBT Roche, Mannheim, Germany 
PageRulerTM prestained protein ladder Fermentas, St. Leon-Rot, Germany 
PFA Carl Roth, Karlsruhe, Germany 
PLL-g-PEG Dr. S. Sekula, INT, KIT, Karlsruhe, 
Germany 
Proteinase K Sigma-Aldrich, Munich, Germany 
SAG Axxora, Lörrach, Germany 
SDS Carl Roth, Karlsruhe, Germany 
TEMED Carl Roth, Karlsruhe, Germany 
TMB tablets Sigma-Aldrich, Munich, Germany 
Tris Carl Roth, Karlsruhe, Germany 
Triton X-100 Carl Roth, Karlsruhe, Germany 
Tween-20 Carl Roth, Karlsruhe, Germany 
ZnCl2 Carl Roth, Karlsruhe, Germany 
 
All other chemicals were purchased from Carl Roth GmbH + Co. KG (Karlsruhe, 
Germany) or Sigma-Aldrich Co. (Munich, Germany) unless otherwise stated. 
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2.1.2. Kits 
 
Kit Supplier 
Alkaline phosphatase colorimetric assay kit Abcam, Cambridge, UK 
Biotin protein ligase GeneCopoeia, Rockville, MD, USA 
Gateway LR Clonase™ II enzyme mix Invitrogen, Darmstadt, Germany 
mMessage Machine T7 kit Ambion, Austin, TX, USA 
Ni-NTA agarose Qiagen, Hilden, Germany 
Ni-NTA purification system Invitrogen, Darmstadt, Germany 
Passive lysis buffer 5X Promega, Mannheim, Germany 
peqGold gel extraction kit Peqlab, Sarisbury Green, UK 
Plasmid maxi kit Qiagen, Hilden, Germany 
 
2.1.3. Buffers and reagents 
 
Buffer or reagent Supplier / Composition 
Alkaline phosphatase (ALP) staining 
buffer, pH9.5 
100mM Tris 
50mM MgCl2 
100mM NaCl 
0.1% Tween-20 
 
BCIP/NBT in ALP staining buffer 7l of 50mg/ml BCIP 
4.5l of 100mg/ml NBT 
in 1ml ALP staining buffer 
 
BT-fix, pH7.4 4% paraformaldeyde 
4% sucrose 
0.12mM CaCl2 
0.1M NaPi 
 
CertiPUR buffer solution di sodium 
hydrogen phosphate / potassium hydrogen 
phosphate 
pH 6.88, 50mM 
 
Merck, Darmstadt, Germany 
  
Materials and Methods
40
Coomassie blue protein staining solution 0.2% Coomassie brilliant blue R-250 
7.5% acetic acid 
50% EtOH 
 
Coomassie gel destaining solution 50% MeOH 
10% acetic acid 
 
Firefly luciferin assay solution 20% firefly luciferin stock solution 
in GlyGly stock buffer 
 
Firefly luciferin stock solution 1mM (0.28mg/ml) firefly luciferin 
in GlyGly stock buffer 
 
Glycylglycine (GlyGly) buffer 
 
Sigma-Aldrich, Munich, Germany 
Glycylglycine (GlyGly) assay buffer 2mM ATP 
1mM DTT 
in GlyGly stock buffer 
 
Glycylglycine (GlyGly) stock buffer 25mM glycylglycine (GlyGly) 
15mM MgSO4 
4mM EGTA 
 
Hybridization buffer (HYB) 50% formamide 
5X SSC 
500g/ml yeast RNA 
50g/ml heparin 
0.1% Tween-20 
9mM citric acid 
 
In situ hybridization (ISH) Blocking buffer 0.1% Tween-20 
0.2% (2mg/ml) BSA 
1% DMSO 
in 1X PBS 
 
Lämmli sample buffer 2X, pH6.8 2% SDS 
10% glycerol 
60mM Tris 
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0.001% bromophenoblue 
100mM DTT 
 
MilliQ H2O Purified and deionized at 18.5M·cm 
by Millipore water purification system 
 
Ni-NTA purification cell lysis buffer 1% TritonX-100 
100M ZnCl2 
1mM EDTA 
1 Complete tablet, EDTA free 
5 spatula of lysozyme 
Fill up to 50 ml with 1X PBS 
 
Ni-NTA purification washing buffer, 
pH7.4 
8.77ml of 200mM NaH2PO4 
1.23ml of 200mM Na2HPO4 
0.5M NaCl 
20mM imidazole 
Fill up to 100ml with H2O 
 
Ni-NTA purification elution buffer, pH7.4 8.77ml of 200mM NaH2PO4 
1.23ml of 200mM Na2HPO4 
0.5M NaCl 
500mM imidazole 
Fill up to 100ml with H2O 
 
PBS 
 
Invitrogen, Darmstadt, Germany 
PBT 1X 0.1% Tween-20 
in 1X PBS 
 
Phosphate-citrate buffer, pH5.0 25.7ml of 0.2M Na2HPO4·2H2O 
24.3ml of 0.1M citric acid·H2O 
Fill up to 50ml with H2O 
 
Renilla luciferase reaction mix 1 108.75ml of 0.4M K2HPO4 
16.25ml of 0.4M KH2PO4 
50ml of 5M NaCl 
1ml of 0.5M EDTA 
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Fill up to 500ml with H2O 
 
Renilla luciferase reaction mix 2 125mM Coelenterazin (Renilla 
luciferin) 
in Renilla luciferase reaction mix 1 
 
SDS electroblotting buffer 1X, pH8.3 30mM Tris 
200mM glycine 
20% MeOH 
 
SDS-PAGE running buffer 1X, pH8.3 25mM Tris 
197.5mM glycine 
0.1% SDS 
 
SSC 1X, pH7.0 150mM NaCl 
15mM sodium citrate 
 
TAE 1X, pH7.8 40mM Tris 
5mM acetic acid 
1mM EDTA 
 
TBST 1X, pH7.6 2mM Tris 
14mM NaCl 
0.2% Tween-20 
 
Western blot (WB) blocking buffer 5% BSA 
in 1X TBST 
 
The pH values of all buffers and reagents were adjusted with 37% hydrochloric acid 
(HCl) and 1N sodium hydroxide (NaOH). 
 
2.1.4. Enzymes 
 
All restriction endonucleases, PCR enzymes and other modifying enzymes were 
purchased from Fermentas GmbH (St. Leon-Rot, Germany) unless otherwise stated 
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2.1.5. Bacteria 
 
Bacteria Strain Usage 
E. coli BL-21 Expression of ShhN variants 
 
E. coli ccdB Survival T1R Propagation of empty pDESTTM14 vector 
 
E. coli DB3.1TM Propagation of empty pENTRTM11 vector 
 
E. coli DH5 Propagation of DNA of ShhN variants in 
pDESTTM14 vector 
 
E. coli TOP10 Propagation of DNA of ShhN variants in 
pENTRTM11 vector 
 
E. coli XL1-Blue General propagation of plasmids 
 
2.1.6. Bacteria media 
 
Medium Composition 
LB 10g tryptone 
5 g yeast extract 
5 g NaCl 
Fill up to 1L with H2O 
 
SOC 2% bacto-tryptone 
0.5% bacto-yeast extract 
10mM NaCl 
2.5mM KCl 
10mM MgSO4 
10mM MgCl2 
20mM glucose 
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2.1.7. Cell lines 
 
Cell line Origin Source Medium 
HEK293 Human embryonic 
kidney cells 
 
M. Litfin, ITG, 
KIT, Karlsruhe, 
Germany 
 
DMEM 
10% FBS 
C3H10T1/2 clone 8 Mouse pluripotent 
mesenchymal cells 
American Type 
Culture Collection 
(ATCC) (LGC 
Standards), Wesel, 
Germany 
 
BME 
10% HI FBS 
2mM L-glutamine 
Shh LIGHT II NIH/3T3 stably 
transfected with 
Gli responsive 
firefly luciferase 
reporter 
Dr. Anita Büttner, 
University of 
Leipzig, Germany 
DMEM (ATCC) 
10% FBS 
0.15mg/ml zeocin 
0.4mg/ml G-418 
 
2.1.8. Cell culture media and reagents 
 
Cell culture medium or reagent Supplier 
BME Invitrogen, Darmstadt, Germany 
DMEM Invitrogen, Darmstadt, Germany 
DMEM (American Type Culture Collection 
(ATCC)) 
LGC Standards, Wesel, Germany 
FBS PAA, Linz, Austria 
Geneticin (G418 sulfate) Invitrogen, Darmstadt, Germany 
L-glutamine Invitrogen, Darmstadt, Germany 
PolyPlus jetPEI transfection reagent Polyplus-transfection, New York, 
NY, USA 
Trypsin Invitrogen, Darmstadt, Germany 
Zeocin Invitrogen, Darmstadt, Germany 
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2.1.9. Zebrafish (Danio rerio) 
 
Wildtype zebrafish (strain AB2O2) were maintained in fish water at 28oC in the fish 
facility at Karlsruhe Institute of Technology (KIT) Campus North. 
 
2.1.10. DNA plasmids 
 
DNA plasmid Supplier 
pcDNA3.1:Shh (ShhNp) Dr. K. Grobe, Westfälische 
Wilhelms-Universität Münster, Germany 
pcDNA3.1:ShhN-Myc-His (ShhN6×his) Dr. K. Grobe, Westfälische 
Wilhelms-Universität Münster, Germany 
pBlueScript KSII:mouse Shh Dr. A. McMahon, Harvard University, 
MA, USA 
pCS2:GFP Prof. Dr. U. Strähle, ITG, KIT, Karlsruhe, 
Germany 
pDESTTM14 Invitrogen, Darmstadt, Germany 
pENTRTM11 Invitrogen, Darmstadt, Germany 
pSS26m Covalys, Witterswil, Switzerland 
 
2.1.11. Oligonucleotides 
 
All oligonucleotides for PCR were purchased from Metabion (Martinsried, Germany) 
unless otherwise stated. 
 
Oligonucleotide Sequence (5’ – 3’) 
EcoRIStartShhNF 5’-gaattcatgtgtgggcccggcagg-3’ 
KpnISalIStartShhNF 5’-aattgggtaccgtcgacatgtgtgggcccggcagggggtttggaaagagg-3’ 
SalIStartShhNG35F 5’-aattcgtcgacatgcggcaccccaaaaagctgacccc-3’ 
NotIStopHisShhNR 5’-aattggcggccgcctaatgatgatgatgatgatggccgccggatttggccgccacg
g-3’ 
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XhoIShhNR 5’-aattcctcgagcgccgccggatttggccgccacgg-3’ 
NotIStopHisGFPR 5’-aattcgcggccgcctaatgatgatgatgatgatgtttgtatagttcatccatgcc-3’ 
NotStopBAR 5’-aattggcggccgcctattcatgccattcaattttctgtgc-3’ 
Hind3HisGFPR 5’-aattgaagcttatgatgatgatgatgatgtttgtatagttcatccatgccatg-3’ 
NotIStopSNAPR 5’-aattggcggccgcctagcccagcccaggcttgcccagtctgtggcc-3’ 
 
2.1.12. Recombinant proteins and antibodies 
 
Recombinant protein Supplier 
Recombinant mouse Sonic hedgehog, 
amino-terminal peptide (RCmShhN) 
Neuromics, Edina, MN, USA 
 
Primary antibody Species Supplier 
Anti-GFP antibody Mouse Cell signaling, Danvers, MA, USA 
Anti-SNAP antibody Rabbit Prof. Dr. D. Wedlich, KIT, 
Karlsruhe, Germany 
Monoclonal anti-Shh antibody 5E1  Mouse Developmental Studies Hybridoma 
Bank (DSHB), Iowa City, IA, 
USA 
Qiagen Penta-his antibody BSA-free Mouse Qiagen, Hilden, Germany 
Shh (N-19):sc1194 Goat Santa Cruz, Santa Cruz, USA 
Shh antibody #2287 Rabbit Cell signaling, Danvers, MA, USA 
 
Secondary antibody Supplier 
Alexa Fluor® 488 goat anti-mouse IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 546 donkey anti-goat IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 546 goat anti-mouse IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 546 goat anti-rabbit IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 591 goat anti-mouse IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 680 donkey anti-goat IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 680 goat anti-mouse IgG Invitrogen, Darmstadt, Germany 
Alexa Fluor® 680 goat anti-rabbit IgG Invitrogen, Darmstadt, Germany 
Anti-digoxigenin-AP, Fab fragments Roche, Mannheim, Germany 
Anti-goat IgG peroxidase conjugate Sigma-Aldrich, Munich, Germany 
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2.1.13. RNA probes for in situ hybridization 
 
Probe Origin Supplier 
nkx2.2b Zebrafish (wildtype) Dr. L. Yang, ITG, KIT, Karlsruhe, Germany
pax2a Zebrafish (wildtype) Dr. L. Yang, ITG, KIT, Karlsruhe, Germany
 
2.1.14. Phospholipids 
 
Phospholipids Supplier 
Biotinylated lipids Dr. S. Sekula, INT, KIT, Karlsruhe, Germany 
BG terminated lipids Dr. A. Welle, IBG, KIT, Karlsruhe, Germany 
DOPC Dr. S. Sekula, INT, KIT, Karlsruhe, Germany 
DOPE Dr. S. Sekula, INT, KIT, Karlsruhe, Germany 
Nickel chelating lipids Dr. S. Sekula, INT, KIT, Karlsruhe, Germany 
 
2.1.15. Disulfides  
 
Compound Supplier 
BGT (C48H82N6O9S2)1,  
FW: 951.3 g/mol 
SensoPath, Bozeman, MT, USA 
EG6OH (C46H94O14S2), [913836-40-5], 
FW: 935.4 g/mol 
Prochimia, Sopot, Poland 
 
 
 
 
 
                                                 
1 This compound is not assigned a CAS-number (chemical abstract service). Its molecular structure is 
shown in figure 2.4. 
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2.1.16. Other materials or equipments 
 
Material or equipment Supplier 
Gold coated sensor crystals 
(gold on chromium adhesion layer) 
Q-Sense, Frölunda, Sweden 
Immobilon™ PVDF transfer membranes Millipore, Schwalbach/Ts., Germany 
Lab-TekTM II Chamber SlidesTM Nunc, Wiesbaden, Germany 
Low pressure mercury NNQ 8/18 lamp  Heraeus Noblelight, Kleinostheim, 
Germany 
PD MiniTrap G25 GE Healthcare, Munich, Germany 
Poly-Prep columns Bio-Rad, Munich, Germany 
Protein A SepharoseTM CL-4B GE Healthcare, Munich, Germany 
QCM-D Q-Sense AB, Västra Frölunda, 
Sweden 
Rotilabo®-syringe filters, pore size 0.22m Carl Roth, Karlsruhe, Germany 
Silicon wafers with a 20nm chromium 
adhesion layer and a 200nm gold layer 
Dr. M. Bruns, IAM-WPT, KIT, 
Karlsruhe, Germany 
TOF.SIMS5 ION-TOF GmbH, Münster, Germany 
UV/Ozone ProCleaner Plus BioForce Nanosciences, Inc., Ames, 
IA, USA 
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2.2. Methods 
 
2.2.1. Peptide sequences of ShhN variants 
 
With reference to the peptide sequences of the biologically active ShhNp (p means 
processed) and the recombinant ShhN (referred as RCmShhN) purchased from 
Neuromics (Edina, MN, USA), and the poly(6)histidine sequence provided by the 
supplier, peptide sequences of different ShhN variants for bacterial expression were 
designed and are presented in table 2.1. 
 
48.840ShhN-GFP-His-BA
45.843ShhN-GFP-His-C25M_del26-34
Schemetic drawing (not to scale)
19.314ShhNp
67.710ShhN-GFP-His-SNAP
19.980RCmShhN
66.600
ShhN-GFP-His-
SNAP-
C25M_del26-34
46.953ShhN-GFP-His
20.202ShhN-His
Size 
(kDa)
Name of protein
GFPM 6xhis SNAP Stop
M 6xhis Stop
6xhis
C25 G198
GFPM 6xhis StopC25 G198
C25 G198
C25 G198
HN-C25 G198
C25 G198
G26 – R34
Signal sequence, removed by autoprocessing
C25 G198M1 A24 C199 S437 Stop
Palmitate
CholesterolShhN
Signal
sequence Autoprocessing domain
Shh-FL
M25 G198
M25 G198
GFP 6xhis Stop
GFP 6xhis SNAP Stop
M GFP 6xhis BA Stop
 
Table 2.1. Peptide sequence of ShhNp, RCmShhN and different versions of ShhN designed for 
bacterial expression and immobilization on nickel(II)-nitrilotriacetic acid (Ni-NTA), 
biotin-streptavidin (biotin-STV) and benzylguanine (BG) functionalized surfaces. 
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ShhN encoded from amino acid residues C25 to G198 were fused with different tags 
for immobilization on nickel(II)-nitrilotriacetic acid (Ni-NTA), biotin-streptavidin 
(biotin-STV) or benzylguanine (BG) functionalized surfaces. Methionine (M) served 
as the starting site of translation. The poly(6)histidine tag was used for purification by 
immobilized metal affinity chromatography (IMAC) or immobilization of ShhN on 
Ni-NTA surfaces. Biotin adaptor (BA) was for biotin fusion to ShhN prior to 
immobilization of ShhN by biotin-streptavidine affinity. The benzylguanine 
transferase (SNAPTM) tag was for covalent binding of ShhN to benzylguanine thiol 
(BGT) for immobilization on gold surfaces. Green fluorescence protein (GFP) was for 
detection and visualization of ShhN. The number after the amino acid symbol 
represents the position of the amino acid in Shh-FL. 
 
Similarly, variants of ShhN for eukaryotic expression were designed according to the 
peptide sequences of ShhNp and RCmShhN (Table 2.2). ShhNp and ShhN6×his were 
biologically active ShhN. The DNA constructs were kindly provided by Dr. K. Grobe, 
Westfälische Wilhelms-Universität Münster, Germany. 
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Schemetic drawing (not to scale)
70.020ShhN-GFP-His-SNAP
19.314ShhNp
49.284ShhN-GFP-His
19.980RCmShhN
28ShhN
6his from
K. Grobe
19.314ShhNp from K.Grobe
Size 
(kDa)
Name of protein
6x His
C25 G198
C25 G198
HN-C25 G198
Removed by autoprocessing
C25 G198
6xhis
GFP 6xhis SNAP Stop
GFP 6xhis StopC25 G198
C25 G198
M1 A24
M1 A24
M1 A24
M1 A24 C199 S437 Stop
C25 G198M1 A24 C199 S437 Stop
G26 – R34
Stop
Palmitate
Cholesterol
Myc
ShhN
Signal
sequence Autoprocessing domain
Shh-FL
 
Table 2.2. Peptide sequence information of the eukaryotic expressed ShhN. 
 
Eukaryotic expressed ShhN encoded from amino acid residues C25 to G198 were 
fused different tags for immobilization on Ni-NTA or BG functionalized surfaces. 
Methionine served as the starting site of translation. The signal sequence (M1 to A24) 
was responsible for ShhN secretion from the expressing cells. The poly(6)histidine tag 
was used for immobilization of ShhN on Ni-NTA surfaces. The SNAPTM tag was for 
covalent binding of ShhN to BGT for immobilization on gold surfaces. GFP was for 
detection and visualization of ShhN. The number after the amino acid symbol 
represents the position of the amino acid in Shh-FL. 
 
ShhN proteins were prepared based on the sequences designed. 
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2.2.2. Polymerase chain reaction 
 
DNA fragments of ShhN were amplified by polymerase chain reaction (PCR) with the 
plasmids shown in section 2.1.10 as templates; and the primers in section 2.1.11. 
 
Reaction mixtures with the components described below were prepared in a total 
volume of 25l. 
 
10X polymerase buffer with MgSO4 2.5l 
25mM dNTPs 1l 
DNA template 100ng 
10pmol/l forward primer 1l 
10pmol/l reverse primer 1l 
Pfu DNA polymerase 1U 
H2O Fill up to 25l 
 
PCR reactions were conducted in GeneAmp® PCR System 9700 (Applied 
Biosystems, Carlsbad, CA, USA) with the following parameters. 
 
94oC 45 sec 1 cycle 
94oC 30 sec  
60oC – 68oC 1 min 35 cycles 
72oC 1 – 2 min  
72oC 10 min 1 cycle 
 
The PCR products were stored at 4oC or subjected directly to agarose gel 
electrophoresis. 
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2.2.3. Agarose gel electrophoresis 
 
1.5g of powder agarose was dissolved in 100ml of 1X TAE buffer by heating in the 
microwave oven. 0.5g/ml of ethidium bromide (EtBr) was added to the melted 
agarose. The agarose was then poured into a gel casting tray equipped with a comb 
and was allowed to set at room temperature (RT). The comb was removed after the 
gel was set. Next agarose gel was placed in the electrophoresis chamber filled with 
1X TAE buffer.  
 
5l of 6X DNA loading buffer was mixed into the 25l PCR products and loaded into 
the gel wells. GeneRulerTM 1kb Plus DNA Ladder (Fermentas, St. Leon-Rot, 
Germany) was used as a size reference. The electrophoresis chamber was connected 
to the power supply. The gel was run at 130 Volts. 
 
After electrophoresis the gel was exposed to UV light at = 185nm in the Gel Doc 
system (Bio-Rad, Munich, Germany). DNA separation was recorded by photography. 
 
2.2.4. Purification of DNA from agarose gel 
 
DNA with correct size was cut from the agarose gel with a razor blade. The DNA was 
extracted and purified using the peqGold gel extraction kit (Peqlab, Sarisbury Green, 
UK) according to the manufacturer’s instruction. 
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2.2.5. Restriction endonuclease digestion of DNA 
 
Reaction mixture with the manufacturer recommended buffer (Fermentas, St. 
Leon-Rot, Germany) was set up as the following: 
 
10X buffer 2l 
DNA 1g 
Restriction endonuclease 1U 
H2O Fill up to 20l 
 
Reaction was allowed to take place at 37oC for 1 to 3 hours. 
 
Digested DNA fragments were examined by agaorse gel electrophoresis. 
 
2.2.6. DNA ligation 
 
DNA ligation reaction was carried out with T4 DNA ligase (Fermentas, St. Leon-Rot, 
Germany) according to the manufacturer’s instruction. 
 
2.2.7. Subcloning of ShhN into pENTRTM11 and pDESTTM14 
vectors 
 
DNA fragments of ShhN were subcloned into pENTRTM11 and pDESTTM14 with 
Gateway LR Clonase™ II enzyme mix (Invitrogen, Darmstadt, Germany) according 
to the manufacturer’s instructions. 
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2.2.8. DNA sequencing 
 
DNA plasmids were sent to either GATC Biotech AG (Konstanz, Germany) or 
Qiagen Sequencing Services (Hilden, Germany) for sequencing. 
 
2.2.9. Transformation of Escherichia coli 
 
For all Escherichia coli (E. coli) strains used, including BL-21, ccdB Survival T1R, 
DB3.1TM, DH5, TOP10, and XL1-Blue, 50l of the competent bacteria was taken 
out from -80oC freezer and thawed on ice. 1g DNA plasmid was added to the thawed 
competent E. coli, incubated on ice for 10 to 30 minutes and heat-shocked at 42oC for 
2 minutes. 500l LB or SOC medium without antibiotics was added to the bacteria. 
Next, the transformed bacteria was grown at 37oC for 1 hour with aeration. The 
propagated bacteria was spread on bacto-agar plate with antibiotics and incubated at 
37oC overnight for colony formation. 
 
2.2.10. Protein production in prokaryotic (bacterial) expression 
system 
 
DNA construct for protein expression was transformed into the E. coli strain BL-21. 
Single bacterial colony was picked for an overnight culture at 37oC in LB medium. 
The overnight culture was diluted to OD600 = 0.1 in LB medium to 100ml and was 
allowed to grow at 37oC until the OD600 reached 0.4 to 0.6. Protein expression was 
induced by addition of 0.5mM isopropyl β-D-1-thiogalactopyranoside (IPTG) into the 
bacterial culture. The culture was incubated at 37oC with aeration for 2.5 hours and 
then harvested. 
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2.2.11. Extraction and purification of bacterial expressed ShhN 
 
Bacterially expressed protein was extracted by lysis and purified either using the 
Ni-NTA purification system (Invitrogen, Darmstadt, Germany) according to the 
manufacturer’s instruction or by immobilized metal affinity chromatography (IMAC) 
with Ni-NTA agarose (Qiagen, Hilden, Germany). 
 
Reagents for protein extraction and purification were stored at 4oC. The extraction 
and purification procedures were conducted on ice in 4oC cold room unless otherwise 
stated. 
 
Bacterial pellet was obtained by centrifugation at 4000rpm at 4oC for 30 minutes. The 
pellet was washed with 10ml ice cold 20mM Tris, pH8.0. The washed pellet was 
stored at -20oC or directly homogenized and lysed in 10ml Ni-NTA purification cell 
lysis buffer. The homogenized pellet was incubated on ice for 30 minutes and then 
subjected to sonication for 3 minutes with pulses for complete bacterial cell lysis. 
Next, bacteria was centrifuged at 4000rpm at 4oC for 30 minutes. Supernatant was 
collected in a new 50ml centrifuge tube. 2ml of 50% Ni-NTA agarose slurry (Qiagen, 
Hilden, Germany) was added to the supernatant. The supernatant was rocked at 4oC 
for 1 hour. The protein bound agarose was spinned down by centrifugation at 
1000rpm at 4oC for 2 minutes and washed 3 times with 8ml Ni-NTA purification 
washing buffer. The agarose was then transferred to a vertically equipped Poly-Prep 
column (Bio-Rad, Munich, Germany) and washed for another 3 times by gravity with 
8ml Ni-NTA purification washing buffer. Protein was eluted from the column with 
500l Ni-NTA purification elution buffer and collected in a 1.5ml microcentrifuge 
tube on ice. 
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Buffer exchange for bacterial expressed and purified protein to 1X phosphate buffered 
saline (PBS) (Invitrogen, Darmstadt, Germany) supplemented with 0.5mM DTT was 
performed on ice at 4oC with PD MiniTrap G25 (GE Healthcare, Munich, Germany) 
according to the manufacturer’s instruction. 
 
2.2.12. Biotinylation of ShhN-GFP-His, the ShhN variant with a 
C-terminal biotin acceptor 
 
Biotinylation was done at the biotin acceptor, which was composed of a 15-mer 
peptide sequence of GLNDIFEAQKIEWHE (Staszczak, 2007), at the C-terminal of 
bacterial expressed ShhN-GFP-His-BA, using biotin protein ligase (GeneCopoeia, 
Rockville, MD, USA) according to the manufacturer’s instruction. The resulting 
biotinylated protein was ShhN-GFP-His-Biotin. 
 
2.2.13. Immunoprecipitation 
 
25mg of protein A SepharoseTM CL-4B (GE Healthcare, Munich, Germany) was 
immersed in 1.5ml 1X TBS and was rocked at 4oC for 2 days. 250l of the 
monoclonal anti-Shh antibody 5E1 (Developmental Studies Hybridoma Bank 
(DSHB), Iowa City, IA, USA) was added to the fully soaked sepharose beads. The 
sepharose-antibody mixture was rocked at 4oC overnight. The antibody bounded 
sepharose beads were spinned down by centrifugation at 1000rpm at 4oC for 3 
minutes, washed with 1.5ml 1X TBS, and resuspended in 100l 1X TBS. The beads 
were either stored at 4oC or used directly for immunoprecipitation. 
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100l of the purified bacterial expressed protein after buffer exchange was mixed 
with 1.5ml 1X TBS and 10l of the 5E1 bound sepharose beads. The mixture was 
rocked at 4oC overnight. The beads were spinned down by centrifugation at 1000rpm 
at 4oC for 3 minutes, washed with 1.5ml 1X TBS and resuspended in 15l Lämmli 
sample buffer. Shh-5E1 binding was analyzed by SDS-PAGE and Western blot. 
 
2.2.14. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
A large glass with 0.75mm thick spacers on both sides and a small glass were slipped 
in a polyacrylamide gel casting stand (Bio-Rad, Munich, Germany). Leakage was 
checked by applying EtOH in between the glasses. 
 
Polyacrylamide gel was prepared as the followings. 
 
5% Stacking gel H2O 
1M Tris pH6.8 
30% acrylamide 
10% SDS 
10% APS 
TEMED 
1.4ml 
250l 
330l 
20l 
20l 
2l 
 
15% separation gel  H2O 
1.5M Tris pH8.8 
30% acrylamide 
10% SDS 
10% APS 
TEMED 
1.1ml 
1.3ml 
2.5ml 
50l 
50l 
2l 
 
The 15% separation gel was poured into the glass sandwich. A layer of isopropanol 
was added above the gel to prevent from drying. The isopropanol was removed and 
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the space was loaded with the 5% stacking gel. A comb with 10 wells was inserted at 
the upper edge of the stacking gel. The gel was allowed to set at room temperature. 
 
The set gel was placed in a SDS-PAGE chamber (Bio-Rad, Munich, Germany) fully 
filled with 1X SDS-PAGE running buffer. Lämmli buffer mixed protein samples were 
loaded into the wells generated with the combs. The SDS-PAGE chamber was 
connected to the power supply and the gel was run at 80 Volts per 10 cm gel length. 
 
2.2.15. Integrity analysis and quantification of bacterial expressed 
ShhN 
 
Protein gel obtained after SDS-PAGE was stained with Coomassie blue protein 
staining solution at room temperature for 15 minutes to 1 hour. The stained gel was 
then washed with Coomassie gel destaining solution several times until bands of the 
purified ShhN proteins were clearly visible on the gel. The Coomassie staining was 
recorded by scanning the gel by Odyssey® infrared imaging system (LI-COR®, 
Lincoln, NE, USA). 
 
Known concentration of bovine serum albumin (BSA) loaded for SDS-PAGE was 
used as a standard for protein quantification. 
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2.2.16. Western blot analysis 
 
Protein gel obtained after SDS-PAGE was situated on 2 pieces of Whatmann filter 
paper and a piece of sponge, which were wetted in advance with IX SDS 
electroblotting buffer. A piece of MeOH activated PVDF transfer membrane 
(Millipore, Schwalbach/Ts., Germany) was placed on top of the gel and covered with 
another 2 pieces of Whatmann filter paper and a piece of sponge. The sandwich was 
fitted in a cassette and chamber was filled with 1X SDS electroblotting buffer with the 
gel facing to the negative electrode and the membrane to the positive electrode. The 
cassette was connected to the power supply and the transfer was run at 100 Volts at 
room temperature for 1 hour. 
 
The membrane after transfer was blocked overnight in Western blot blocking buffer at 
4oC with rocking. The membrane was then incubated with primary antibody solution 
in blocking buffer at room temperature with rocking for 1 hour. Next membranes 
were rinsed 2 times with 1X TBST, each for 5 minutes. The membrane was exposed 
to secondary antibody (dilution 1:5000) solution in blocking buffer in dark at room 
temperature with rocking for 1 hour. The membrane was washed 3 times with 1X 
TBST, each for 5 minutes and analyzed by Odyssey® infrared imaging system 
(LI-COR®, Lincoln, NE, USA). 
 
Western blot with Shh antibody #2287 (dilution 1:1000; Cell Signaling, Danvers, 
MA, USA), Shh (N-19):sc1194 (dilution 1:20; Santa Cruz, Santa Cruz, USA), 
Penta-his (dilution 1:500; Qiagen, Hilden, Germany) and anti-SNAP antibody 
(dilution 1:1000; kindly provided by Prof. Dr. D. Wedlich, KIT, Karlsruhe, Germany) 
antibodies were conducted for the 5E1 immunoprecipitated ShhN. 
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2.2.17. Subcloning of signal sequence containing ShhN into 
pcDNA3.1 vector 
 
DNA fragment of the Shh signal sequence (M1 to A24) and ShhN was cut out from 
the ShhNp construct (Dr. K. Grobe, Westfälische Wilhelms-Universität Münster, 
Germany) at the restriction endonuclease digestion sites of HindIII and SphI. DNA 
fragments encoding GFP, poly(6)histidine, SNAPTM and stop codon were cut out 
from the pENTRTM11 construct at the SphI and NotI sites. The DNA fragments 
obtained from both constructs were then subcloned into the HindIII and NotI sites of 
the pcDNA3.1 vector. 
 
2.2.18. mRNA preparation  
 
mRNA was prepared using the mMessage Machine T7 kit (Ambion, Austin, TX, 
USA) according to the manufacturer’s instruction with pcDNA3.1 empty vector, and 
constructs of ShhNp (kindly provided by Dr. K. Grobe, Westfälische 
Wilhelms-Universität Münster, Germany), ShhN-GFP-His and ShhN-GFP-His-SNAP 
(Table 2.2) as templates. 
 
2.2.19. Maintenance and raising of zebrafish (Danio rerio) 
 
Adult zebrafish were maintained in fish water at 28oC in the fish facility at Karlsruhe 
Institute of Technology (KIT) Campus North. 
 
Embryos were obtained by mating adult zebrafish (AB2O2 strain) in pairs. Laid 
embryos was collected and washed with fish water in a mesh. Next washed embryos 
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were kept in Petri dishes at 28oC in fish water supplemented with 0.01% methylene 
blue to prevent fungal growth. 5-day-old larvae were transferred to fish tanks. Feeding 
was started. 
 
2.2.20. Microinjection of mRNA into zebrafish embryos 
 
Wildtype (AB2O2 strain) adult zebrafish were mated in pairs. Embryos was collected 
and washed with fish water in a mesh right after they were laid. Embryos were 
maintained in fish water at 28oC. 
 
Microinjection of 600ng/l mRNA of the full length zebrafish shh (shh-FL) or 1g/l 
mRNA of eukaryotic expressed ShhN-GFP-His and ShhN-GFP-His-SNAP was 
performed when the embryos were at 1-cell stage with Eppendorf FemtoJet® 
microinjector (Eppendorf, Hauppauge, NY, USA). 
 
2.2.21. In situ hybridization 
 
In situ hybridization (ISH) of the sonic hedgehog (shh) target genes nkx2.2b and 
pax2a was done for the zebrafish embryos at 18-somite stage. 
 
On the day before ISH, zebrafish embryos at 18-somite stage after mRNA 
microinjection were washed with 1X PBS and fixed in 4% BT-fix at 4oC overnight to 
maintain the injected embryos at the desired developmental stage and preserve the 
mRNA for detection by RNA probes. 
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On day 1, the zebrafish embryos were rinsed once with 1X PBT and washed 4 times 
with 1X PBT, each for 5 minutes. The embryos were then incubated in 10g/ml 
Proteinase K in 1X PBT at room temperature for 6 minutes. The Proteinase K was 
removed and replaced by 4% BT-fix. The embryos were incubated at room 
temperature for 20 minutes, washed 5 times with 1X PBT, each for 5 minutes and 
next rinsed once in hybridization buffer (HYB) at room temperature. The embryos 
were then prehybridized in HYB at 70oC for at least 4 hours to homogenize the in vivo 
microenvironment. The embryos were hybridized overnight with the DIG-labeled 
RNA probes of nkx2.2b and pax2a (dilution 1:400) in HYB at 70oC.. Two or three 
embryos were used for overnight preabsorption of the anti-digoxigenin-AP, Fab 
antibody fragments (Roche, Mannheim, Germany) in blocking buffer at 4oC. 
 
On day 2, hybridized embryos were washed twice in solution 50% formamide with 
50% (2X SSC/0.1% Tween-20) at 70oC, each for 30 minutes; next washed once with 
2X SSC/0.1% Tween-20 at 70oC for 15 minutes; and twice in 0.2X SSC/0.1% 
Tween-20 at 70oC, each for 30 minutes. Finally embryos were rinsed with solution 
50% (0.2% SSC/0.1 Tween20) / 50% 1X PBT at 70oC. The embryos were washed in 
ISH blocking buffer at room temperature for 5 minutes and incubated in new blocking 
buffer at room temperature for 3 to 4 hours. Next embryos were incubated overnight 
in the preabsorbed anti-digoxigenin-AP, Fab antibody fragment (dilution 1:4000) 
solution in the blocking buffer at 4oC.. 
 
On day 3, embryos were rinsed twice with 1X PBT at room temperature. They were 
next washed 6 times in 1X PBT at room temperature, each for 15 minutes and twice 
in alkaline phosphatase (ALP) staining buffer at room temperature, each for 5 
minutes. The embryos were transferred to a 24-well plate and stained in 
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5-bromo-4-chloro-3-indolyl phosphate (BCIP) / nitro blue tetrazolium chloride 
(NBT), toluidine salt in 67% dimethyl sulfoxide (DMSO) (v/v) (Roche, Mannheim, 
Germany) in the ALP staining buffer at room temperature until signal revealing the 
target gene expression was observed. The staining reaction was stopped by removing 
the ALP staining buffer. The stained embryos were washed 5 times in 1X PBT at 
room temperature, each for 5 minutes and fixed in 4% BT-fix at room temperature for 
1 hour. Next fixed embryos were rinsed twice with 1X PBT at room temperature and 
washed 4 times in 1X PBT at room temperature, each for 5 minutes. Stained embryos 
were kept overnight in 1X PBT in dark at room temperature in order to dilute the 
background formed by unspecific probe and antibody binding . After that step the 
embryos were ready for microscopic imaging. 
 
For long term storage, the stained embryos were kept in 70% glycerol/1X PBT in 
dark, at room temperature. 
 
2.2.22. Optical microscopy and image acquisition of zebrafish 
embryos 
 
Zebrafish embryos after ISH were visualized under a stereomicroscope (model 
MZ16F, Leica, Solms, Germany) equipped with a CCD digital camera (model 
DFC320). Images revealing gene expression patterns were taken and processed using 
Adobe Photoshop CS3. 
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2.2.23. Cell culture 
 
2.2.23.1. HEK293 cells for eukaryotic expression of ShhN 
 
The HEK293 cell line was derived from human embryonic kidney cells. 
 
It was maintained at 37oC with 5% CO2 in Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen, Darmstadt, Germany) supplemented with 10% fetal bovine 
serum (FBS) (PAA, Linz, Austria). 
  
To express ShhN, the cells were seeded in 6-well tissue culture plate, 2×104 cells/cm2, 
24 hours prior to transfection. 24 hours later the cells were transfected as described in 
section 2.2.25. 
 
2.2.23.2 C3H10T1/2 clone 8 cells for biological activity analysis of ShhN 
by alkaline phosphatase assays 
 
C3H10T1/2 clone 8, a murine pluripotent mesenchymal cell line, was purchased from 
American Type Culture Collection (ATCC) (LGC Standards) (Wesel, Germany). 
Cells were expressing alkaline phosphatase (ALP), a marker of chondrogenic 
differentiation induced by Shh. 
 
The cell line was cultivated at 37oC with 5% CO2 with a density of 2,000 cells/cm2 in 
basal medium Eagle (BME) (Invitrogen, Darmstadt, Germany) supplemented with 
2mM L-glutamine (Invitrogen, Darmstadt, Germany) and 10% heat-inactivated FBS 
(PAA, Linz, Austria). Cells were split after reaching 70% confluency. 
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For biological activity analyses of ShhN, the cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM) (Invitrogen, Darmstadt, Germany) supplemented 
with 0.5% FBS and the soluble ShhN (i.e. non-immobilized form of ShhN) or the Shh 
agonist SAG; or immobilized ShhN or SAG on modified surfaces (details can be 
found in section 2.2.26). Treated cells were incubated at 37oC with 5% CO2 for 5 
days. After 5 days, ALP assay was carried out as described in sections 2.2.27 and 
2.2.28.  
 
2.2.23.3 Shh LIGHT II for biological activity analysis of ShhN by 
Gli-luciferase assay 
 
The Shh LIGHT II cell line was kindly provided by Dr. A. Büttner, University of 
Leipzig, Germany. This cell line is derived from the NIH/3T3 cells stably transfected 
with the Gli responsive firefly luciferase reporter gene (Sasaki et al., 1997). In the 
presence of Shh, the cells responded by producing firely luciferase, a light generating 
enzyme, the activity of which can be measured with a luminometer after addition of 
Shh or the Shh agonist SAG. 
 
For routine maintenance, Dulbecco's modified Eagle's medium (DMEM) (American 
Type Culture Collection (ATCC) (LGC Standards), Wesel, Germany) was used with a 
supplement of 10% FBS, 0.15mg/ml zeocin (Invitrogen, Darmstadt, Germany) and 
0.4mg/ml geneticin (G-418) (Invitrogen, Darmstadt, Germany). 
 
DMEM (ATCC (LGC Standards), Wesel, Germany) supplemented with 0.5% FBS 
was used for treatment of the cells with ShhN expressed in E. coli or the HEK293 
cells. 
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2.2.24. Propagation, freezing and thawing of cells 
 
For propagation of the HEK293, C3H10T1/2 clone 8 and Shh LIGHT II cell lines in 
T-75 cell culture flasks, cells at 80 – 90% confluency were washed twice with 1X 
PBS, trypsinized with 1ml trypsin for 5 minutes at 37oC, resuspended in 10ml 
medium and collected by centrifugation. Cells were resuspended at dilution 1:10 in 
complete medium and cultured at 37oC with 5% CO2. 
 
For freezing, cells were washed twice with 1X PBS, trypsinized and collected by 
centrifugation. Complete medium supplemented with 5% DMSO (Fluka 
(Sigma-Aldrich), Munich, Germany) was used to resuspend the cells. Resuspended 
cells (3×106 cells/ml for HEK293; 1.5×105 cells/ml for C3H10T1/2 clone 8; and 
4×105 cells/ml for Shh LIGHT II) were transferred to cryotubes in the cryogenic 
freezing container and kept at -80oC overnight. Frozen cells were next transferred to 
cryobox in liquid nitrogen container for long term storage. 
 
For thawing, frozen cells were taken out from the liquid nitrogen container and 
thawed quickly in 37oC water bath. The thawed cells were inoculated in fresh medium 
without antibiotics. After 24 hours the medium was replaced with fresh complete 
medium with antibiotics. 
 
2.2.25. Transfection of HEK293 cells 
 
pcDNA3.1 empty vector, and constructs of ShhNp (from Dr. K. Grobe), 
ShhN-GFP-His and ShhN-GFP-His-SNAP (Table 2.2) were transfected into HEK293 
cells with PolyPlus jetPEI transfection reagent in fresh complete medium, which is 
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composed of Dulbecco's modified Eagle's medium (DMEM) and 10% FBS, according 
to the manufacturer’s instruction. 
 
Transfected cells were further cultured at 37oC with 5% CO2 for 48 hours. 
Conditioned medium from each transfection was collected and filtered through 22m 
syringe filters (Carl Roth, Karlsruhe, Germany) to get rid of any cell debris. The 
collected conditioned medium was stored at 4oC and used for ShhN treatment on 
C3H10T1/2 clone 8 or Shh LIGHT II cells, or ShhN immobilization on modified 
surfaces within 24 hours. 
 
2.2.26. Treatment of C3H10T1/2 clone 8 and Shh LIGHT II cells 
 
Different concentrations of the Shh agonist SAG, RCmShhN or bacterially expressed 
ShhN, or different volume ratios of conditioned media of eukaryotic expressed ShhN 
were added to the C3H10T1/2 clone 8 cells or Shh LIGHT II cells with the medium 
conditions described in sections 2.2.23.2 and 2.2.23.3. 
 
The treated C3H10T1/2 clone 8 and Shh LIGHT II cells were maintained at 37oC with 
5% CO2 for 5 days and 48 hours, respectively. Alkaline phosphatase assays were then 
carried out for cellular response analysis in C3H10T1/2 clone 8 cells. Shh LIGHT II 
cells were used for Gli-luciferase assay. 
 
For determining the presence of ShhN in the conditioned media of the HEK293 cells 
transfected with ShhN DNA constructs, the filtered conditioned media were added to 
the C3H10T1/2 clone 8 or Shh LIGHT II cells together with the Shh antibody 5E1, 
which prevents Shh from binding to its receptor Patched (Ptc), at dilution 1:5. The 
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recombinant ShhN signaling domain was fused with green fluorescent protein (GFP). 
Anti-GFP antibody (dilution 1:250; Cell Signaling) was used to test GFP effect on the 
ligand binding to Ptc. 
 
2.2.27. Alkaline phosphatase expression assay and cell counting  
 
After 5 days incubation of C3H10T1/2 clone 8 cells with soluble or immobilized 
ShhN, the cells were fixed with 4% paraformaldehyde (PFA) at room temperature for 
20 minutes, washed 6 times with 1X PBS and detected with the BCIP/NBT substrate 
in dark at room temperature for ALP expression, which acts as a read-out of 
chondrogenic differentiation of the C3H10T1/2 clone 8 cells in response to Shh 
induced signaling. Figure 2.1 illustrates response of the C3H10T1/2 clone 8 cells to 
50nM RCmShhN (Neuromics, Edina, MN, USA), which serves as the positive control 
for ALP expression in response to Shh induced signaling. 
 
 
Figure 2.1. Expression of alkaline phosphatase by C3H10T1/2 clone 8 cells. Cells were treated with 
50nM RCmShhN. Cell staining indicates the cellular response to Shh induced signaling 
and cell differentiation. 
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To analyze the biological activity of soluble ShhN, staining for ALP in the 
C3H10T1/2 clone 8 cells was done. Cells were seeded on a 4- or 8-chambered slide 
(Nunc, Wiesbaden, Germany) with the density of 5×103 cells/cm2 24 hours prior to 
the addition of ShhN to the medium. After protein addition, the cells were cultivated 
for 5 days at 37oC with 5% CO2. Staining for ALP and cell counting for ALP 
expressing cells were done. 
 
For functional analysis of immobilized ShhN, C3H10T1/2 clone 8 cells were cultured 
on the functionalized protein surface for 5 days as described. Staining for ALP and 
cell counting were performed. 
 
For the eukaryotic expressed ShhN, all measurements were normalized by converting 
the quantity of ShhN to volume ratios of the ShhN containing conditioned medium to 
the differentiation medium composed of DMEM and 0.5% FBS. 
 
2.2.28. Alkaline phosphatase colorimetric assay 
 
To quantify the biological activity of soluble ShhN in the C3H10T1/2 clone 8 cells, 
cells were seeded on 24-well tissue culture plates, 5×103 cells/cm2. For the 
functionalized protein surfaces, the area of cultivation was restricted to 1cm2 to 
standardize the cell number and volume of medium. All treatments and 
quantifications of ALP expression were conducted in triplicates. 
 
After 5 days of treatment, the ShhN treated C3H10T1/2 clone 8 cells were washed 
twice with 1X PBS on ice. The assay was conducted with the alkaline phosphatase 
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colorimetric assay kit (Abcam, Cambridge, UK) according to the manufacturer’s 
instruction. 
 
2.2.29. Gli-luciferase reporter assay 
 
Three days before ShhN treatment, the Shh LIGHT II cells were cultivated with the 
density of 5×104 cells/cm2 in a 24-well plate format. Different volume ratios of the 
ShhN conditioned medium to the assay medium, DMEM, 0.5% FBS and 5mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH7.4), were added to 
the wells accordingly. Treated cells were kept at 37oC with 5% CO2 for 48 hours. 
 
On the day of luciferase assay, treated cells were gently washed twice with 1X PBS. 
100l 1X passive lysis buffer (Promega, Mannhem, Germany) was added to the 
cleaned cell layer on ice. Cell lysis progress was monitored regularly for about 1 hour, 
visible individual nuclei observed under stereomicroscope. The cell layer was scraped 
to facilitate further lysis. 20l of the cell lysate was transferred to a white 96-well 
plate. Firefly luciferase activity was measured with Wallac 1420 luminescence 
counter (Perkin Elmer, Waltham, MA, USA) and was normalized to Renilla luciferase 
activity (Ubi-Renilla). 
 
2.2.30. Immunofluorescence of cells 
 
Cells were washed once with cell culture medium without FBS and twice with 1X 
PBS containing Ca2+ and Mg2+ (PBS++). Next cells were fixed in 4% PFA at room 
temperature for 20 minutes. The fixed cells were rinsed 3 times with PBS++ and 
permeabilized with 0.2% Triton X-100 solution in PBS++ at room temperature for 10 
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minutes. Next cells were rinsed 3 times with PBS++ and blocked in 1% BSA in 
PBS++ solution at room temperature for 15 minutes. The blocked cells were rinsed 
twice with PBS++ and incubated in 100l primary antibody in 1% BSA in PBS++ 
solution at room temperature for 1 hour. The cells were rinsed three times with 
PBS++, blocked in 1% BSA in PBS++ at room temperature for 15 minutes and rinsed 
twice with PBS++. 100l of secondary antibody solution carrying a fluorescence label 
(dilution 1:500) in 1% BSA in PBS++ was added to the cells. The cells were 
incubated in dark at room temperature for 1 hour. Next cells were rinsed 3 times with 
PBS++ at room temperature, mounted with 96% glycerol and imaged under 
fluorescence microscope. 
 
Immunofluorscence of transfected HEK293 cells were performed with the Shh 
antibody #2287 as the primary antibody (dilution 1:50) in 1% BSA in PBS++ and 
Alexa Fluor® 488 goat anti-rabbit IgG (dilution 1:500) as the secondary antibody. 
 
2.2.31. Microscopy and imaging of cells 
 
Cells were visualized under an upright compound microscope (model DM5000B, 
Leica, Solms, Germany) equipped with DIC optics and different fluorescence 
channels. Images were taken with the DFC300FX digital camera and processed using 
Adobe Photoshop CS3. 
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2.2.32. UV photopatterning and nickel functionalization of 
polystyrene surfaces 
 
Glass slides were spin-coated applying a solution of 5% polystyrene in toluene at 
3,000rpm. They were then irradiated with UV from a low pressure mercury NNQ 
8/18 lamp (Heraeus Noblelight, Kleinostheim, Germany). This lamp has a 254nm, 
quartz tube, 10W, providing a UV irradiation density of 200µW/cm2 at = 185nm as 
measured with a calibrated UV power meter (traceable to NIST USA) (C8026, 
Hamamatsu Photonics K.K., Japan). It emits mainly the two sharp mercury UV 
spectral lines, nearly no visible light and no infra red, therefore sample heating during 
irradiation is negligible. After 20 minutes of UV irradiation, carboxyl (COOH) groups 
were formed at the polymer surfaces. The polymer surfaces were functionalized to 
provide a nickel chelating moiety. The COOH groups on the polystyrene surface 
obtained by deep UV lithography were activated with an EDC/NHS reactive ester and 
reacted with N2,N2-bis (carboxymethyl)-lysine forming the nickel chelating group. 
Activated surfaces were loaded with Ni2+ ions from an aqueous 40mM NiSO4 
solution. The slides could be kept dry in air until protein coating or incubation directly 
with 50nM ShhN-GFP-His in PBS at 37oC for 24 hours (Figure 2.2). 
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Figure 2.2. Procedure of immobilizing ShhN-GFP-His on UV irradiated and nickel functionalized 
polystyrene surfaces. 
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2.2.33. Immobilization of ShhN on surfaces functionalized via 
dip-pen nanolithography 
 
By functionalizing surfaces with nickel, biotin and benzylguanine modified 
phospholipids with dip-pen nanolithography (DPN), ShhN proteins fused with 
poly(6)histidine, biotin and SNAPTM tags were immobilized. 
 
2.2.33.1 Immobilization of ShhN-GFP-His via nickel(II)/poly(6)histidine 
affinity interaction on nickel chelating lipid functionalized 
surfaces 
 
Glass slides were coated with 1mg/ml poly(L-lysine)-graft-poly(ethylene glycol) 
(PLL-g-PEG) (surface solution) for 30 minutes, washed with Milli Q water and blown 
dry with nitrogen. The polyethylene glycol (PEG) compound possesses biomaterial 
repulsive properties when applied on untreated (hydrophilic) glass surfaces and 
renters protein or cell adhesion, thereby minimizing unspecific binding (Deglau et al., 
2006; Tessmar and Göpferich, 2007). Dioleoylphosphatidylcholine (DOPC) lipids 
were found to be a suitable ink for DPN (Lenhert et al., 2007). It was mixed with 
different molar percentage/ratio (mol%) of nickel chelating lipids and used for DPN 
on the PEG coated glass surfaces. The substrates were then blocked with 0.5% BSA at 
room temperature for 30 minutes, washed twice with PBS and exposed to either 1M 
E. coli expressed ShhN-GFP-His solution or undiluted conditioned medium collected 
from the HEK293 cells transfected with the DNA construct of ShhN-GFP-His. The 
adsorption of protein took place at room temperature for 30 minutes (Figure 2.3). 
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2.2.33.2 Immunofluorescence of ShhN-GFP-His bound onto nickel 
functionalized polyethylene glycol surfaces 
 
After protein binding the functionalized surfaces were blocked in 0.5% BSA in PBS 
at room temperature for 30 minutes. Next substrates were washed twice with PBS at 
room temperature, each for 5 minutes and were incubated in the solution of Shh 
antibody 5E1 (dilution 1:10) in PBS at room temperature for 1 hour. The surfaces 
were washed twice with PBS at room temperature, each for 5 minutes and were 
incubated with the Alexa Fluor® 488 goat anti-mouse IgG antibody solution (dilution 
1:500) in PBS at room temperature for 1 hour. After two washes in PBS at room 
temperature, each for 5 minutes, the surfaces were examined by fluorescence 
microscopy. 
 
2.2.33.3 Immobilization of ShhN-GFP-His-Biotin via biotin/streptavidin 
affinity interaction on biotinylated lipid functionalized glass 
surfaces 
 
Glass slides were coated with 1mg/ml PLL-g-PEG (surface solution) for 30 minutes, 
washed with Milli Q water and dried with nitrogen. DOPC lipids admixed with 0 to 
8mol% of biotinylated lipids were used for DPN on the PEG coated glass surfaces 
The patterned substrates were blocked with 0.5% BSA at room temperature for 30 
minutes, washed twice with PBS and coated with 5g/ml streptavidin at room 
temperature for 30 minutes. Next samples were washed three times and finally 
exposed to 1M ShhN-GFP-His-Biotin solution at room temperature for 30 minutes. 
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Figure 2.3. Scheme of immobilizing biotinylated and poly(6)histidine-tagged Shh protein on  
biotin-streptavidin and nickel functionalized surfaces by DPN (Adapted from Sekula et 
al., 2008) 
 
2.2.33.4 Covalent immobilization of ShhN-GFP-His-SNAP by 
benzylguanine/SNAPTM reaction 
 
DOPC lipids mixed with BG terminated dioleoylphosphatidylethylene (DOPE) lipids 
at the ratio 1:1 were deposited via DPN on polystyrene coated glass surfaces. The 
substrates were blocked with 0.5% BSA at room temperature for 30 minutes, washed 
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three times with PBS and then exposed to 1M ShhN-GFP-His-SNAP protein 
solution at room temperature for 30 minutes. 
 
2.2.33.5 Immunofluorescence of ShhN-GFP-His-SNAP on benzylguanine 
functionalized polystyrene surfaces 
 
For immunodetection of the SNAPTM tag, the anti-SNAP antibody (kindly provided 
by Prof. Dr. D. Wedlich, KIT, Karlsruhe, Germany) was used as the primary 
antibody, dilution of 1:50 and Alexa Fluor® 546 goat anti-rabbit IgG (dilution 1:500) 
as the secondary antibody. To detect the poly(6)histidine tag, a combination of 
Penta-his antibody (dilution 1:50) and Alexa Fluor® 591 goat anti-mouse IgG 
(dilution 1:500) was used. 
 
To start the immunofluorescence staining, the functionalized surfaces were blocked in 
0.5% BSA in PBS at room temperature for 30 minutes, washed twice with PBS at 
room temperature, each for 5 minutes and incubated in the primary antibody solution 
in PBS at room temperature for 1 hour. Next the surfaces were washed twice with 
PBS at room temperature, each for 5 minutes and incubated in the solution of the 
secondary antibody (dilution 1:500) in PBS at room temperature for 1 hour. After 
2-time washes in PBS at room temperature, each for 5 minutes, the surfaces were 
examined with fluorescence microscopy. 
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2.2.34. Functionalization of gold surfaces with benzylguanine thiol 
and immobilization of ShhN-GFP-His-SNAP 
 
BGT and the passivating thiol EG6OH (Figure 2.4), being waxy solids, were 
dissolved in analytical grade ethanol (Sigma, Steinheim, Germany) in 0.1mM 
concentrations. Stock solutions (0.1 and 1mM) were sealed in all-glass vials for 
storage at -80°C up to 6 months. Aliquots were kept up to 3 weeks at -20°C in screw 
cap glass vials. 
 
 
Figure 2.4. Molecular structures of the used disulfides. (A) benzylguanine terminated, active 
disulfide (BGT); (B) passivating disulfide EG6OH. 
 
Silicon wafers having a 20nm chromium adhesion layer and a 200nm gold layer were 
provided by Michael Bruns, IAM-WPT, KIT. For QCM-D measurements standard 
gold coated sensor crystals were used. These sensors were recycled for subsequent 
experiments by boiling used crystals in a mixture of 1:1:5 volumes of hydrogen 
peroxide (30% in water, no Sn stabilizers, EMSURE, Merck, Darmstadt, Germany), 
ammonia (28-30% in water, Merck, Darmstadt, Germany) and distilled water. Prior to 
SAM formation these substrates were subjected to a UV cleaning step, 20 min in an 
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UV/Ozone ProCleaner Plus (BioForce Nanosciences, Inc., Ames, IA, USA). This 
treatment effectively removed airborne contaminations from gold. Immediately after 
this cleaning step the substrates were immersed in solutions mixed from the stock 
solutions of BGT or EG6OH. Afterwards the substrates were rinsed with pure ethanol 
and used for surfaces analysis or protein binding. 
 
Patterning was achieved by photo degradation of a deposited EG6OH SAM. 
Therefore, the samples were covered with a quartz/chromium mask having 
transparent squares of 50m×50µm spaced by 100µm. This sandwich was exposed to 
UV irradiation as described in section 2.2.32. Following irradiation, the sample was 
washed with pure ethanol and water and exposed to the second, BGT containing, 
disulfide solution to fill the exposed areas on the sample surface. Finally, samples 
were rinsed with ethanol. 
 
2.2.35. Immunofluorscence of ShhN-GFP-His-SNAP on 
benzylguanine thiol functionalized surfaces 
 
The functionalized surfaces were washed twice with PBS at room temperature, each 
for 5 minutes and incubated in the Shh antibody 5E1 (dilution 1:10) in PBS at room 
temperature for 1 hour for the detection of the pseudo-active site of ShhN. The 
surfaces were washed twice again with PBS at room temperature, each for 5 minutes 
and were incubated in the solution of the Alexa Fluor® 488 goat anti-mouse IgG 
antibody (dilution 1:2500) in PBS at room temperature for 1 hour. After two washes 
in PBS at room temperature, each for 5 minutes, the surfaces were examined under 
fluorescence microscope. 
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2.2.36. Time-of-flight secondary ion mass spectroscopy (ToF-SIMS) 
for surface analysis of benzylguanine thiol modified gold 
substrate 
 
ToF-SIMS was performed on a TOF.SIMS5 instrument of ION-TOF GmbH, 
Münster, Germany. This instrument is equipped with a Bi cluster liquid metal primary 
ion source and a non-linear time of flight analyzer. Dynamic emittance matching in 
the analyzer allows high mass resolution at large scanning areas. The primary ion 
source was operated in the "bunched" mode to produce ultra short primary Bi1+ or 
Bi3+ ion pulses at 25keV, optimized for spectroscopy. Therfore, the lateral resolution 
is limited to approx 5µm. Pictures with high lateral resolution were taken in “burst 
alignment” mode. This primary ion gun operation mode allows for a precisely 
focussed beam to the disadvantage of limitation to nominal mass resolution. 
Spectrometry was performed in static SIMS mode by limiting the primary ion dose to 
<1011 impingent ions/cm2. No charge compensation was required. Spectra were 
calibrated on the omnipresent C-, C2-, C3- C3H-, C4H- peaks. Deviations from the 
theoretical mass were usually < 10ppm.  
 
2.2.37. Adsorption of ShhN-His and ShhN-GFP-His on collagen 
and fibronectin functionalized glass surfaces 
 
Glass slides were sterilized with 70% ethanol or isopropanol, rinsed with MilliQ H2O, 
and either air dried or blown dry with nitrogen. The surfaces were then exposed to 25 
to 240g/ml collagen or fibronectin solution at room temperature for 1 hour. The 
protein binding substrates were washed twice with H2O. Next, solutions of the Shh 
agonist SAG, E. coli expressed ShhN-His or ShhN-GFP-His; or the conditioned 
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medium collected from ShhN-GFP-His transfected HEK293 cells was applied on the 
surfaces at room temperature for 1 hour. The protein coated surfaces were finally 
rinsed twice with PBS. 
 
2.2.38. Immunofluorscence of ShhN-His and ShhN-GFP-His on 
collagen and fibronectin functionalized surfaces 
 
For immunodetection of the pseudo-active site of ShhN, the Shh antibody 5E1 1was 
used as the primary antibody with the dilution of 1:10 and Alexa Fluor® 488 or 591 
goat anti-mouse IgG (dilution 1:2500) as the secondary antibody. For ShhN in 
general, Shh (N-19):sc1194 (dilution 1: 20) and Alexa Fluor® 546 donkey anti-goat 
IgG (1:2500) were used. In the case of detection of the poly(6)histidine tag, a 
combination of Penta-his antibody (dilution 1:100) and Alexa Fluor® 488 or 546 goat 
anti-mouse IgG (dilution 1:2500) was used. 
 
The functionalized surfaces were washed twice with PBS at room temperature, each 
for 5 minutes and were incubated in solutions of the primary antibodies mentioned 
above in PBS at room temperature for 1 hour. The surfaces were washed twice again 
with PBS at room temperature, each for 5 minutes and were incubated in the solutions 
of the fluorescence labelled secondary antibodies mentioned (dilution 1:2500) in PBS 
at room temperature for 1 hour. After 2-time washes in PBS at room temperature, 
each for 5 minutes, the surfaces were examined with fluorescence microscopy. 
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2.2.39. Blocking of collagen functionalized surfaces by 
microcontact printing of bovine serum albumin 
 
Glass surfaces were coated with collagen as described in section 2.2.37. BSA was 
applied on patterned polydimethylsiloxane (PDMS) stamps at a concentration of 
1mg/ml at room temperature for 15 minutes. The stamp was blown dry with nitrogen 
stream and was then pressed onto the collagen coated surfaces. The stamp was in 
contact with the surface for 1 minute and was removed carefully. This procedure is 
depicted schematically in Figure 2.5. 
 
Figure 2.5. Diagram illustrating microcontact printing of BSA on collagen coated surface. 1mg/ml 
BSA was applied on a patterned PDMS stamp. The setup was kept at room temperature 
for 15 minutes. The stamp was blown dry with nitrogen stream and was then inverted and 
pressed onto the collagen coated surfaces. The stamp was allowed to stand on the surface 
for 1 minute and was removed carefully. 
BSA in H2O 
BSA
BSA
Collagen coated surface 
BSA
H2O 
  
Materials and Methods
84
Next, the BSA stamped collagen or fibronectin modified surfaces were exposed to 
solutions of E. coli expressed ShhN-GFP-His with different concentrations for at 
room temperature for 2 hours. The surfaces were then ready for microscopy and 
FRAP experiments. 
 
2.2.40. Quartz micro gravimetry for quantification of 
ShhN-GFP-His and ShhN-GFP-His-SNAP on collagen and 
benzylguanine thiol functionalized surfaces 
 
A quartz crystal microbalance with dissipation monitoring (QCM-D) (Q-Sense AB, 
Västra Frölunda, Sweden) was employed to determine the amount of ShhN-GFP-His 
or ShhN-GFP-His-SNAP adsorbed on the collagen or BGT functionalized surfaces 
prepared as described in section 2.2.34. 
 
The applied instrument uses the ac output of the damped oscillation of an AT-cut 
quartz crystal at 15, 25 and 35MHz to extract the resonance frequencies and energy 
dissipations. Measurements were performed with an ‘axial flow chamber’ having a 
very small exchange volume of the measurement chamber (0.05ml), a central inflow 
towards the crystal surface, and an internal temperature controlled loop of 
approximately 0.5ml volume. The presented data was measured in a stopped flow 
mode. The temperature in the measurement chamber was kept at 250.02°C. The 
sample was equilibrated in phosphate buffer (CertiPUR buffer solution di-sodium 
hydrogen phosphate / potassium hydrogen phosphate, pH6.88, Merck, Darmstadt, 
Germany). In the case of the BGT adsorption of ShhN-GFP-His-SNAP, an additional 
step of flushing of a BSA solution (1mg/ml in afore mentioned buffer; Albumin 
fraction V, Merck, Darmstadt, Germany) into the measurement chamber was 
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performed. After the signals had stabilized after 30min, the chamber was flushed with 
buffer and the solution of ShhN-GFP-His or ShhN-GFP-His-SNAP (5µM in buffer) 
was injected. Finally, after another hour the chamber was rinsed with buffer. Readings 
of both adsorption steps were taken in the buffer steps to avoid effects of reversibly 
bound proteins. 
 
Data handling was performed with the manufacturers’ software allowing modeling the 
protein adsorbate as a viscoelastic solid with a frequency dependent complex shear 
modulus according to the Voight model. Here, it was sufficient to rely on the straight 
forward model of Sauerbrey to quantify the protein adsorption. The density, , of all 
protein adsorbates was fixed to 1.15106g/m3 corresponding to a densely packed low 
hydrated protein film. Film thickness values, d, scale nearly linear with 1/. Results 
are presented as average  standard deviation. 
 
2.2.41. Enzyme linked immunosorbent assay (ELISA) for quantity 
measurement of ShhN-GFP-His adsorbed on collagen 
coated surfaces 
 
After each QCM-D experiment, the crystals coated with collagen and ShhN-GFP-His 
were subjected to an ELISA assay, an alternative approach for protein quantification 
and cross-checking with the measurement made by QCM-D. 
 
An ELISA response curve with different concentrations of RCmShhN (Neuromics, 
Edina, MN, USA) was established by coating the protein onto a 96-well ELISA 
microplate at room temperature for 1 hour. The plate was washed 5 times with PBS 
and blocked with 0.5%BSA in PBS at room temperature for 1 hour. The RCmShhN 
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was detected by 10g/ml Shh (N-19) antibody (Santa Cruz, Santa Cruz, USA). After 
one hour incubation at room temperature, the plate was washed three times with PBS. 
The anti-goat IgG peroxidase conjugate (Sigma-Aldrich, Munich, Germany) for 
coupling Shh (N-19) was added at a dilution of 1:40,000 at room temperature for 30 
minutes. The plate was washed 7 times with PBS with 30-second intervals. Substrate 
solution reacting with the peroxidase conjugate was prepared by mixing 11ml 
phosphate-citrate buffer, pH 5.0, 2l 30% H2O2 and a TMB tablet (Roche, Mannheim, 
Germany). 100l of the prepared substrate solution was added to each well of the 
microplate. The reaction was allowed to take place at room temperature for 30 
minutes in dark and stopped with 50l 2M H2SO4. The plate was then read by an 
ELISA microplate reader at 450nm. An ELISA response curve was plotted. 
 
The corresponding procedure was applied to the QCM-D crystals coated with 
ShhN-GFP-His for the quantification of this protein by ELISA. 
 
2.2.42. Fluorescence recovery after photobleaching (FRAP) for 
determination of the protein adsorption efficiency of 
collagen and fibronectin 
 
Glass surfaces were exposed to collagen or fibronectin solutions with concentrations 
of 25 to 240g/ml, and 500nM ShhN-GFP-His protein solution was bound as 
described in section 2.2.37. After washing twice with H2O, the surfaces were analyzed 
by FRAP with the Leica SP2 confocal miscroscopic system. The surfaces were 
photobleached at 488nm with 800Hz for 3 seconds. The fluorescence recovery was 
measured every 1 second after bleaching. Graphs illustrating the fluorescence 
intensity recovery of the photobleached area against time were plotted. 
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3. Results 
 
3.1. Introduction 
 
Recombinant mouse ShhN (denoted as RCmShhN in the rest of the text; ShhN – the 
signaling domain of the Sonic hedgehog protein (amino acid residues C25 to G198), 
RC – the recombinant, m – mouse source of the ShhN sequence) was purchased from 
Neuromics (Edina, MN, USA). Unlike the wildtype ShhNp, which is derived from 
full length mouse Shh and possesses post-translational modifications – palmitoylation 
at the N-terminus and lipidation with cholesterol at the C-terminus, the commercially 
available RCmShhN is produced in an E. coli expression system and does not undergo 
post-translational processing. RCmShhN is therefore incapable of forming multimeric 
complex like ShhNp and remains monomeric (Chen et al., 2004). Despite the absence 
of these modifications, RCmShhN is biologically active. Palmitate and cholesterol is 
not necessary for the biological activity of ShhN in in vitro system. The modifications 
are responsible for the secretion and diffusion of ShhNp in in vivo environments 
(Heussler and Suri, 2003; Peters et al., 2004; Varjosalo and Taipale, 2008). 
 
To engineer substrates with immobilized ShhN, two major research and development 
issues arose. The first issue was the production of biologically active ShhN in 
sufficient quantity with reference to the information obtained from RCmShhN cloning 
and expression. However, since RCmShhN lacks functional groups for the attachment 
and detection of ShhN on surfaces, relevant linker groups and fluorescence molecules 
were fused to the proteins. The second issue was then the development of efficient 
strategies to attach ShhN on surfaces in a spatially controlled manner.  
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Parameters for these two critical issues were investigated in parallel, however the 
results show firstly the protein production step and secondly the surface 
immobilization approaches. 
 
3.2. Part 1 – Production of biologically active ShhN proteins 
 
3.2.1. Production and purification of E. coli expressed mouse 
ShhN proteins 
 
Bacterial expression systems are commonly utilized for mass production of functional 
proteins, since growth of bacteria on a large scale does not require sophisticated 
equipment, is economic and can be repeated routinely with stable performance. 
Moreover, protocols for bacterial culture and purification of biologically active ShhN 
from bacteria are well established with a wide variety of developed extraction 
methods from bacterial lysates (Williams et al., 1999). Although it is clear that in 
bacteria the Shh protein will not undergo post-translational modifications (cholesterol 
lipidation and palmytoylation) as it happens in mammalian cells, there is evidence 
that the recombinant ShhN expressed in bacteria is also highly active (Williams et al., 
1999). 
 
The design of the commercially available mouse RCmShhN was closely imitated 
(Table 3.1). This protein also served as a positive control. However, as mentioned 
before, this protein does not possess any functional groups to attach or detect ShhN on 
surfaces. The cloning of a number of variants that contained additional sequences was 
therefore embarked on. ShhN-His contained the same sequence as RCmShhN with the 
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exception of an additional methionine at the N-terminus (Table 3.1). This protein was 
intended as a control of my purification procedure. In addition, constructs of different 
ShhN variants for E. coli expression were designed. 
 
Table.3.1 illustrates the peptide information of ShhNp and RCmShhN as reference. 
Details of the ShhN variants, with included additional tags sequences used for 
purification, immobilization and visualization of the proteins are shown. ShhN-His 
was designed based on the sequence of RCmShhN protein with modifications 
including: addition of the ATG codon, which encodes methionine, at the N-terminus 
for initiation of translation; addition of the poly(6)histidine tag at the C-terminus for 
purification on Ni-NTA agarose (Qiagen, Hilden, Germany) and immobilization of 
the protein on nickel functionalized surfaces; and addition of the stop codon for 
termination of translation. For visualization of immobilized ShhN-His on surfaces 
green fluorescence protein (GFP) was fused at the C-terminus and ShhN-GFP-His 
was produced. Another variant of ShhN, ShhN-GFP-His-SNAP possessed the 
SNAPTM tag included at the C-terminus of the peptide. The SNAPTM tag is derived 
from the human alkylguanine transferase and can covalently bind to benzylguanine 
(BG). ShhN-GFP-His-SNAP can therefore be immobilized on nickel functionalized 
surfaces as well as on BG modified surfaces. 
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Schemetic drawing (not to scale)
19.314ShhNp
67.710ShhN-GFP-His-SNAP
19.980RCmShhN
46.953ShhN-GFP-His
20.202ShhN-His
Size 
(kDa)
Name of protein
GFPM 6xhis SNAP Stop
M 6xhis Stop
6xhis
C25 G198
GFPM 6xhis StopC25 G198
C25 G198
C25 G198
HN-C25 G198
G26 – R34
Removed by autoprocessing in eukaryotic expression system
C25 G198M1 A24 C199 S437 Stop
Palmitate
CholesterolShhN
Signal
sequence Autoprocessing domain
Shh-FL
 
Table 3.1. Schematic drawings showing the amino acid sequences of the ShhN variants expressed in 
E. coli. ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP were designed based on the 
peptide sequence of RCmShhN (Neuromics, Edina, MN, USA). ShhNp is shown as a 
reference for the biologically active ShhN. The ShhN is encoded from the amino acid 
residues C25 to G198. The ATG start codon (methionine; M) and stop codon (Stop) were 
included in the two termini of the peptide for initiation and termination of translation. The 
poly(6)histidine tag was added for purification with Ni-NTA columns and immobilization 
of ShhN-GFP-His on nickel functionalized surfaces. The SNAPTM tag was added for 
covalent binding of ShhN-GFP-His-SNAP onto benzylguanine (BG) modified surfaces. 
GFP was fused to the protein sequence for detection and visualization of the expressed 
ShhN. Owing to the absence of the signal sequence (amino acids M1 to A24) and the 
autoprocessing domain (C199 to S437), and that the production was conducted in 
bacterial expression system, ShhN, ShhN-GFP-His and ShhN-GFP-His-SNAP do not 
undergo post-translational modifications. The number after the amino acid symbol 
corresponds to the position of the amino acid in Shh-FL. 
 
The ShhN sequence in different ShhN variants was obtained from the pBlueScript 
KSII:mouse Shh plasmid (gift from Dr. A. McMahon, Harvard University, MA, USA). 
The start and stop codons, and the poly(6)histidine tag were cloned by the polymerase 
chain reaction (PCR). The sequence of the poly(6)histidine tag was provided by 
Neuromics. For ShhN-GFP-His, the ShhN fragment was subcloned into the 
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pCS2:GFP plasmid in fusion with the GFP protein. The pSS26m vector (Covalys, 
Witterswil, Switzerland) was employed to fuse the SNAPTM tag at the C-terminus of 
ShhN-GFP-His-SNAP. All of the ShhN variants were subcloned into the pENTRTM11 
vector (Invitrogen, Darmstadt, Germany), resulting in entry clones for the Gateway 
cloning system, which were sent to Qiagen Sequencing Services (Hilden , Germany). 
Correct ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP fragments were then 
cloned to the pDESTTM14 vector (Invitrogen) for plasmid propagation and protein 
expression in E. coli. 
 
The ShhN variants in the pDESTTM14 vector were then expressed in the E. coli strain 
BL-21 with IPTG as the inducing agent of expression. The expressed proteins were 
extracted by lysing the bacteria and were purified with Ni-NTA agarose. During the 
Ni-NTA chromatographic purification, green fluorescence was visualized from the 
ShhN-GFP-His and ShhN-GFP-His-SNAP proteins. 
 
3.2.2. Molecular analysis of the E. coli expressed ShhN proteins 
 
After purification from the bacterial lysates, the amount and purity of the isolated 
ShhN proteins were analyzed. The ShhN proteins were resolved by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The quantity was assessed 
by running in parallel bovine serum albumin (BSA) standards of known 
concentrations. Comparison of the band intensities allowed to quantify the purified 
ShhN proteins. 
 
Figure 3.1 illustrates an example of protein quantification using a BSA standard of 
known concentrations and the purified ShhN proteins loaded into the same 
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SDS-PAGE gel. The run gel was Coomassie stained, and images of the stained bands 
were captured. The intensity of the BSA and ShhN bands were measured using the 
software provided by the manufacturer. A standard curve of the BSA intensity against 
the known BSA concentration was plotted, and was used to estimate the amount of 
ShhN proteins purified from E. coli. 
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Figure 3.1. Quantification of E. coli expressed ShhN proteins. (A) ShhN-GFP-His-SNAP was loaded 
on the SDS-PAGE gel together with the BSA standard solutions with known 
concentrations. Lanes 1: ShhN-GFP-His-SNAP; 2: protein marker; 3 – 6: 1, 2, 3 and 4g 
BSA. (B) A standard curve was plotted with the intensity obtained from the BSA standard 
solutions. The intensity of the ShhN-GFP-His-SNAP band was measured, and the protein 
amount was determined from the BSA standard curve. 
 
Next, Western blot was carried out to probe the Shh N-terminal signaling domain of 
the isolated proteins. For enrichment of the ShhN proteins before WB, 
immunoprecipitation step was done with the monoclonal antibody 5E1 (Maun et al., 
2010a). This antibody competes with the Shh receptor Patched (Ptc) and blocks Shh 
activity by occupying the pseudo-active site involving the five histidine residues at 
positions 133, 134, 140, 180 and 182 of biologically active Shh (Bosanac et al., 2009). 
5E1 antibody was bound to protein A sepharose and Shh proteins were 
immunoprecipitated, subjected to SDS-PAGE and immunoblotted. 
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Figure 3.2 shows the Western blot results of the E. coli expressed ShhN proteins using 
the Shh (N-19):sc1194 antibody after 5E1 immunoprecipitation. Markers for protein 
size reference are illustrated in the lane on the left. The untransformed BL21 lysate 
and supernatant purified from the GFP-His transformed E. coli acted as the negative 
controls for Shh (N-19):sc1194 detection, while the 19kDa RCmShhN served as 
positive control. Bands, indicated by arrows, with the sizes of about 20, 47 and 68 
kDa are observed for the purified supernatants from the E. coli transformed with the 
ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP constructs, respectively, 
indicating the presence of the proteins with the expected sizes. Successful 5E1 
immunoprecipitation of the ShhN proteins demonstrates that the pseudo-active site, 
where Shh binds to its receptor Ptc, is available. 
 
 
Figure 3.2. The Shh N-terminal signaling domain is present in the E. coli expressed proteins. Proteins 
were resolved on SDS-PAGE gel and blotted. Membranes were incubated with Shh 
(N-19):sc1194 antibody. Bands, indicated by arrows, visualized on the membranes 
illustrated the presence of ShhN purified from the lysates of E. coli transformed with the 
DNA expression constructs of the ShhN variants. 
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3.2.3. Analysis of the biological activity of the E. coli expressed 
ShhN proteins 
 
Supernatants from E. coli cultures of ShhN-GFP-His and ShhN-GFP-His-SNAP 
showed green fluorescence indicating the correct folding of the GFP peptide fused to 
the ShhN proteins. Next step was to test if the ShhN proteins are biological active. 
Assays for the detection of alkaline phosphatase (ALP) expression of the Shh 
responsive cells were employed. 
 
3.2.3.1. Detection of Shh signaling induced alkaline phosphatase 
expression in C3H10T1/2 clone 8 cells and cell counting assay 
 
C3H10T1/2 clone 8 cells are mouse mesenchymal cells capable of expressing ALP as 
a marker of differentiation induced by Shh signaling (Kinto et al., 1997). To confirm 
that the ShhN variants induced specific ALP expression, the Sonic hedgehog agonist 
SAG (Axxora, Lörrach, Germany) and the E. coli expressed RCmShhN (Neuromics, 
Edina, MN, USA) were used as the positive controls together with the purified ShhN 
proteins. GFP-His served as the negative control of Shh signaling. 
 
Different concentrations of SAG, RCmShhN, GFP-His or the E. coli expressed ShhN 
variants were applied to the C3H10T1/2 clone 8 cells, which were pre-cultured in 
8-well chamber slides for 24 hours. After addition of proteins, the cells were 
cultivated for 5 days at 37oC with 5% CO2. Next the cells were fixed and stained for 
ALP expression with BCIP/NBT substrates in the ALP staining buffer. Draq5 was 
used to stain the nuclei for cell number counting. Alternatively, the treated cells were 
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lysed and analyzed with the alkaline phosphatase colorimetric assay kit (Abcam, 
Cambridge, UK). 
 
Images of ALP expression detection in the C3H10T1/2 clone 8 cells are illustrated in 
figure 3.3. In the negative controls with no Shh proteins or with 100nM GFP-His, no 
ALP expression was detected. On the other hand, ALP expression indicated by the 
bluely stained cells, was detected in cells treated with 100nM SAG or RCmShhN. 
These observations suggested that the C3H10T1/2 clone 8 cells differentiate and 
express ALP in response to the presence of Shh signaling. In the case of treatment 
with 100nM of the E. coli expressed ShhN-His, ShhN-GFP-His and 
ShhN-GFP-His-SNAP variants, ALP expression was detected in a small number of 
C3H10T1/2 clone 8 cells. Quantification of ALP expressing cells are shown in graph 
3.1. 
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Figure 3.3. Staining for ALP expressed in C3H10T1/2 clone 8 cells treated with E. coli expressed 
ShhN variants. C3H10T1/2 clone 8 cells were treated for 5-day with 100nM of E. coli 
expressed ShhN variants: ShhN-His, ShhN-GFP-His or ShhN-GFP-His-SNAP, and with 
GFP-His, SAG, RCmShhN as controls. In the no-Shh (A) and GFP-His (B) negative 
controls, no ALP expression was detected. SAG (C) and RCmShhN (D) served as 
positive controls for Shh signaling and ALP expression. Treatment of C3H10T1/2 clone 8 
cells with ShhN-His (E), ShhN-GFP-His (F) or ShhN-GFP-His-SNAP (G) resulted in 
ALP expression only in a small population of the cells. Quantification of ALP expressing 
cells is shown in graph 3.1. 
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A concentration dependent ALP expression was triggered in C3H10T1/2 clone 8 cells 
after treatment of cells with SAG and the E. coli expressed ShhN variants (Graph 3.1). 
A concentration series of 0 to 500nM of proteins was tested. SAG and RCmShhN 
were the positive controls for Shh signaling and ALP expression, while GFP-His 
served as the negative control. 
 
With the increasing concentration of the SAG and RCmShhN, from 0 to 300nM, an 
increased percentage of the ALP expressing cells was observed. The highest 
percentages of ALP expressing cells were noticed for SAG (36%) and RCmShhN 
(32%) at the concentration of 300nM. Application of higher concentration of SAG 
and RCmShhN led to a decrease of the number of ALP expressing cells. 
 
GFP-His induced unspecific ALP expression in a small population of the C3H10T1/2 
clone 8 cells. 9% of the cells expressed ALP in the culture medium containing 500nM 
GFP-His. ShhN treated C3H10T1/2 clone 8 cells responded similarly as the GFP-His 
treated cells. 10% of the cells expressed ALP when 400 to 500nM of ShhN-His, 
ShhN-GFP-His or ShhN-GFP-His-SNAP was applied onto the cells. These findings 
suggested that the E. coli expressed ShhN protein variants could not trigger specific 
ALP expression in the C3H10T1/2 clone 8 cells thus were biologically inactive. 
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Graph 3.1. Biological activity of E.coli expressed ShhN variants recorded by BCIP/NBT staining for 
the expressed ALP in C3H10T1/2 clone 8 cells and cell counting. C3H10T1/2 clone 8 
cells were specifically responsive to the positive controls Sonic hedgehog agonist SAG 
and RCmShhN. The percentage of ALP expressing cells increased with an increasing 
concentration of SAG and RCmShhN and reached the saturation point of 36% with 
300nM SAG and 32% with 300nM RCmShhN. GFP-His induced unspecific ALP 
expression. The percentages of ALP expressing cells treated with ShhN-His, 
ShhN-GFP-His and ShhN-GFP-His-SNAP remained low and were comparable to that of 
the GFP-His treated ones. 
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3.2.3.2. Quantification of Shh signaling induced alkaline phosphatase 
expression in C3H10T1/2 clone 8 cells by cell lysate based 
colorimetric assay 
 
The ALP expressing cell counting assay provided qualitative information on cellular 
responses to Shh signaling. Nevertheless, it could be subjective in quantifying and 
comparing the cellular responses. Individual cells were not stained to the same 
intensity and normalization of the staining is challenging. The colorimetric assay, 
based on cell lysate analysis, for the quantification of ALP expression can compensate 
for the bias. 
 
As revealed from the ALP colorimetric assay, ALP expression in C3H10T1/2 clone 8 
cells was triggered by the positive controls SAG and RCmShhN in a concentration 
dependent manner (Graph 3.2). Cells treated with 100nM SAG showed the highest 
level of ALP expression: optical density measured at = 405nm (OD405) of about 
1.5. An OD405 of 1.2 was measured when 100nM RCmShhN was used Owing to the 
limited supply of RCmShhN, higher concentrations of RCmShhN were not tested in 
this assay. 
 
GFP-His served as the negative control and the OD405 value remained at 0.1 in all 
concentrations applied. Cells treated with the E. coli expressed ShhN-His, 
ShhN-GFP-His and ShhN-GFP-His-SNAP showed even lower values of OD405, 
implying that Shh variants were incapable of inducing ALP expression in C3H10T1/2 
clone 8 cells and were biologically inactive. 
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Graph 3.2. Biological activities of E. coli expressed ShhN variants measured by ALP colorimetric 
assay. The positive controls SAG and RCmShhN induced concentration dependent ALP 
expression in the C3H10t1/2 clone 8 cells. An OD405 of 1.5 was noted when 100nM 
SAG was added to the cells. 100nM RCmShhN also induced a substantial level of ALP 
expression (OD405 of 1.2). Concentrations higher than 100nM were not investigated for 
RCmShhN due to source limitation of RCmShhN. The negative control GFP-His gave a 
low OD405 value of around 0.1 for all concentrations tested. ShhN-His, ShhN-GFP-His 
and ShhN-GFP-His-SNAP did not show any OD405 value higher than that of GFP-His 
for all applied concentrations, indicating that the E. coli expressed ShhN proteins did not 
induce ALP expression at all in the C3H10T1/2 clone 8 cells. 
 
Table 3.2 summarizes the peptide sequences and biological activities of ShhNp, 
RCmShhN and the different E. coli expressed ShhN variants. Despite the availability 
of the Ptc binding site detected by 5E1 immunoprecipitation, the E. coli expressed 
ShhN proteins were biologically inactive. The constructs encoding ShhN were 
sequenced again and the differences between RCmShhN and ShhN were compared. 
The DNA and the inferred peptide sequences of ShhN (C25 to G198) were identical 
to the corresponding amino acid sequence of Shh. The poly(6)histidine tag at the 
N-terminus of ShhN did not affect the biological activity of RCmShhN, suggesting 
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that fusions at the C-terminus, including the poly(6)histidine, GFP, SNAPTM tag and 
the stop codon, should not interfere with the biological activity of E. coli expressed 
ShhN. The only concern remains the addition of a methionine residue, the ATG codon 
encoding which is required for the start of translation, at the N-terminus of ShhN. 
This N-terminal methionine forms disulfide bonds by oxidation and hydrolysis 
(Lemke, 2003). It changes the electric properties and destabilizes the native state of 
the recombinant protein through a conformational entropy effect, thereby altering the 
biological and physicochemical properties of the protein (Chaudhuri et al., 1999). 
 
Schemetic drawing (not to scale)
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Table 3.2. Comparison of the peptide sequences and the biological activities of the E. coli expressed 
ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP variants analyzed by the ALP 
assays. The peptide sequence of ShhN (C25 to G198) was identical to that of RCmShhN. 
The major difference of the E. coli expressed ShhN variants and the biologically active 
RCmShhN was the methionine residue at the N-terminus of the ShhN. The ATG codon, 
which encodes methionine, is responsible for the initiation of translation but yet the 
methionine produced can adversely affect the biological activity of the E. coli expressed 
proteins. 
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3.2.3.3. Enhancement of the biological activity of E. coli expressed ShhN 
proteins 
 
The ATG codon encoding methionine was required to start translation and therefore 
could not be omitted for protein expression. In order to produce biologically active 
ShhN in bacterial expression system, the protocol for extraction and purification of 
ShhN from E. coli was modified with regard to the unique properties of ShhN. 
Modifications included addition of 0.5mM DTT to eliminate ShhN dimerization; and 
substitution of Zn2+ ions in the ShhN pseudo-acitve site to stabilize the Ptc binding 
groove. 
 
During ShhN expression, a dimeric form of ShhN is formed spontaneously by the 
formation of disulfide bonds (Hochman et al., 2006; Kellner et al., 2002). The ShhN 
dimer is ten times less active than the monomeric form (Kellner et al., 2002). By 
applying proteins on the SDS-PAGE gel one is not able to distinguish the monomeric 
and dimeric ShhN, since the disulfide bonds are broken by 50mM dithiothreitol 
(DTT), a reducing agent in the Lämmli sample buffer and by heat denaturation prior 
to gel loading. 
 
To get rid of dimeric ShhN, 0.5mM DTT was included in all buffers used for 
extraction and Ni-NTA chromatography. This DTT concentration was low enough to 
reduce ShhN without interfering with the nickel(II)/poly(6)histidine interaction. 
Purified ShhN was eluted and stored under reducing condition in DTT containing 
PBS to ensure that the ShhN proteins were in monomeric form in all cell treatment 
experiments. 
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In biologically active Shh the pseudo-active site is comprised of five histidine 
residues at positions 133, 134, 140, 180 and 182 of the peptide (Bosanac et al., 2009). 
It is those positions where Shh/Ptc binding takes place (Bosanac et al., 2009; Maun et 
al., 2010a, b) and also coordination of the Zn2+ ion in the groove comprised of His141, 
Asp148 and His183 of Shh (Maun et al., 2010a) occurs. In the presence of Zn2+, the 
affinity of Shh to Ptc receptor increases 10 to 20 folds (Maun et al., 2010b). 
 
To stabilize the Shh/Ptc binding pseudo-active site and improve the receptor affinity 
of the E. coli expressed ShhN, purified ShhN was dialyzed against 100M ZnCl2 for 
Zn2+ coordination to the Zn2+ containing groove of ShhN. However, dialysis resulted 
in enormous loss and contamination of the protein. Alternatively, 100M ZnCl2 was 
added to the bacterial cell lysis buffer and ShhN is expected to coordinate the Zn2+ 
ions from the ZnCl2 solution. The anti-Shh monoclonal antibody 5E1, which 
competes with Ptc for the Shh pseudo-active site, was used to immunoprecipitate the 
ShhN variants. The results of the Western blots after 5E1 immunoprecipitation 
suggested that the ShhN variants bind to Ptc. The Western blot images are shown in 
figures 3.4 to 3.6. 
 
3.2.3.4. Stability analysis of the E. coli expressed ShhN proteins 
 
Shh is capable of binding to heparin sulfate proteoglycan (HSPG) for effective 
transportation in vivo (Saha and Schaffer, 2005; Varjosalo and Taipale, 2007). The 
ability of Shh to recognize and interact with HSPG or heparin depends on the 
Cardin-Weintraub sequence at the amino acid residues Lys33 to Lys39 (Cardin and 
Weintraub, 1989). ShhN protein variants sequence starts at Cys25 and the 
Cardin-Weintraub sequence is located close to its N-terminus. Since E. coli proteases 
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could unspecifically cleave the N-terminus of a protein during protein expression, it is 
plausible that ShhN may be truncated at the N-terminus or Cardin-Weintraub 
sequence and became biologically inactive. 
 
To test if the peptide sequence of bacterially expressed ShhN was complete, Shh 
antibody #2287 (Cell Signaling, Danvers, MA, USA) was used to detect the 
Cardin-Weintraub sequence at the N-terminus (Figure 3.4). Penta-his (Qiagen, 
Hilden, Germany) and anti-SNAP (D. Wedlich, KIT, Germany) antibodies were 
employed to detect the corresponding tags at the C-terminus of ShhN (Figures 3.5, 
3.6). Immunoprecipitation with 5E1 was done to enrich the ShhN protein variants 
before Western blot, and to detect the pseudo-active site. 
 
 
Figure 3.4. The N-terminal Cardin-Weintraub sequence of the E. coli expressed ShhN variants was 
available. The E. coli expressed ShhN variants were immunoprecipitated by 5E1 and 
probed with Shh antibody #2287 (indicated by arrows). The untransformed BL21 lysate 
and GFP-His served as the negative controls, illustrating that 5E1 and Shh antibody 
#2287 detections were ShhN specific. 
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Figure 3.5. The E. coli expressed ShhN variants contained the histidine tag. The poly(6)histidine tag 
at the N-terminus of the purified ShhN variants were detected by the Penta-his antibody 
after 5E1 immunoprecipitation. Detected bands are indicated by arrows. The 
untransformed BL21 lysate served as the negative control ; while GFP-His was the 
positive control, illustrating that 5E1 immunoprecipitation and Penta-his detection were 
histidine specific. The multiple bands observed for ShhN-GFP-His and 
ShhN-GFP-His-SNAP may be due to unspecific antibody detection. 
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Figure 3.6. The SNAPTM tag is present in the E. coli expressed ShhN-GFP-His-SNAP protein. The 
purified ShhN-GFP-His-SNAP was 5E1 immunoprecipitated and probed with the 
anti-SNAP anitbody. The probed band corresponding to ShhN-GFP-His-SNAP is shown 
by an arrow. The BL21 lysate served as the negative control. The multiple bands 
observed may be due to unspecific antibody detection. 
 
Probing the membranes with the Shh antibody #2287 showed the presence of the 
N-terminal Cardin-Weintraub sequence in the E. coli expressed ShhN variants (Figure 
3.4). The bands visualized on the membranes incubated with the Penta-his antibody 
demonstrated that the C-terminal poly(6)histidine tag was fused with the ShhN 
variants (Figure 3.5). And the anti-SNAP antibody was able to detect the C-terminally 
fused SNAPTM tag ShhN-GFP-His-SNAP (Figure 3.6). All of these observations 
implied that the peptide sequences of the E. coli expressed ShhN variants detected by 
the antibodies with expected sizes (as indicated by the arrows) were complete. 
 
The multiple bands in the samples after probing with Penta-his and anti-SNAP 
antibodies may be a result of unspecific antibody detection. Histidine rich proteins 
from the E. coli genome may be isolated from the Ni-NTA column purification along 
with the ShhN variants. Since the ATG codons of the GFP and SNAP were not 
  
Results
107
removed from the expression plasmids, translation starting at the GFP or SNAP may 
give rise to the production of Shh free peptides and contribute to the multiple band 
detection with the Penta-his and anti-SNAP antibodies. Nevertheless, these 
"contaminants" were not detected by the Shh specific antibodies. There was one and 
specific band detected for both ShhN-GFP-His and ShhN-GFP-His-SNAP with the 
Shh (N-19):sc1194 antibody (Figure 3.2) and the Shh antibody #2287 (Figure 3.4) but 
not in the case when Penta-his or anti-SNAP antibody was applied. Detection of the 
multiple bands may also be a result of degraded peptide residues. Degradations were 
not detected by the anti-Shh antibodies because they may occur at the Shh 
(N-19):sc1194 recognition site or at the Cardin-Weintraub sequence, where 
degradation can interrupt the binding of the Shh (N-19):sc1194 antibody and Shh 
antibody #2287 to these target sites. 
 
In spite of the presence of contaminants and degradations, substantial amounts of the 
E. coli expressed ShhN variants with expected sizes were obtained as detected by the 
anti-Shh antibodies (Figures 3.2, 3.4). Experiments of ShhN immobilization, which 
are described in later sections, also showed that ShhN-GFP-His and 
ShhN-GFP-His-SNAP were immobilized on nickel and BG functionalized surfaces, 
respectively. 
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3.2.3.5. Analysis of the biological activity of the E. coli expressed ShhN 
proteins with selective truncation 
 
Regardless of the DTT and Zn2+ supplementation of protein extracts, the E. coli 
expressed ShhN variants still showed no biological activity as tested in the ALP 
assays (data not shown). 
 
According to Chaudhuri et al. (1999), the methionine at the N-terminus blocks the 
biological activity of bacterially expressed proteins. Therefore it is plausible that the 
biological activities of the E. coli expressed ShhN variants were inhibited by 
methionine (M24). However, since methionine is important for the initiation of 
translation, it has to be retained at the N-terminus of the peptide sequence. Recently it 
was found by the collaborator K. Grobe (Westfälische Wilhelms-Universität Münster, 
Germany) that removal of the amino acid residues G26 to A34 rescued the biological 
activity of the eukaryotic expressed mutant ShhN-C25S. In ShhN-C25S, cysteine 
(C25), which is the first amino acid at the N-terminus, is replaced by serine. This 
C25S replacement perturbs the biological activity of the mutated Shh. For the G26 – 
A34 removal helps ShhN-C25S regain its biological activity, it is plausible that in the 
E. coli system, biologically active ShhN proteins can be expressed with C25 
substituted with methionine (i.e. C25M), provided that the amino acids G26 to A34 is 
removed. 
 
In light of the findings by K. Grobe, the variant of ShhN-His with the mutation 
C25M_del26-34, was produced in the E. coli expression system. C25 was replaced by 
methionine instead of serine for the start of translation. The amino acid residues G26 
to A34 were removed. Since the C-terminal tags did not interfere with the biological 
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activity of ShhN (as demonstrated by ShhN6his, the autoprocessing domain of which 
is replaced by a Myc tag and a poly(6)histidine tag (Dierker et al., 2009a); sequence 
detail in table 2.2), the poly(6)histidine tag was retained for purification by Ni-NTA 
chromatography. Schematic description illustrating the Shh variants with mutations is 
presented in table 3.3.  ShhN-His-C25M_del26-34 was expected to have properties 
similar to the eukaryotic expressed variant ShhN-C25S_del26-34, which is 
biologically active. 
 
 
 
 
 
  
Results
110
19.092ShhN-His-C25M_del26-34
45.843ShhN-GFP-His-C25M_del26-34
Schemetic drawing (not to scale)
19.425ShhN-C25S
18.426ShhN-C25S_del26-34
19.314ShhNp
19.314C25S
67.710ShhN-GFP-His-SNAP
19.980RCmShhN
66.600
ShhN-GFP-His-
SNAP-
C25M_del26-34
46.953ShhN-GFP-His
20.202ShhN-His
Size 
(kDa)
Name of protein
GFPM 6xhis SNAP Stop
M 6xhis Stop
6xhis
C25 G198
GFPM 6xhis StopC25 G198
C25 G198
C25 G198
HN-C25 G198
S25 G198
S25 G198
S25 G198
M25 G198 6xhis Stop
M1 A24
M1 A24
M1 A24
G26 – R34
Signal sequence, removed by autoprocessing in eukaryotic expression system
C25 G198M1 A24 C199 S437 Stop
Stop
Stop
Palmitate
CholesterolShhN
C199 S437 Stop
Signal
sequence Autoprocessing domain
Shh-FL
M25 G198
M25 G198
GFP 6xhis Stop
GFP 6xhis SNAP Stop
 
Table 3.3. Scheme of peptide sequences of the mutated variants of the E. coli expressed ShhN 
proteins: ShhN-His-C25M_del26-34, ShhN-GFP-His-C25M_del26-34 and 
ShhN-GFP-His-SNAP-C25M_del26-34. Peptide sequences of the mutants were designed 
with reference to modifications made in the eukaryotic expressed Shh-C25S_del26-34. 
C25 was replaced by methionine for the start of translation. G26 to R34 were removed. 
GFP fusion, poly(6)histidine and SNAP tags were remained at the C-termini of ShhN. 
 
After extraction and purification form E. coli, ShhN-His-C25M_del26-34, 
ShhN-GFP-His-C25M_del26-34 and ShhN-GFP-His-SNAP-C25M_del26-34 were 
subjected to 5E1 immunoprecipitation and Western blot analysis in order to test for 
the presence of the Ptc binding pseudo-active site, the N-terminal Cardin-Weintraub 
sequence, and the C-terminal poly(6)histidine and SNAPTM tags. 
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The mutated ShhN variants were first immunoprecipiatated by 5E1 and detected by 
Shh (N-19):sc1194 antibody. The bands visualized from the probed membrane 
illustrated the presence of the Shh signaling domain (Figure 3.7). Detection of 
Cardin-Weintraub sequence by Shh antibody #2287 and poly(6)histidine by Penta-his 
antibody indicated that the ShhN were produced with complete peptide sequences 
(Figure 3.7). The multi bands noticed for ShhN-GFP-His-C25M_del26-34 and 
ShhN-GFP-His-SNAP-C25M_del26-34 with Penta-his antibodies may be because of 
unspecific antibody detection. 
 
 
Figure 3.7. The E. coli expressed ShhN-His-C25M_del26-34, ShhN-GFP-His-C25M_del26-34 and 
ShhN-GFP-His-SNAP-C25M_del26-34 possessed the Shh signaling domain (A), the 
N-terminal Cardin-Weintraub sequence (B) and the C-terminal histidine tag (C). The 
purified proteins were immunoprecipitated with 5E1 and probed with Shh (N-19):sc1194 
antibody, ShhN antibody #2287 and Penta-his antibody for the detections of the Shh 
signaling domain, Cardin-Weintraub sequence, and histidine, respectively. Probed bands 
were indicated by arrows. GFP-His served as the negative controls for the Shh 
(N-19):sc1194 antibody and Shh antibody #2287, and as the positive control for the 
Penta-his antibody. 
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Shh has diverse functions in embryo development. Induction of alkaline phosphatase 
expression is only one of the many parameters that can be used to verify the 
biological activity of Shh. Therefore, the activity of the newly expressed ShhN 
mutants, as well as the other ShhN variants, was tested with a chondrocyte 
differentiation system instead of the ALP assays. The chondrocyte differentiation 
assay is a very sensitive system for investigating the biological activity of Shh by 
detecting the expression of the chondrogenic marker Collagen X (ColX), which is 
responsive to Shh signaling (Dreier et al., 2008). This assay however was conducted 
by the collaborator K. Grobe, where the facilities and experienced man power for 
culturing and analysis of the chondrocyte progenitor cells were available. All the E. 
coli expressed ShhN variants were produced in house and then sent to K. Grobe for 
analysis after purification. 
 
To do the chondrocyte differentiation assay, the chondrocyte progenitor cells were 
cultivated in serum free medium. Next the E. coli expressed ShhN-GFP-His, 
ShhN-GFP-His-C25M_del26-34, ShhN-GFP-His-SNAP and 
ShhN-GFP-His-SNAP-C25M_del26-34 were added to the cells in two concentrations: 
2.848g (5l) and 28.48g (50l). Then the cells were allowed to undergo 
differentiation for 2 weeks, after which they were lysed and the cell lysates were 
resolved by SDS-PAGE. Western blot was then performed with the radioactively 
labeled anti-ColX antibody with an exposure time of 2 to 3 weeks until signals were 
detected. 
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Figure 3.8 shows a Western blot image illustrating the expression of ColX in the 
chondrogenic progenitor cells after the cells were treated with the E. coli expressed 
ShhN-GFP-His, ShhN-GFP-His-C25M_del26-34, ShhN-GFP-His-SNAP and 
ShhN-GFP-His-SNAP-C25M_del26-34. 
 
When a lower dose (2.848g (5l)) of ShhN-GFP-His, 
ShhN-GFP-His-C25M_del26-34, ShhN-GFP-His-SNAP and 
ShhN-GFP-His-SNAP-C25M_del26-34 was applied, only weak induction of ColX 
expression in the chondrocyte progenitor cells was detected. When the dosage of the 
ShhN proteins was increased by 10 times to 28.48g (50l), the expression of ColX 
became clearly detectable. Taken together, these results suggested that the E. coli 
expressed ShhN proteins, whether with or without C25S mutation and the removal of 
the amino acid residues G26 to A34, were biologically active. They stimulated the 
Shh induced expression of the chondrogenic marker ColX and triggered 
differentiation of the chondrocyte progenitor cells. 
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Figure 3.8. E. coli expressed ShhN variants stimulated expression of the chondrocyte differentiation 
marker ColX. The four ShhN variants: ShhN-GFP-His, ShhN-GFP-His-C25M_del26-34, 
ShhN-GFP-His-SNAP and ShhN-GFP-His-SNAP-C25M_del26-34 were applied to the 
chondrocyte progenitor cells with the doses of 2.848g/5l or 28.48g/50l. The cells 
were allowed to differentiate for 2 weeks. SDS-PAGE was performed for the cell lysates. 
The expression of ColX was immunodetected by the radioactively labeled anti-ColX 
antibody. The bands visualized on the blot demonstrate ColX expression. All of the tested 
proteins were noticed to induce ColX expression, implying that they are biologically 
active in chondrocyte differentiation assay. Weak expression of ColX was observed when 
2.848g/5l of the proteins was used for cell treatment (left 4 lanes). A 10-time higher 
dosage (28.48g/50l) resulted in higher expression level of ColX (right 4 lanes). 
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Unlike RCmShhN, the biological activity of the E. coli expressed ShhN variants: 
ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP, was not detected by the ALP 
assays, which are based on the differentiation of pluripotent mesenchymal cells. 
However, it was visualized in the chondrocyte differentiation assay, no matter if there 
are C25S mutation and deletion of the amino acids G26 to A34. These findings 
demonstrated that ShhN-His, ShhN-GFP-His and ShhN-GFP-His-SNAP are 
biologically active but the intensity of activity from the tested dosages is not high 
enough to induce differentiation of the mesenchymal cells. On the contrary, they were 
capable of stimulating differentiation of the chondrocytic progenitor cells when used 
in high dosages (i.e. 2.848g/5l and 28.48g/50l). 
 
Table 3.4 summaries the biological activity of all the E. coli expressed ShhN variants. 
The black + or – indicate if the proteins were tested biologically active in the ALP 
assays. The red + shows the positive biological activity of the protein in the 
chondrocyte differentiation assay. 
 
 
 
  
Results
116
+45.843ShhN-GFP-His-C25M_del26-34
Schemetic drawing (not to scale)
-19.425ShhN-C25S
+18.426ShhN-C25S_del26-34
+19.314ShhNp
-19.314C25S
+67.710ShhN-GFP-His-SNAP
+19.980RCmShhN
+66.600
ShhN-GFP-His-
SNAP-
C25M_del26-34
+46.953ShhN-GFP-His
+20.202ShhN-His
Biological 
activity
Size 
(kDa)
Name of protein
GFPM 6xhis SNAP Stop
M 6xhis Stop
6xhis
C25 G198
GFPM 6xhis StopC25 G198
C25 G198
C25 G198
HN-C25 G198
S25 G198
S25 G198
S25 G198
M1 A24
M1 A24
M1 A24
G26 – R34
Signal sequence, removed by autoprocessing in eukaryotic expression system
C25 G198M1 A24 C199 S437 Stop
Stop
Stop
Palmitate
CholesterolShhN
C199 S437 Stop
Signal
sequence Autoprocessing domain
Shh-FL
M25 G198
M25 G198
GFP 6xhis Stop
GFP 6xhis SNAP Stop
 
Table 3.4. Summary of the biological activity of the E. coli expressed ShhN variants in ALP assays 
(black + or –) and chondrocyte differentiation assay (red +). Removal of the amino acid 
residues G26 to R34 rescued the biological activity of eukaryotic expressed ShhN-C25S. 
In the case of bacterially expressed ShhN, the tested ShhN-GFP-His, 
ShhN-GFP-His-C25M_del26-34, ShhN-GFP-His-SNAP and 
ShhN-GFP-His-SNAP-C25M_del26-34 were all found to be biologically active in the 
chondrocyte differentiation assay, regardless of the presence or absence of the G26-R34 
residues. 
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3.2.4. Usage of the E. coli expressed ShhN proteins in 
functionalized surface development for protein 
immobilization 
 
The E. coli expressed ShhN proteins were detected biologically active with the 
chondrocyte differentiation assay. Nevertheless, it takes altogether 4 to 5 weeks for 
the activity verification of the proteins. On the other hand, the ALP assays take a 
comparatively shorter time for ALP detection. But it was incapable to detect the 
biological activity of the E. coli expressed ShhN variants used in the current project. 
In light of the time consumption of the protein activity detection assay, the E. coli 
expressed ShhN variants were not used for biological analysis on functionalized 
surfaces. 
 
However, because of the capability of E. coli to produce enormous amount of proteins 
in a routine basis, the bacterial expression system was still employed in the project in 
order to provide a feasible amount of ShhN variants for protein immobilization on 
functionalized surfaces, and surface-protein binding analysis. The green fluorescence 
visualized from the GFP fusion proteins ShhN-GFP-His and ShN-GFP-His-SNAP 
offered a hand for surface analysis after protein immobilization. 
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3.2.5. Production of ShhN-GFP-His and ShhN-GFP-His-SNAP in 
a eukaryotic expression system using HEK293 cells 
 
In parallel to the efforts made to produce biologically active ShhN in E. coli, a 
eukaryotic expression system was set up. 
 
Bacterially expressed ShhN do not have the post-translational modifications such as 
lipidation by the addition of cholesterol at the C-terminus and palmitoylation at the N- 
terminus. On the other hand, the ShhNp expressed in the eukaryotic Bosc23 cells is 
lipidated by cholesterol and membrane-tethered with the added palmitate, and is also 
processed by metalloprotease-mediated ectodomain shedding at the N-terminus prior 
to being released from the expressing cells (Dierker et al., 2009a). Bosc23 expressed 
ShhNp is thus considered to be biologically active (Dierker et al., 2009a). 
 
In order to produce biologically active ShhN-GFP-His and ShhN-GFP-His-SNAP, the 
HEK293 cell line, which is derived from human embryonic kidney cells and is a 
derivative of the Bosc23 cell line, was employed. 
 
Constructs of ShhN-GFP-His and ShhN-GFP-His-SNAP for protein expression in 
HEK293 cells were cloned. Consistent with the constructs for E. coli expression, the 
expression plasmids possessed the DNA fragment encoding the amino acids of the 
Shh signaling domain (C25 to G198) (i.e. ShhN). They are fused with the DNA 
encoding GFP for detection and visualization, the poly(6)histidine tag for purification 
via Ni-NTA columns and immobilization on nickel functionalized surfaces, and the 
SNAPTM tag for immobilization on BG functionalized surfaces. To ensure protein 
secretion from the expressing cells, the signaling sequence was integrated at the 
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N-terminus of ShhN (amino acids M1 to A24). This signaling sequence was 
automatically cleaved off after translation and right before the post-translational 
modifications (refer to figure 1.4 for details). The autoprocessing domain (amino 
acids C19 to S437) was not included in the ShhN-GFP-His and ShhN-GFP-His-SNAP 
constructs, since the absence of cholesterol modification at the C-terminus of ShhN 
does not adversely influence the cellular response to ShhN, as indicated by the 
biological activity of ShhN6his (Dierker et al., 2009a). Detailed information on the 
DNA plasmid constructs is shown in table 3.5. The pcDNA3.1 vector was used as the 
backbone of all constructs. 
 
The ShhNp and ShhN6his constructs were kindly provided by K. Grobe (Westfälische 
Wilhelms-Universität Münster, Germany). The biological activity of the proteins 
expressed by Bosc23 cells was confirmed by ALP induction in C3H10T1/2 cells 
(Dierker et al., 2009a). ShhNp and ShhN6his therefore served as the positive controls 
for expression in the HEK293 cells. 
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Schemetic drawing (not to scale)
70.020ShhN-GFP-His-SNAP
19.314ShhNp
49.284ShhN-GFP-His
19.980RCmShhN
28ShhN
6his from
K. Grobe
19.314ShhNp from K.Grobe
Size 
(kDa)
Name of protein
6x His
C25 G198
C25 G198
HN-C25 G198
Removed by autoprocessing
C25 G198
6xhis
GFP 6xhis SNAP Stop
GFP 6xhis StopC25 G198
C25 G198
M1 A24
M1 A24
M1 A24
M1 A24 C199 S437 Stop
C25 G198M1 A24 C199 S437 Stop
G26 – R34
Stop
Palmitate
Cholesterol
Myc
ShhN
Signal
sequence Autoprocessing domain
Shh-FL
 
Table 3.5. Schematic drawing of the amino acid sequences of the ShhN variants expressed in the 
eukaryotic HEK293 cells. The N-terminal signal sequence of ShhN was composed of 
amino acid residues M1 to A24 required for secretion of ShhN from the expressing cells. 
The poly(6)histidine tag was added for purification with Ni-NTA columns or 
immobilization of ShhN-GFP-His on nickel functionalized surfaces. The SNAPTM tag 
was used for covalent binding of ShhN-GFP-His-SNAP to BGT for immobilization on 
gold surfaces. GFP was used for visualization of the expressed ShhN. 
 
Transfection of the ShhN plasmids was performed in 6-well tissue culture plates. 24 
hours prior to transfection, HEK293 cells were seeded with the density of 2104 
cells/cm2. 2ml of the culture medium (DMEM supplemented with 10% FBS) was 
added in each well.  Cells were cultivated at 37oC with 5% CO2. On the day of 
transfection, the culture medium was replaced with 2ml of the fresh DMEM medium, 
supplemented with 10% FBS. Transfection of the cells was conducted with PolyPlus 
jetPEI transfection reagent (Polyplus-transfection, New York, NY, USA) according to 
the manufacturer’s instruction. Transfected HEK293 cells were cultured at 37oC with 
5% CO2 for the following 48 hours in order to achieve protein expression. 
Conditioned medium from the transfected cells was collected and filtered through 
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22m syringe filters (Carl Roth, Karlsruhe, Germany) to remove cell debris. The 
collected conditioned medium was stored at 4oC and used within 24 hours. 
 
Since the ShhN-GFP-His and ShhN-GFP-His-SNAP were fused with GFP, their 
expression in the HEK293 cells was visualized under the green fluorescence channel 
with the upright compound fluorescence microscope (model DM5000B, Leica, Solms, 
Germany). Figure 3.9 shows the images taken 48 hours post transfection. Tissue 
culture surface filled with culture medium (DMEM and 10% FBS) alone does not 
show a fluorescence signal. No GFP signal was detected from the untransfected 
HEK293 cells and HEK293 cells transfected with the empty vector pcDNA3.1, which 
is the backbone of the ShhN-GFP-His and ShhN-GFP-His-SNAP constructs. The 
green fluorescence observed therefore indicates the expression of ShhN-GFP-His and 
ShhN-GFP-His-SNAP in HEK293 cells (Figure 3.9). 
 
 
Figure 3.9. Expression of ShhN-GFP-His and ShhN-GFP-His-SNAP in HEK293 cells. The HEK293 
cells were transiently transfected with the constructs of ShhN-GFP-His and 
ShhN-GFP-His-SNAP. Images were taken 48 hours post transfection. The green 
fluorescence indicates expression of ShhN-GFP-His and ShhN-GFP-His-SNAP in the 
transfected HEK293 cells (D’, E’). Tissue culture surface with culture medium (DMEM 
and 10% FBS) alone does not show a fluorescence signal and was used as the negative 
control. (A’). Untransfected HEK293 cells and HEK293 cells transfected with the empty 
vector pcDNA3.1 were used as the negative control., respectively (B’, C’).  
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3.2.6. Analysis of the biological activity of ShhN-GFP-His and 
ShhN-GFP-His-SNAP expressed in the HEK293 cells 
 
In contrast to the E. coli expression system, expression of the ShhN variants in the 
HEK293 cells resulted in barely detectable amounts of the proteins. None of the 
expressed proteins from the HEK293 cells was detected in Western blot using the Shh 
(N-19):sc1194 antibody (Santa Cruz, Santa Cruz, USA) and the Shh antibody #2287 
(Cell signaling, Danvers, MA, USA). The biological activity of the HEK293 
expressed ShhN variants were therefore directly examined by ALP staining, 
colorimetric assays, and Gli-luciferase reporter assay. 
 
For the ALP assays, the conditioned medium of individual ShhN variants collected 
from the transfected HEK293 cells was applied onto the mouse mesenchymal 
C3H10T1/2 clone 8 cells, which are capable of expressing ALP as a marker of cell 
differentiation in response to Shh signaling. The cells were cultivated in the 
conditioned medium at 37oC with 5% CO2 for 5 days. Next, the cells were either fixed 
and stained for ALP expression with the BCIP/NBT substrates in the ALP staining 
buffer or lysed and analyzed with the alkaline phosphatase colorimetric assay kit 
(Abcam, Cambridge, UK) according to the manufacturer’s instruction. 
 
In the case of the Gli-luciferase reporter assay, the conditioned medium of individual 
ShhN variants collected from the transfected HEK293 cells was applied to the Shh 
LIGHT II cells, stably transfected with the Gli responsive firefly luciferase reporter 
(Sasaki et al., 1997). Those cells respond to the Shh signaling via production of the 
firefly luciferase enzyme. Shh LIGHT II cells were treated for 48 hours in standard 
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cell culture conditions. Luciferase assay was then conducted by lysing the cells and 
measuring the firefly luciferase activity normalized to Ubi-Renilla luciferase activity. 
 
Since the amount of the ShhN variants expressed in HEK293 cells could not be 
determined via Western blot, dosage dependent response analyses were done by 
applying the conditioned media containing the expressed proteins in ratios. For 
instance, a conditioned medium to fresh medium ratio of 1:1 implies that 500l of the 
protein containing conditioned medium was mixed with 500l of the fresh medium. 
The final volume is therefore 1ml. The fresh medium is composed of DMEM and 
0.5% FBS for the C3H10T1/2 clone 8 cells, and DMEM supplemented with 0.5% 
FBS and 5mM HEPES, pH 7.4 for the Shh LIGHT II cells.. 
 
3.2.6.1. Functional specificity of the ShhN-GFP-His and 
ShhN-GFP-His-SNAP expressed in HEK293 cells 
 
BCIP/NBT staining for the ALP expressed from the C3H101/2 clone 8 cells treated 
with the conditioned media collected from the HEK293 cells transfected with 
ShhN-GFP-His and ShhN-GFP-His-SNAP showed that the HEK293 expressed ShhN 
proteins were biologically active (Figure 3.10). When the same ratio of conditioned 
medium to fresh medium (1:1) of the ShhN variants and the positive control ShhNp 
was applied, the two ShhN variants: ShhN-GFP-His and ShhN-GFP-His-SNAP 
demonstrated a comparable intensity of ALP expression to ShhNp. The Shh agonist 
SAG is another positive control showing Shh signaling specific induction of ALP 
expression in C3H10T1/2 clone 8 cells. The untreated C3H10T1/2 clone 8 cells and 
the cells treated with conditioned medium of untransfected HEK293 cells were the 
negative controls for transfection; while those treated with conditioned medium from 
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HEK293 transfection of the empty vector of pcDNA3.1 (mock transfection) were the 
negative control of ShhN expression. 
  
 
Figure 3.10. Biological activity of the HEK293 expressed ShhN variants revealed from staining for 
ALP expression in C3H10T1/2 clone 8 cells. 500l of the conditioned medium was 
collected from the HEK293 cells of different transfections and mixed with 500l of fresh 
medium (i.e. DMEM and 0.5% FBS). The mixed medium (with the conditioned medium 
to fresh medium ratio of 1:1) was added to the C3H10T1/2 clone 8 cells for a 5-day 
treatment. The C3H10T1/2 clone 8 cells treated with the conditioned media of HEK293 
cells transfected with ShhN-GFP-His and ShhN-GFP-His-SNAP plasmids showed ALP 
expression (F, G). In the untreated C3H10T1/2 clone 8 cells (A), and the negative 
controls with the conditioned media from untransfected HEK293 cells (B) and mock 
transfection (empty vector of pcDNA3.1) (C), no ALP expression was detected. 100nM 
SAG (D) and the conditioned medium from HEK293 cells transfected with the construct 
of ShhNp (E) served as the positive control for Shh signaling and ALP expression. Nuclei 
were stained with Draq 5 (A’ to G’). 
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The high-affinity, neutralizing anti-Shh monoclonal antibody 5E1 can disrupt Shh 
activity by competing with the Shh receptor Ptc for the pseudo-active site of Shh 
(Bosanac et al., 2009; Maun et al., 2010a, b). As the HEK293 cell expressed 
ShhN-GFP-His and ShhN-GFP-His-SNAP could not be detected by Western blot, 
blockage of the Shh activity by 5E1 is an alternative approach to determine the 
functional specificity of these ShhN variants. The 5E1 antibody was used to block 
Shh signaling in the C3H10T1/2 clone 8 and Shh LIGHT II cells treated with the 
conditioned media from the HEK293 cells transfected with the constructs of 
ShhN-GFP-His and ShhN-GFP-His-SNAP. The effects of 5E1 antibody treatment on 
the biological activity of the proteins were examined by ALP colorimetric and 
Gli-luciferase reporter assays. 
 
For the ALP colorimetric assay, 500l of the conditioned medium collected from the 
HEK293 cells transfected with the constructs of ShhN-GFP-His or 
ShhN-GFP-His-SNAP, and 500l of fresh medium (i.e. DMEM with 0.5% FBS) were 
added to the C3H10T1/2 clone 8 cells. The 5E1 antibody with the dilution of 1:5 
(Gulacsi and Lillien, 2003) was then applied onto the cells. The cells were incubated 
at 37oC with 5% CO2 for 5 days. Next cells were lysed and ALP expression was 
detected as the optical density at the wavelength of 405nm (OD405). 
 
For the Gli-luciferase assay, Shh LIGHT II cells were treated the same way with the 
conditioned medium as for ALP assay but were incubated for 48 hours prior to the 
measurement of luciferase activity. 
 
Graphs 3.3 and 3.4 summarize the results of Shh signaling blockage by the 5E1 
antibody in the ALP colorimetric and Gli-luciferase reporter assays. 
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Graph 3.3. Inhibition of the biological activity of the HEK293 expressed ShhN variants by 5E1 
blocking of the Ptc binding pseudo-active site analyzed by ALP colorimetric assay. ALP 
expression induced by the treatment with ShhNp, ShhN-GFP-His and 
ShhN-GFP-His-SNAP in C3H10T1/2 cells was reduced after treatment with the anti-Shh 
antibody 5E1. The ShhNp conditioned medium was the positive control of Shh signaling 
and ALP expression. 100nM SAG was both a positive control of Shh signaling and ALP 
expression, and a negative control of 5E1 blocking. 
 
The blockage of ALP expression by 5E1 was specific only in the cells treated with the 
conditioned media of ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP (Graph 3.3).  
This result indicated that the ALP expression detected in the C3H10T1/2 clone 8 cells 
was specifically induced by and only due to the presence of the ShhN variants in the 
conditioned media of the transfected HEK293 cells. 
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Graph 3.4. Specificity of the HEK293 expressed ShhN variants on Gli activity induction shown by 
5E1 inhibition of the biological activity of the HEK293 expressed ShhN variants. The 
Gli-luciferase activity induced by the ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP 
variants was reduced in in Shh LIGHT II cells treated with 5E1 antibody. The untreated 
Shh LIGHT II cells, the cells treated with the conditioned media of the untransfected 
HEK293 cells and the empty vector mock transfection served as negative controls of Shh 
signaling and luciferase activity. The ShhNp conditioned medium was the positive control 
of Shh signaling and luciferase activity. 100nM SAG was both a positive control of Shh 
signaling and luciferase activity, and a negative control of 5E1 blocking. 
 
Similar to the ALP expression in the C3H10T1/2 clone 8 cells, the Gli-luciferase 
activity in ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP treated Shh LIGHT II 
cells was blocked by the 5E1 antibody. It illustrated that the activation of Gli 
transcription was specific to the HEK293 expressed ShhN variants. 
 
Efficient blockage of Shh signal transduction by 5E1 (Graphs 3.3, 3.4) showed that 
the activities recorded in both ALP colorimetric and Gli-luciferase assays resulted 
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from ShhN-GFP-His or ShhN-GFP-His-SNAP activity and not from metabolites or 
contaminants from the expressing cells or culture medium. The ALP colorimetric 
assay and the Gli-luciferase reporter assay showed comparable results of the 
biological activity of ShhN variants and its blockage by the 5E1 antibody. 
 
3.2.6.2. Dosage dependent analysis of the biological activity of ShhN 
variants expressed in HEK293 cells by the alkaline phosphatase 
expression detection and cell counting assay 
 
After confirming the biological activity and specificity of the HEK293 cell expressed 
ShhN-GFP-His and ShhN-GFP-His-SNAP, the dosage effect of the proteins on 
cellular responses was determined by applying different ratios of the ShhN-GFP-His 
and ShhN-GFP-His-SNAP containing conditioned media onto the Shh responsive cell. 
ALP expression detection and colorimetric assays, and Gli-luciferase reporter assay 
were employed again for dosage dependent analysis of the ShhN variants. 
 
Different volume ratios of the ShhN-GFP-His or ShhN-GFP-His-SNAP conditioned 
medium were mixed with the fresh medium (i.e. DMEM supplemented with 0.5% 
FBS). The C3H10T1/2 clone 8 cells were then treated with the mixed medium and 
incubated for 5 days at 37oC with 5% CO2. Next, cells were fixed and stained for ALP 
expression with the BCIP/NBT substrate. The number of cells expressing ALP was 
counted. 
 
Graph 3.5 shows the dose response curves of the C3H10T1/2 clone 8 cells to the 
HEK293 expressed ShhN variants. Treatment with the conditioned medium from the 
untransfected HEK293 cells or from the HEK293 cells transfected with the empty 
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vector of pcDNA3.1 (mock transfection) did not induce ALP expression. The 
percentage of the ALP expressing C3H10T1/2 clone 8 cells increased with the 
increasing volume ratios of the applied conditioned media with ShhNp, 
ShhN-GFP-His and ShhN-GFP-His-SNAP variants. 70 to 80% of the C3H10T1/2 
clone 8 cells were expressing ALP when the ShhNp, ShhN-GFP-His or 
ShhN-GFP-His-SNAP conditioned medium was applied at the volume ratio of 1:1.5 
to 1:1. This result shows that the induction of ALP expression was specific to Shh 
induced signaling. 
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Graph 3.5. Dose dependent biological activity of the HEK293 expressing ShhN variants analyzed by 
BCIP/NBT detection of ALP expression in C3H10T1/2 clone 8 cells. The percentages of 
ALP expressing C3H10T1/2 clone 8 cells after  5-day treatment with the conditioned 
media of untransfected HEK293 cells, mock transfection (empty vector of pDNA3.1) and 
HEK293 cells transfected with the constructs of ShhNp, ShhN-GFP-His and 
ShhN-GFP-His-SNAP are shown. 
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The percentage of the ALP expressing cells increased in a dosage dependent manner 
with the volume ratios of the conditioned media applied (Graph 3.5). While SAG and 
RCmShhN gave rise to a maximal percentage of ALP expressing cells (about 32 to 
36%) with the concentration of 300nM and showed a declination of biological activity 
in higher concentrations (Graph 3.1), the ShhN variants expressed in HEK293 cells 
showed a steady increase in ALP expression up to 80% with an increase in the 
conditioned medium ratio.  
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3.2.6.3. Dosage dependent analysis of the biological activity of Shh 
variants expressed in HEK293 cells by alkaline phosphatase 
colorimetric assay 
 
ALP colorimetric assay was employed to test the dose dependent biological activity of 
the ShhN-GFP-His and ShhN-GFP-His-SNAP variants. 
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Graph 3.6. Dose dependent induction of ALP expression in C3H10T1/2 clone 8 cells by the HEK293 
expressed ShhN variants measured by ALP colorimetric assay. Different volume ratios of 
the conditioned media collected from the HEK293 cells transfected with the constructs of 
ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP were added to the C3H10T1/2 clone 8 
cells and incubated for 5 days. The optical density revealing the ALP activity was 
measured at the wavelength of 405nm (OD405). 
 
The highest ALP activity was noticed at the ShhN variant containing conditioned 
medium to fresh medium ratio of 1:1 (Graph 3.6). However, although there was a 
general increase in ALP expression in the C3H10T1/2 clone 8 cells with an increasing 
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dosage of the Shh variants, it was observed that ShhN fused with different tags gave 
rise to different intensities of cellular response. This is quite different from what was 
observed in the ALP expression detection and cell counting assay (Graph 3.5), in 
which all ShhN variants showed comparable intensity of cellular responses. In the 
ALP colorimetric assay (Graph 3.6), ShhNp, which is 19kDa and does not possess 
any tags, shows a dosage dependent response curve with a shallow slope. 
ShhN-GFP-His and ShhN-GFP-His-SNAP are 49 and 70kD, respectively and show 
steeper dosage dependent response curves. These variations in cellular responses 
detected may be due to the different detection limits of the two assays. The 
BCIP/NBT staining of ALP expression is based on the substrate interaction with the 
intracellular ALP. The color intensity as well as the number of cells stained are 
dependent on the reaction between the BCIP/NBT substrate and alkaline phosphatase 
enzyme in the cells. On the other hand, the ALP colorimetric assay relies on cell lysis 
and the release of the expressed ALP for the detection by the ALP specific substrate 
para-nitrophenylphosphate (pNpp) for color development. 
  
3.2.6.4. Dosage dependent analysis of the biological activity of ShhN 
variants expressed in HEK293 cells by Gli-luciferase reporter 
assay 
 
In the Gli-luciferase reporter assay, induction of the  luciferase activity, which 
dependent on Shh signaling, was done in Shh LIGHT II cells. Graph 3.7 illustrates the 
dosage dependent response curves of the Shh LIGHT II cells treated with the 
conditioned media containing ShhNp, ShhN-GFP-His and ShN-GFP-His-SNAP 
variants. 
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Graph 3.7. Dose dependent induction of Gli-luciferase activity in Shh LIGHT II cells by the HEK293 
ShhN variants. Different volume ratios of the conditioned media collected from the 
HEK293 cells transfected with the constructs of ShhNp, ShhN-GFP-His and 
ShhN-GFP-His-SNAP were added to the Shh LIGHT II cells and incubated for 48 hours. 
Firefly luciferase activity revealing the Gli response to Shh signaling was measured and 
normalized with the constitutive Renilla luciferase activity to give the relative luciferase 
units. The response curve showed that Shh LIGHT II cells were specifically responsive to 
the conditioned media collected from the HEK293 cells transfected with the constructs of 
ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP. The luciferase activity increased in a 
dosage dependent manner. Conditioned media from the untransfected HEK293 cells and 
mock transfection (empty vector of pcDNA3.1) served as negative controls of 
transfection and Shh signaling, indicating the luciferase activity detected from the ShhNp, 
ShhN-GFP-His and ShhN-GFP-His-SNAP conditioned media was specifically induced 
by Shh signaling. 
 
The highest luciferase activity (40 to 50%) was observed when the conditioned media 
with the ratio of 1:1 to the fresh medium were applied (Graph 3.7). While the 
luciferase activity of the Shh LIGHT II cells treated with the conditioned media of 
untransfected HEK293 cells and the HEK293 cells transfected with the empty vector 
of pcDNA3.1 was low and could be considered as a background, the cells treated with 
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the ShhNp, ShhN-GFP-His and ShhN-GFP-His-SNAP conditioned media 
demonstrated a dosage dependent increase in luciferase activity. These findings were 
comparable with results obtained in the ALP assays (Graph 3.6). 
 
3.2.6.5. Analysis of the biological activity of ShhN-GFP-His and 
ShhN-GFP-His-SNAP in zebrafish embryos 
 
Owing to the high homology of the peptide sequences of ShhN in mouse and Danio 
rerio (zebrafish) (95% homology) (Figure 3.11), it was speculated that mouse ShhN 
protein may maintain its biological activity in zebrafish. Therefore zebrafish was 
employed as another eukaryotic assay system for determining the biological activity 
of the ShhN-GFP-His and ShhN-GFP-His-SNAP proteins, the ShhN sequence of 
which was the same as that of the signaling domain of mouse Shh. In vitro 
transcription of the constructs of ShhN-GFP-His and ShhN-GFP-His-SNAP plasmids 
was done with the mMessage Machine T7 kit (Ambion, Austin, TX, USA). The 
transcribed mRNAs were injected into 1-cell stage zebrafish embryos. The injected 
embryos were raised and collected at 18-somite stage for in situ hybridization for 
nkx2.2b and pax2a, which are target genes of shh induced signaling in zebrafish. 
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Figure 3.11. Alignment of the N-terminal signaling domains of the mouse ShhN and zebrafish shh 
(shhN). The amino acid sequence alignment shows that the mouse ShhN and zebrafish 
shhN share a sequence homology of 95% with 8 amino acids different ( indicated by red 
arrows),  
 
600ng/l mRNA of the full length zebrafish shh (shh-FL) or 1g/l mRNA of 
ShhN-GFP-His and ShhN-GFP-His-SNAP were injected into zebrafish embryos. 
600ng/l zebrafish shh-FL was found enough to induce Shh signaling; while a higher 
concentration of the mouse ShhN variants was used to ensure the induction of Shh 
signaling. The ShhN sequences in mouse and zebrafish are very similar, but there are 
still 8 amino acids different in the 174 residue containing peptide sequences. In 
addition, the mouse ShhN protein variants expressed would lack the C-terminal 
cholesterol modification, which is important for the extracellular diffusion of 
morphogens. Higher dosage of mouse ShhN may be required to compensate the slight 
sequence difference as well as the transport inefficiency for generating the same 
phenotype induced by zebrafish shh signaling. The mRNA of zebrafish shh-FL, and 
mouse ShhN-GFP-His and ShhN-GFP-His-SNAP protein variants injected led to 
expanded expression pattern of and the shh target gene pax2a at 18-somite stage 
(Figure 3.12). A very mild up-regulation of nkx2.2b was detected in the telencephalon 
of the embryos injected with zebrafish shh-FL and ShhN-GFP-His-SNAP mRNA. 
 
shhN 
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The mRNA of full length zebrafish shh gene served as the positive control of shh 
signaling in the injected zebrafish embryos. The similar results obtained after 
injection of the mRNA of ShhN-GFP-His and ShhN-GFP-His-SNAP variants, and the 
mRNA of full length zebrafish shh indicated that ShhN-GFP-His and 
ShhN-GFP-His-SNAP were biologically active. 
 
 
Figure 3.12. Expansion of pax2a expression pattern (A – D) and weak up-regulation of nkx2.2b (E – H) 
by overexpression of ShhN variants in zebrafish embryos. In situ hybridization of 
18-somite stage zebrafish embryos injected with mRNA of full length zebrafish shh, 
ShhN-GFP-His and ShhN-GFP-His-SNAP was done. Numbers at the right hand upper 
corner indicated the numbers of embryos with the phenotypes shown in the image and the 
total numbers of embryos counted, respectively. 
 
Taken together, the biological activity of the HEK293 cell expressed ShhN variants 
was found to be consistent in assays with different read out systems. 
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3.3. Part 2 – Development of biological compatible interfaces 
for ShhN immobilization 
 
To immobilize ShhN protein on functionalized surfaces for cellular response analysis 
in vitro, it is essential not only to know if ShhN is available to the responsive cells but 
also to understand how ShhN recognizes and interacts with its receptor at the 
membrane of the responsive cells. The tag or linker group used for protein 
immobilization on a surface should not block the accessibility of the receptor to the 
protein. In the case of ShhN, the poly(6)histidine, biotin and SNAPTM tags were fused 
at the C-terminus of the protein. The 5E1 immunoprecipitation experiments suggested 
the availability of the pseudo-active site (Figures 3.2, 3.4 to 3.6). Further, the 
immobilization technologies have to provide exceptional selectivity for ShhN to allow 
specific binding of ShhN to the target molecule from a complex mixture of other 
proteins. This is of special importance for immobilizations directly from the HEK293 
cell supernatant without any purification step like e.g. affinity chromatography. 
 
For binding to its receptor Ptc, the availability of the binding groove of ShhN is 
essential. The pseudo-active site of Shh is comprised of five histidine residues at 
positions 133, 134, 140, 180 and 182 of the ShhN peptide (Bosana et al., 2009). In the 
tertiary structure of the biologically active ShhN, those 5 histidine residues are in 
close vicinity in the binding pocket for Ptc (Bosana et al., 2009; Maun et al., 2010a, 
b). Since this pseudo-active site is located in the middle of the ShhN peptide, both N- 
and C-termini of ShhN can serve as immobilization sites. Published literature does not 
indicate involvements of both termini of ShhN for ShhN/Ptc binding, hence 
immobilization of ShhN via its C-terminus was tested. 
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The ShhN variants expressed in E. coli were used for development and optimization 
of the immobilization conditions unless otherwise stated. The convenient large scale 
production using E. coli guaranteed the availability and required quantities of the 
proteins. The fusion with GFP provided easy visualization. 
  
3.3.1. Immobilization of ShhN-GFP-His on modified polystyrene 
surfaces via nickel(II)/poly(6)histidine affinity interaction 
 
Irradiation of polystyrene surfaces with ultraviolet light of = 185nm leads to 
formation of hydrophilic surfaces rich in carboxylic acid (COOH) groups (Welle et al., 
2002; Welle et al., 2005). These surface properties affect strongly the adsorption of 
proteins from single protein solutions or from complex mixtures like fetal calf serum. 
It was found that native, hydrophobic polystyrene preferentially adsorbs albumin, 
whereas UV irradiated polystyrene favored the adsorption of cell attractive proteins 
from serum containing media (Welle et al., 2002, 2005). To allow selective binding of 
ShhN-GFP-His via the nickel(II)/poly(6)histidine interaction the polymer surface was 
functionalized to provide a nickel chelating moiety. 
  
The first step was to introduce the COOH groups on the polystyrene surface by deep 
UV lithography followed by a wet chemical activation of the COOH groups with an 
EDC to form a NHS reactive ester. The following coupling of N2,N2-bis 
(carboxymethyl)-L-lysine via the terminal amino group formed the nickel chelating 
groups at the polymer surface. Finally the surfaces were loaded with nickel (Ni2+) ions 
from a 40mM NiSO4 solution (Ashe and Briscoe, 2006; Ekblad and Liedberg, 2010; 
Gallet and Therond, 2005; Wong et al., 2009). To examine if the C-terminally 
poly(6)histidine tagged ShhN could be immobilized on the obtained nickel 
  
Results
139
functionalized polystyrene surfaces, ShhN-GFP-His was used. ShhN-GFP-His fused 
with GFP is easily detectable under a fluorescence microscope if bound onto the 
surfaces. 
 
After 24 hours of incubation in 500nM ShhN-GFP-His solution at 4oC, GFP signal 
was observed on the UV photopatterned polystyrene surfaces modified with Ni2+ ions 
(Figure 3.13). Fluorescence micrographs demonstrate the successful immobilization 
of ShhN-GFP-His on nickel modified polystyrene surfaces. 
 
 
Figure 3.13. ShhN-GFP-His immobilization on polystyrene surfaces after masked UV irradiation and 
nickel modification. Ni-NTA was coupled exclusively to the photo modified areas. (A, B) 
ShhN-GFP-His was immobilized only in the UV irradiated and nickel functionalized 
areas, as revealed by the green fluorescence. 
 
However, it is known that UV induced surface hydrophilization yields not exclusively 
carboxylate groups on the PS surface but also some intermediates and by products 
affecting protein binding on polystyrene surfaces. Regardless of the presence of 
nickel, the applied UV lithography based preprocessing step results in random 
adsorption of non-histidine tagged proteins onto the UV irradiated surface (figure 
1.9). Apart from the possibility of some randomly oriented ShhN molecules which 
might not be functional, a sample of this type might exhibit unwanted effects in the 
Non-irradiated 
Non-irradiated 
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cell culture experiment due to the adsorption of some unknown proteins from the cell 
culture medium. Therefore it was tested if BSA preadsorbed onto the patterned 
samples can act as blocking agent against unspecific adsorption. To prove this 
possibility, a QCM-D measurement of the deposition of BSA and FBS on non-nickel 
functionalized UV irradiated polystyrene surfaces was performed (Graph 3.8). 
Adsorption of both BSA and FBS on the surfaces is irreversible as they could not be 
washed away with PBS. The thicknesses of BSA and FBS measured indicate that UV 
modified polystyrene surfaces adsorb protein unselectively. 
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Graph 3.8. QCM-D measurement of the deposition of BSA and FBS on UV irradiated polystyrene 
surfaces. All protein adsorption experiments were performed by exposing the polymer 
coated quartz crystals to the following solutions: 15 min, PBS; 60 min, 50 µg/ml BSA in 
PBS; 75 min, PBS; 135 min, 1 vol% FCS in PBS; 135 min, PBS. Changes of the resonant 
frequencies and dissipation values were recorded, and converted to adsorbate thicknesses 
as indicated in the graph. 
 
 BSA 
B  
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As shown in graph 3.8. BSA blocking of UV irradiated PS does not provide an inert 
surface with respect of unspecific adsorption of other proteins from FBS containing 
media. Other experiments, data not shown, however, demonstrated that BSA is indeed 
passivating a pristine PS surface with respect of deposition of other proteins from 
FBS. Because the UV irradiated polystyrene, with or without further nickel 
modification, can induce unspecific protein absorption, it was not possible to quantify 
the amount of ShhN-GFP-His, being actually immobilized via the specific 
nickel(II)/poly(6)histidine interaction on the UV irradiated areas. 
 
To minimize unspecific adsorption of ShhN-GFP-His and to reduce effects of 
possibly co-adsorbed proteins, the development of protein repellent surfaces and 
application of highly selective protein anchoring head groups were critical. 
 
3.3.2. Immobilization of ShhN by dip-pen nanolithography 
 
In order to ensure immobilization of ShhN only on specific areas of the functionalized 
surfaces, dip-pen nanolithography (DPN) was employed. Nickel chelating as well as 
biotinylated phospholipids were used to immobilize the ShhN-GFP-His and 
ShhN-GFP-His-BA variants on polyethylene glycol (PEG) modified surfaces via 
nickel(II)/poly(6)histidine and biotin/streptavidin affinity interactions, respectively. 
BG terminated DOPE lipids were delivered on polystyrene surfaces for 
ShhN-GFP-His-SNAP immobilization via BG/SNAPTM covalent binding. 
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3.3.2.1. ShhN immobilization via poly(6)histidine tag on nickel 
presenting phospholipids 
 
As shown, UV irradiated polystyrene surfaces exhibited unspecific protein adsorption 
which could interfere with the immobilization of ShhN-GFP-His via 
nickel(II)/poly(6)histidine interaction and possibly affect the specific ShhN/Ptc 
receptor binding or introduce other unwanted side effects during the in vitro 
experiment. However, if the unspecific protein binding could be eliminated, the 
nickel(II)/poly(6)histidine interaction would be reliable and convenient for protein 
immobilization on functionalized surfaces. 
 
Unlike polystyrene, PEG does not favor protein adsorption (Huang et al., 2001). 
Therefore, PEG modified surfaces can allow for selective protein immobilization on 
designated areas where a specific functionalization was introduced. Nickel chelating 
lipids were printed in 10m10m square patterns by DPN on a PEG coated glass 
surface. The surfaces were then exposed to 1M solution of E. coli expressed 
ShhN-GFP-His at room temperature for 30 minutes. 
 
As shown in figure 3.14, green fluorescence signal from ShhN-GFP-His was 
detectable on the square patterns where the nickel presenting lipids were printed but 
not on the non-functionalized PEG areas. On control patterns, where pure DOPC (no 
nickel chelating lipids admixed to DOPC) were printed, no signal from 
ShhN-GFP-His was detected. The green fluorescence signal intensity, which was 
measured by ImageJ, increased with the increasing molar ratio of the nickel chelating 
lipids in DOPC and reached a maximum at 30mol% (Figure 3.14). With reference to 
the applied range of molar ratio of nickel chelating lipids in DOPC, different amounts 
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of ShhN-GFP-His could be immobilized via nickel(II)/poly(6)histidine interaction on 
PEG coated glass surfaces with high specificity. 
 
 
Figure 3.14. Immobilization of E. coli expressed ShhN-GFP-His on nickel presenting phospholipids 
patterns printed by DPN. Phospholipid patterns were deposited on PEG coated glass 
surfaces to form supported lipid multilayers. DOPC was admixed with 0, 10, 20, 30, 40, 
and 50 mol% nickel chelating lipids. Bright field image was taken immediately after 
printing (A). The numbers at the top of this figure represent the mol% of nickel chelating 
lipids in DOPC. 1M ShhN-GFP-His solution was applied on the surfaces and incubated 
at room temperature for 30 minutes. Fluorescence image was taken and GFP fluorescence 
intensity was quantified (B). The highest green fluorescence intensity was observed for 
30mol% nickel chelating lipids in DOPC.  
 
21.41±0.44 29.12±2.07 34.14±1.98 50.54±6.80 33.38±0.42 33.95±2.36 
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After testing the E. coli expressed ShhN-GFP-His binding to the nickel chelating 
lipids, glass surfaces with the same PEG modification and DPN patterns of 30mol% 
nickel chelating lipids in DOPC were used to immobilize the HEK293 expressed 
ShhN-GFP-His. HEK293 cells were first transfected with the DNA construct of 
ShhN-GFP-His. The conditioned medium containing the expressed ShhN-GFP-His 
protein was then collected after 48 hours and applied on the PEG modified glass 
surfaces, on which 30mol% nickel chelating lipids admixed with DOPC and 
rhodamine was printed in 50m×50m square patterns, prepared in advance. The 
adsorption and availability of the pseudo-active site of the immobilized 
ShhN-GFP-His was detected by the anti-Shh antibody 5E1. Figure 3.15 shows the 
immunofluorescence images of the surfaces exposed to the HEK293 expressed 
ShhN-GFP-His. The green fluorescence detected suggests that the ShhN-GFP-His 
was immobilized on the surfaces and that the pseudo-active site of ShhN was 
available. There was no signal detected from the pure PEG coated glass or the one 
incubated with the conditioned medium from untransfected HEK293. The poor lipid 
pattern quality was due to some printing error. Nonetheless, the rhodamine signal 
indicates the locations of the nickel chelating lipids. The signal was correspondent to 
the green fluorescence signal, where the anti-Shh antibody 5E1 detected the HEK293 
expressed ShhN-GFP-His protein. 
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Figure 3.15. Immobilization of HEK293 expressed ShhN-GFP-His on the nickel chelating 
phospholipid patterns produced by DPN. Phospholipids were admixed with 30mol% 
nickel chelating lipids and rhodamine labelled lipids (red fluorescence). These 
phospholipids were then deposited on the PEG treated glass surfaces in 50m×50m 
square patterns to form supported lipid multilayers. The surfaces were incubated with the 
conditioned medium containing HEK293 expressed ShhN-GFP-His at room temperature 
for 2 hours. Immunodetection of the immobilized protein with the anti-Shh antibody 5E1 
shows the green fluorescence signal (D’). Conditioned medium from untransfected 
HEK293 cells and pure PEG surfaces served as the negative controls for protein binding 
(A’ to C’). 
 
Apart from the poly(6)histidine tag at the C-terminus, there are another 6 individual 
histidine residues at different positions in the ShhN peptide. Five of these histidine 
residues get into close vicinity as a result of tertiary peptide folding ending up with 
the formation of the pseudo-acive site, the binding pocket to the Shh receptor Ptc 
(Bosana et al., 2009; Maun et al., 2010a, b). This binding pocket coordinates with a 
zinc (Zn2+) ion for Ptc binding. That means for identical ionic charge and similar ion 
sizes, the pseudo-active site of ShhN may also strongly interact with Ni2+ ion. 
Therefore, a nickel immobilization would not just couple ShhN-GFP-His via the 
poly(6)histidine tag but also potentially block the pseudo-active site of ShhN, 
hindering the ShhN/Ptc binding and its biological activity. The weaker green 
fluorescence signal detected and the smaller area coverage by 5E1 than the rhodamine 
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may indicate partial blockage of the pseudo-active site by the Ni2+ ions. Therefore 
another tagging system was employed for ShhN immobilization. 
 
3.3.2.2. ShhN immobilization via biotin/streptavidin affinity interaction 
on the biotinylated phospholipids 
 
To ensure that ShhN could only be immobilized via the C-terminus without disturbing 
the histidine rich pseudo-active site, the specificity and position of the tag are crucial. 
Therefore the well known biotin/streptavidin system was also tested for ShhN 
immobilization on the DPN printed biotinylated lipids. The biotin/streptavidin binding 
is remarkably strong with a dissociation constant (Kd) of 4×10-14M (Holmberg et al., 
2005; Livnah et al., 1993). A biotin, which recognizes and binds to streptavidin, was 
fused at the C-terminus of ShhN. The resulting protein was ShhN-GFP-His-Biotin 
with GFP for visualization and the histidine tag for Ni-NTA column purification. By 
introducing streptavidin to the biotin functionalized surfaces, the biotinylated 
ShhN-GFP-His-Biotin could be adsorbed onto the surfaces with streptavidin as an 
intermediate substrate in a "sandwich system" of biotin-streptavidin-biotin. 
 
Biotinylated lipids were deposited in 10m10m square patterns by DPN on PEG 
coated glass surface. The surfaces were then incubated in 5g/ml streptavidin solution 
at room temperature for 30 minutes, washed twice with PBS and then exposed to 1M 
E. coli expressed ShhN-GFP-His-Biotin solution at room temperature for 30 minutes. 
 
As expected, ShhN-GFP-His-Biotin (sequence information in table 2.1) was 
immobilized on the biotinylated lipids via streptavidin. The maximal amount of 
ShhN-GFP-His-Biotin, with quantified GFP fluorescence intensity of 30.38±2.64 
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arbitraty units, was immobilized on the biotinylated phospholipid patterns via binding 
with 4 mol% biotinylated lipids in DOPC (Figure 3.16). 
 
 
Figure 3.16. Immobilization of E. coli expressed ShhN-GFP-His-Biotin on biotinylated phospholipid 
patterns with streptavidin as the linker between the lipids and the protein. Phospholipid 
patterns were deposited on PEG treated glass surfaces to form supported lipid multilayers. 
Phospholipids were admixed with 2, 4, and 8 mol% biotinylated lipids. Bright field image 
indicated the DPN patterns of the biotinylated lipids (A). The surfaces with the 
biotinylated patterns were incubated in 5g/ml streptavidin at room temperature for 30 
minutes, rinsed twice with PBS and incubated in 1M ShhN-GFP-His-Biotin at room 
temperature for 30 minutes. The fluorescence image shows the highest green intensity 
when ShhN-GFP-His-Biotin was immobilized on 4mol% biotinylated lipids (B), 
indicating that the maximal amount of ShhN-GFP-His-Biotin was immobilized. The 
numbers above the figure represent the mol% of biotinylated lipids admixed in DOPC. 
 
Since biotin/streptavidin binding is restricted to the C terminus of 
ShhN-GFP-His-Biotin, the orientation of immobilized ShhN-GFP-His-Biotin was 
controlled. This biotin/streptavidin immobilization system also ensures the 
availability of the pseudo-active site of ShhN-GFP-His-Biotin for Ptc binding. 
 
19.49±0.41 21.22±0.24 30.38±2.64 23.56±0.37 
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Despite the strength of biotin/streptavidin interaction, immobilization of 
ShhN-GFP-His-Biotin is based on the affinity between biotin and streptavdin, and is 
non-covalent. To irreversibly immobilize ShhN on functionalized surfaces, the 
SNAPTM system was employed. 
 
3.3.2.3. ShhN immobilization via benzylguanine/SNAPTM covalent 
reaction on the benzylguanine functionalized phospholipids 
 
The SNAPTM system relies on the adaptation of the alkylguanine transferase 
(SNAPTM), which was tagged to ShhN resulting in ShhN-GFP-His-SNAP (sequence 
information in table 2.1). To immobilize this SNAPTM tagged ShhN-GFP-His-SNAP 
via the BG/SNAPTM interaction, the BG terminated lipids were first mixed with 
DOPC at the ratio of 1:1. The mixed lipids were then delivered by DPN on the 
polystyrene surfaces in 10m10m square patterns. The modified surfaces were then 
exposed to 1M ShhN-GFP-His-SNAP solution at room temperature for 30 minutes. 
It would finally lead to covalent immobilization of the protein onto the patterns of BG 
terminated lipids. Figure 3.17 shows specific binding of ShhN-GFP-His-SNAP to the 
BG terminated lipid printed areas on native polystyrene surfaces. No protein 
adsorption was detected on the polystyrene surfaces where no BG functionalized 
lipids were deposited, since the surfaces were not made hydrophilic and protein 
attractive by UV irradiation as what was mentioned in section 3.3.1. 
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Figure 3.17. Immobilization of ShhN-GFP-His-SNAP on the biotin functionalized lipids via covalent 
binding between the BG and the SNAPTM tag fused at the C-terminus of 
ShhN-GFP-His-SNAP. BG terminated DOPE lipid was mixed with DOPC at the ratio of 
1:1. Binding of ShhN-GFP-His-SNAP to BG was visualized by the green fluorescence 
signal (A, B), and detected by immunofluorescence using anti-SNAP and Penta-his 
antibodies (in red) (A’, B’). 
 
Similar to the biotin tag, the SNAPTM tag was introduced at the C terminus of 
ShhN-GFP-His-SNAP, hence the BG/SNAPTM immobilization reaction should not 
interfere with the binding between the pseudo-active site of ShhN-GFP-His-SNAP 
and the Shh receptor Ptc. 
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3.3.3. Immobilization of ShhN-GFP-His-SNAP on gold surfaces 
via benzylguanine thiol/SNAPTM covalent binding 
 
3.3.3.1. Microcontact printing of benzylguanine terminated thiol on gold 
surfaces 
 
Microcontact printing (Cp) was used to introduce a monolayer of benzylguanine 
thiol (BGT) on gold surfaces for covalent immobilization of ShhN-GFP-His-SNAP. 
 
The immobilization was started by mixing the BGT and the passivating thiol EG6OH 
with BGT=0.1. BGT represents the molar fraction or ratio of BGT concentration to the 
total concentration of BGT and EG6OH. A solution of 0.1mM BGT/EG6OH was 
formed. The solution was coated onto the PDMS stamp with 50m50m square 
patterns, which would then be used to deliver the BGT/EG6OH in patterns onto gold 
surfaces. Next, patterned gold surfaces were backfilled with 0.1mM pure EG6OH 
solution at room temperature for 1 hour and exposed to 500nM ShhN-GFP-His-SNAP 
at room temperature for 1 hour for BG/SNAPTM specific covalent binding. The thiol 
groups have a strong affinity to the gold surface and the bond formed between the 
BGT and the SNAPTM tag fused to ShhN-GFP-His-SNAP was covalent. Therefore the 
protein was irreversibly attached to the gold substrate (Figure 3.18). 
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Figure 3.18. Immobilization of ShhN-GFP-His-SNAP on gold surface. The gold surface was stamped 
with a mixture of BGT and EG6OH by Cp. The immobilized ShhN-GFP-His-SNAP in 
squares was observed via fluorescence microscopy. 
 
Though ShhN-GFP-His-SNAP was immobilized on the BGT stamped area on the 
gold surface, aggregate formation of the protein was noticed (Figure 3.18). It was 
discovered that SNAPTM tagged proteins have the tendency of forming aggregates 
because the SNAPTM binding domain is poor in resisting extreme temperature and pH, 
and the presence of denaturant (Chivers et al., 2010). Even the immobilized protein 
would remain attached under these harsh conditions, the protein may unfold, 
aggregate and promote unspecific binding (Chivers et al., 2010). However, in this 
experiment, immobilization of ShhN-GFP-His-SNAP was done at room conditions 
using PBS as the buffer. Rather, GFP tends to oligomerize and form aggregates, and 
therefore contributes to massive clustering of ShhN-GFP-His-SNAP through 
crosslinking (Miyawaki, 2005; Yanushevich et al., 2002). Moreover, precipitation of 
BGT on the stamp surface upon drying prior to stamping onto the gold substrate could 
result in disordered BGT containing SAMs on the stamped gold areas. These 
disordered SAMs increase unspecific protein adsorption and affect specific 
BG/SNAPTM binding adversely. 
 
  
Results
152
To minimize aggregation of ShhN-GFP-His-SNAP, 0.5mM DTT was added to the 
protein buffer. ShhN-GFP-His-SNAP was produced fresh for every experiment and 
used within a week. UV photolithography instead of Cp was employed for 
patterning on gold surfaces to avoid disorganization of BGT upon drying since BGT 
would be used in a solution form to backfill the UV photopatterned area. 
 
3.3.3.2. UV photopatterning and ToF-SIMS analysis of BGT SAM, and 
immobilization of ShhN-GFP-His-SNAP on gold surfaces 
 
To form a uniform SAM on gold surface 0.1mM EG6OH solution was applied at 
room temperature for 16 hours. Selected areas of the EG6OH SAM were decomposed 
by deep UV light for 100 minutes, resulting in formation of 50m50m square 
patterns. Backfilling with BGT containing solution was then performed by incubating 
the surface in 0.1mM BGT/EG6OH solution with BGT=0.1 at room temperature for 1 
hour. 
 
By comparing the negative secondary ion spectra of both pristine thiols, gold surfaces 
coated with EG6OH or BGT could be distinguished using ToF-SIMS. As shown in 
Figure 3.19, EG6OH contains 6 ethylene glycol (-CH2CH2O-) repeat units at the tail, 
which can be identified by their corresponding fragments in ToF-SIMS. BGT contains 
several nitrogen containing moieties which in turn result in e.g. strong CN- and CNO- 
secondary ions. In addition, it was possible to detect also the intact guanine fragment 
of BGT in ToF-SIMS providing direct evidence for the successful formation of a 
BGT SAM. 
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Figure 3.19. Molecular structures of the applied disulfides that form a self-assembled monolayer on 
gold surfaces for the immobilization ShhN-GFP-His-SNAP. (A) Benzylguanine 
terminated disulfide (BGT). (B) Passivating thiol EG6OH. 
 
Graphs 3.9 and 3.10 are negative secondary ion spectra of pristine EG6OH and BGT 
SAMs. 
 
Signals of the ethylene glycol repeat units C2H3O-, and the C2H5O2- head group 
indicate the presence of EG6OH (Graph 3.9). The intensity for oxidized species such 
as CHO2- is low. Also no significant CN- and CNO- signals were detected. 
 
  
Results
154
 
Graph 3.9. Negative secondary ion spectrum from a pristine EG6OH self assembled monolayer. 
Spectra recorded in bunched mode with high mass resolution, total counts: 1.8106. 
Insert: Detail spectrum around 665amu, 5 points binning of original data, for two different 
SAMs: EG6OH (solid line), and BGT (dotted line). Spectra scaled by total intensity. 
 
In the negative secondary ion spectrum of BGT (Graph 3.10), characteristic CN- and 
CNO- signals for BGT were detectable. Like the spectrum of EG6OH, weak signal 
was detected for CHO2- in pristine BGT SAM in the absence of photo degradation. 
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Graph 3.10. Negative secondary ion spectrum from a pristine BGT self assembled monolayer. Spectra 
recorded in bunched mode with high mass resolution. Insert: Detail spectrum around 
149amu, 5 points binning of original data. The CN-, CNO- and guanine signals indicated 
the presence of BGT, which contained amine and amide groups at the tail of the thiol. 
 
Images of time-of-flight secondary ion mass spectroscopy (ToF-SIMS), shown in 
Figures 3.20 and 3.21 illustrated EG6OH and BGT assembling on gold surface with 
UV photopatterning and backfilling. Signals of C2H3O- and C2H5O2- from EG6OH 
were recorded from the area where there was no UV degradation of the SAM (Figure 
3.35). Localized degradation of EG6OH by masked UV exposure led to formation of 
oxidized species resulting in CHO2- and SO4H- signals in the square areas exposed to 
UV light. Prior to the BGT backfilling, the CN- and CNO- signals remained weak. 
 
  
Results
156
 
Figure 3.20. ToF-SIMS images of photo patterned EG6OH SAM. 100min UV exposure. Data 
recorded in bunched mode with high mass resolution. C2H3O- and C2H5O2-, which 
composed of the tail of EG6OH, were detected in the non-irradiated area. UV degradation 
of the EG6OH SAM led to formation of oxidation species, which resulted in signals of 
CHO2- and SO4H- in the squares exposed to UV. 
 
When BGT, mixed with EG6OH at the ratio of 1:5, was backfilled on the 
photopatterned EG6OH coated surface, the CN-, and CNO-, and guanine signals 
became clearly detectable (Figure 3.21), indicating the adsorption of BGT in the 
regions of photo damaged EG6OH, since the gold surface, previously occupied by the 
EG6OH, was available again for deposition of BGT. In summary, a patterned SAM of 
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BGT and EG6OH was obtained and could be used to selectively bind the 
ShhN-GFP-His-SNAP protein. 
 
 
Figure 3.21. ToF-SIMS images of photo patterned EG6OH sample with 60min UV exposure after 
backfill with BGT/EG6OH 1:5. C2H3O- and C2H5O2- signals from EG6OH were still 
detected in the non-irradiated area. Strong signals of CN- and CNO- in the patterned 
squares indicated the presence of BGT, which occupied the space where photo 
degradation of the EG6OH SAM was carried out. 
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3.3.3.3. QCM-D analysis of BGT/ShhN-GFP-His-SNAP binding on gold 
surfaces 
 
Because of the presence of the SNAPTM tag, ShhN-GFP-His-SNAP could covalently 
bind to the BG terminated molecules with high specificity. Even so, background 
interference by unspecific protein adsorption should be taken into account. 
 
To determine the immobilization efficiency of ShhN-GFP-His-SNAP on the BGT 
SAM on gold surface, quartz crystal microbalance with dissipation monitoring 
(QCM-D) was employed. QCM-D is a method used for measuring molecular 
adsorption/desorption and binding kinetics to various types of surfaces. It is useful for 
determining molecular interactions with surfaces as well as between molecules. 
 
Crystals with golden electrodes were exposed to 0.1mM BGT/EG6OH solution with 
different molar ratio of BGT concentration to the total concentration of BGT and 
EG6OH (BGT) at room temperature for 1 hour. 1mg/ml BSA and 500nM 
ShhN-GFP-His-SNAP solutions were subsequently applied on the same surfaces. The 
thicknesses of the proteins deposited were calculated from the changes of the 
resonance frequencies. 
 
From Graph 3.11, it could be noticed that as the BGT increased, the thickness (i.e. 
amount) of ShhN-GFP-His-SNAP increased accordingly. At the same time, more 
BSA was also adsorbed on the surface, indicating that BGT could introduce 
unspecific protein binding when its ratio to the passivating thiol was high enough. 
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Graph 3.11. QCM-D measurement of adsorption of BSA and ShhN-GFP-Hi-SNAP on BGT modified 
gold surfaces with different BGT. The thickness (i.e. amount) of the both BSA and 
ShhN-GFP-His-SNAP increased with an increasing BGT applied to the gold surface. A 
BGT of 0.10 was found to be the optimal for immobilizing ShhN-GFP-His-SNAP 
specifically on BGT while unspecific protein binding, as revealed by BSA, is bearable. 
 
After several replicates of measurement by QCM-D, it was concluded that a BGT = 
0.1 could compromise the background effect and allowed an acceptable amount of 
ShhN-GFP-His-SNAP to be specifically immobilized on gold surfaces via BGT. 
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3.3.3.4. Immobilization and immunodetection of the HEK293 cell 
expressed ShhN-GFP-His-SNAP on gold surfaces 
 
After optimizing the immobilization condition on gold surfaces via BGT using the E. 
coli expressed ShhN-GFP-His-SNAP, the ShhN-GFP-His-SNAP was immobilized 
directly from the conditioned media of transfected HEK293 cells. Since the protein 
amount is under the detection limit of Western blotting, it was detected by 
immunofluoresence using the anti-Shh antibody 5E1, which recognizes the 
pseudo-active site of Shh for Ptc binding, and a green fluorescence labeled secondary 
antibody. 
 
Figure 3.22 shows the immunofluorescence images of immobilized 
ShhN-GFP-His-SNAP (from the conditioned medium of HEK293 cells transfected 
with ShhN-GFP-His-SNAP construct). 0.1mM of the passivating thiol EG6OH was 
applied to gold surfaces for 16 hours to ensure thorough coverage with EG6OH. The 
modified surfaces were placed underneath a patterned mask and exposed to UV 
irradiation for 1 hour, resulting in square patterns with decomposed EG6OH. The 
surfaces were then backfilled with 1:10 BGT/EG6OH solution for 1 hour to fill up the 
areas where EG6OH had been decomposed. The collected conditioned medium of 
ShhN-GFP-His-SNAP from HEK293 cells was filtered with a 0.22m syringe filter to 
get rid of any cell debris and was applied to the BGT/EG6OH functionalized gold 
surfaces without dilution at room temperature for 2 hours. The surfaces were 
immunostained with the anti-Shh monoclonal antibody 5E1, which recognizes and 
binds to the Ptc binding pseudo-active site, and a GFP labeled secondary antibody for 
the detection of ShhN-GFP-His-SNAP. 
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Figure 3.22. Immunofluorescence of the HEK293 cell expressed ShhN-GFP-His-SNAP on 1:10 
BGT/EG6OH functionalized gold surfaces. Gold surfaces were exposed to 0.1mM 
EG6OH for 16 hours. UV irradiation was employed to decompose selective areas of the 
EG6OH SAM in 50m50m square patterns. An 1:10 BGT/EG6OH solution as used to 
functionalize the irradiated surfaces for 1 hour. The anti-Shh antibody 5E1 was used to 
detect the immobilized ShhN-GFP-His-SNAP. The green fluorescence signals indicate 
the ShhN-GFP-His-SNAP immobilized and the availability of the pseudo-active site of 
ShhN for Ptc binding (D). Conditioned medium from untransfected HEK293 cells and 
pure EG6OH surfaces were the negative controls of SNAP protein binding (A to C). 
 
The green fluorescence signal detected in the square patterns, where there was a SAM 
of BGT/EG6OH, indicates the presence of ShhN-GFP-His-SNAP. Binding of the 5E1 
antibody and the GFP labeled secondary antibody indicated the availability of the 
pseudo-active site of ShhN. It suggests that the protein immobilization via BGT does 
not block the binding of ShhN-GFP-His-SNAP to its receptor Ptc. 
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3.3.4. Adsorption of ShhN-His and ShhN-GFP-His on surfaces 
coated with the extracellular matrix components collagen 
and fibronectin 
 
Collagen and fibronectin were expected to have similar abilities in retaining ShhN in 
their networks, since both of them are extracellular matrix (ECM) substances involved 
in morphogen distribution. Collagen or fibronectin were applied from 25 to 240g/ml 
solutions in H2O onto glass surfaces at room temperature for 1 hour. The collagen or 
fibronectin coated surfaces were then exposed to 500nM solution of ShhN-His or 
ShhN-GFP-His at room temperature for 1 hour. Adsorption of ShhN-His or 
ShhN-GFP-His was analyzed by immunofluorescence, enzyme linked immunosorbent 
assay (ELISA), quartz crystal gravimetry (QCM), and fluorescence recovery after 
photobleaching (FRAP). 
 
3.3.4.1. Detection and quantification of adsorbed ShhN-His and 
ShhN-GFP-His on collagen and fibronectin coated glass surfaces 
 
From Figure 3.23, it can be seen that both ShhN-His and ShhN-GFP-His were 
adsorbed in collagen, regardless if the protein was fused merely with a 
poly(6)histidine tag or with an additional GFP. The absence of fluorescence and 
immunodetection signals from GFP-His indicated that there was no GFP-His 
adsorbed on the collagen coated surfaces, indicating that collagen shows no affinity to 
GFP-His. The adsorption of ShhN-His and ShhN-GFP-His by collagen was not 
contributed by any interaction between collagen and GFP or poly(6)histidine but 
between collagen and ShhN. The findings suggested that collagen is a good substrate 
for label free adsorbed of ShhN-His and ShhN-GFP-His. 
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Figure 3.23. Immunofluoresence detection of ShhN-His and ShhN-GFP-His adsorption on collagen 
coated surfaces from a 240g/ml collagen solution. The anti-Shh antibodies 5E1 and Shh 
(N-19):sc1194, and Penta-his antibody were used to detect ShhN-His and ShhN-GFP-His. 
Collagen surfaces without any protein served as negative controls for fluorescence and 
immunodetection (A to E, F to J). Green fluorescence signal was observed from 
ShhN-GFP-His on collagen surfaces (F’). Positive immunofluorescence signals were 
noticed from application of ShhN-His and ShhN-GFP-His on collagen surfaces, 
indicating adsorption of the proteins (C’ to E’, H’ to J’). Very weak green fluorescence 
and immunofluorescence signals were seen when GFP-His was applied on collagen 
surfaces (F’’ to J’’). The antibodies 5E1, Shh (N-19):sc1194, and Penta-his are written in 
colors, which represent the fluorescence of the secondary antibodies used for the 
detection of the antibodies. The numbers at the right hand lower corners are arbitrary 
units of green fluorescence intensity ±  standard deviation. Abbr.: GFP, green 
fluorescence protein; RFP, red fluorescence protein. 
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Adsorption of ShhN-His and ShhN-GFP-His on collagen surfaces was label free and 
yet selective comparing to GFP-His. The adsorbed proteins could be detected by 
antibodies, indicating the availability of the Ptc binding site. The potential drawback 
of collagen adsorption of ShhN was possible random adsorption, imposing binding 
between collagen and ShhN may block a certain ratio of the pseudo-active site, 
though it is not necessarily the case. Collagen allowed migration of ShhN in the 
matrix. Motility of ShhN was not hindered while the advantage of controlling the 
spatial and concentration distributions of the protein could be taken. 
 
On the contrary, no satisfactory result was obtained from the fibronectin adsorption 
setups for ShhN-His and ShhN-GFP-His. Immunofluorescence signals revealed from 
the Shh specific and histidine antibodies were weak, indicating poor adsorption of 
ShhN-GFP-His on fibronectin coated surfaces (Figure 3.24). 
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Figure 3.24. Immunofluoresence detection for adsorption of ShhN-His and ShhN-GFP-His on 
fibronectin coated surfaces from a 240g/ml fibronectin solution. The anti-Shh antibodies 
5E1 and Shh (N-19):sc1194, and Penta-his antibody were used to detect ShhN-His and 
ShhN-GFP-His. Fibronectin surfaces without any protein served as negative controls for 
fluorescence and immunodetection (A to E, F to J). Very weak green fluorescence signals 
were observed from ShhN-GFP-His on FN surfaces (F’). Application of ShhN-His and 
ShhN-GFP-His on fibronectin surfaces demonstrated poor IF signals (C’ to E’, H’ to J’, 
H’’ to J’’), indicating that ShhN-His and ShhN-GFP-His were as badly adsorbed on 
fibronecitn coated surfaces. No signal was shown by GFP-His on fibronectin (F’’). 
Fibronectin did not promote protein adsorption. The antibodies 5E1, Shh (N-19):sc1194, 
and Penta-his were written in colors, which represent the fluorescence of the secondary 
antibodies used for the detection of the antibodies. The numbers at the right hand lower 
corners were arbitrary units of green fluorescence intensity ± standard deviation. Abbr.: 
GFP, green fluorescence protein; RFP, red fluorescence protein. 
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Although both collagen and fibronectin were ECM substances, they possess different 
capabilities in adsorption of ShhN-His and ShhN-GFP-His. Fibronectin does not 
allow for efficient adsorption of ShhN proteins. 
 
To analyze the effects of different collagen amounts deposited on a substrate for 
ShhN-GFP-His binding, a concentration series of 25 to 240g/ml of collagen was 
tested. A minimal concentration of 25g/ml of collagen is suggested for surface 
coating (Roche, Mannheim, Germany). The collagen coated surfaces were exposed to 
a fixed concentration of ShhN-GFP-His (500nM). As seen in Figure 3.25 (E – H), 
concentrations of collagen between 25 and 240g/ml had comparable ability in 
adsorbing ShhN-GFP-His, as they showed similar intensities of GFP fluorescence. 
Increase in collagen concentration within the tested range did not contribute to the 
surface’s capacity for further protein adsorption. 
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Figure 3.25. ShhN-GFP-His adsorption on collagen coated surfaces. (A – D) GFP-His was the 
negative control that is not adsorbed on collagen. (E – H) Collagen with a series of 
concentrations (from 25 to 240g/ml) was used to adsorb ShhN-GFP-His from a 100nM 
solution on glass surfaces. (E’ – H’) Supplement of 1M heparin resulted in slight 
increase of green fluorescence intensity from ShhN-GFP-His. (E’’ – H’’) Supplement of 
1mg/ml BSA resulted in dramatic increase of green fluorescence intensity from 
ShhN-GFP-His. (I, J) Blockage of adsorption of ShhN-GFP-His with microcontact 
printed BSA in selected areas of collagen coated surfaces. BSA was stamped on collagen 
functionalized surfaces in square patterns by Cp. The unstamped areas were not 
influenced and showed comparable green fluorescence intensity to the image (G) that no 
Cp was conducted. The numbers at the right hand lower corners were arbitrary units of 
green fluorescence intensity ± standard deviation. 
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In Graph 3.12, it can be seen that an ELISA response curve was obtained by 
depositing collagen from a 100g/ml solution and ShhN-GFP-His from solutions with 
different concentrations on glass surfaces. ELISA was carried out with Shh 
(N-19):sc1194 antibody conjugated with anti-goat IgG peroxidase conjugate. The 
amount of ShhN-GFP-His adsorbed on a given area on the collagen coated glass 
surfaces was found to be dependent on the ShhN-GFP-His concentration. Since there 
was only one band detected by the Shh (N-19):sc1194 antibody in the Western blot 
(Figure 3.2), the ELISA quantification of ShhN-GFP-His was protein-antibody 
specific. The amount of protein measured on the surfaces could only come from the 
ShhN-GFP-His but not any other proteins possibly adsorbed on the surfaces. Quartz 
crystal microbalance with dissipation monitoring (QCM-D) was used to quantify the 
deposited mass of ShhN-GFP-His on collagen surfaces with an input ShhN-GFP-His 
concentration of 1M. 
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Graph 3.12. ELISA response curve showing the surface densities (ng/cm2) of ShhN-GFP-His 
deposited on collagen coated surfaces. The surface density of ShhN-GFP-His on collagen 
surfaces was proportional to the concentration of ShhN-GFP-His applied for deposition. 
The pink data point indicates the surface density of ShhN-GFP-His resulting from 
ShhN-GFP-His adsorption from 1M ShhN-GFP-His solution on collagen coated 
QCM-D sensors. The average surface density of ShhN-GFP-His deposited measured by 
QCM-D was comparable to the value shown from the ELISA response curve. 
 
QCM is a methodology based on the masses of the substances adsorbed on the surface 
but has no selectivity on any particulars. It provides an overall information of the 
masses of all input molecules deposited. On the other hand, ELISA is a selective 
method of detecting target proteins using specific antibodies. Though being two 
independent methods for determination of the amount of ShhN-GFP-His deposited on 
collagen functionalized surfaces, the measurements by QCM-D and ELISA were 
found to be comparable. Although multiple bands were detected in the Western blot 
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using Penta-his antibody (Figure 3.5), the QCM-D quantification demonstrated that 
the amount of other non-ShhN proteins adsorbed on collagen was insignificant. 
Further, it was found from ELISA that for a constant concentration of collagen, the 
amount of ShhN-GFP-His adsorbed on the collagen surfaces was dependent on the 
applied concentration of ShhN-GFP-His. 
 
Heparin is a component of the ECM and is capable of binding to the 
Cardin-Weintraub sequence of ShhN (Cardin and Weintraub, 1989). Therefore 1M 
heparin was mixed with the collagen solutions prior to exposure of the surfaces to 
substrate and adsorption of ShhN-GFP-His. This was to test if supplementation by 
heparin could enhance the adsorption of ShhN-GFP-His in the collagen matrix. Figure 
3.25 (E’ – H’) demonstrates that exposure of collagen coated surfaces to 
ShhN-GFP-His with 1M heparin supplement in the collagen. results in an increase of 
green fluorescence intensity suggesting an increase of amount of ShhN-GFP-His 
adsorbed onto the modified surfaces. This effect is most pronounced at low collagen 
concentrations. 
 
Apart from heparin, supplement of 1mg/ml BSA to the collagen matrix was observed 
to have similar effect on facilitating adsorption of ShhN-GFP-His on collagen 
functionalized surfaces. It can be seen from Figure 3.25 (E’’ – H’’) that a mixture of 
collagen and BSA almost doubled the green fluorescence intensity measured, and 
hence the amount of ShhN-GFP-His adsorbed. Again this effect is the most prominent 
for low collagen concentration solutions applied for collagen deposition. 
 
While supplement of BSA in the collagen matrix resulted in enhancement of the 
adsorption of ShhN-GFP-His in collagen, microcontact printing (Cp) of BSA on the 
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collagen functionalized surfaces was observed to block ShhN-GFP-His adsorption on 
the printed areas (Figure 3.25 (I, J)).In this experiment, glass surfaces were exposed to 
100g/ml collagen at room temperature for 1 hour and blown dry with nitrogen 
stream. A square patterned PDMS stamp was soaked in a 1mg/ml BSA solution at 
room temperature for 15 minutes and dried in a stream of nitrogen. The BSA from the 
stamp was then transferred onto the collagen coated surfaces by Cp for 1 minute. 
Finally these layers were exposed to ShhN-GFP-His at room temperature for 1 hour. 
In the square patterned areas where BSA was stamped, there was no green 
fluorescence signal observed from ShhN-GFP-His, suggesting that the stamped BSA 
formed a layer in the middle isolating collagen and ShhN-GFP-His and thereby 
inhibited the adsorption of ShhN-GFP-His in the collagen matrix. While BSA blocked 
the stamped area, the unstamped area showed comparable green fluorescence 
intensity, indicating that adsorption of ShhN-GFP-His on unstamped collagen was 
unaffected. 
 
3.3.4.2. Analysis of the motility of ShhN-GFP-His on collagen coated 
glass surfaces by fluorescence recovery after photobleaching 
 
Fluorescence recovery after photobleaching (FRAP) denotes an optical technique 
capable of quantifying lateral molecule diffusion or protein binding. The molecules or 
proteins under investigation are fluorescence labeled. By exposure to a strong laser 
light under a confocal microscope, a selected area of the sample is photobleached. 
Fluorescence intensity of the bleached area is then recorded in set time intervals to 
monitor a fluorescence recovery. The time and extent of recovery of fluorescence 
intensity in a photobleached area is dependent on the migration of the target 
molecules or proteins from the surrounding non-bleached areas into the bleached area. 
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FRAP was employed to measure the motility of adsorbed ShhN-GFP-His in the 
collagen network. To do so, surfaces with different collagen layers (deposited from 
concentrations of 25 to 240g/ml) were exposed to solutions of the same 
concentration (500nM) of ShhN-GFP-His, and washed twice in PBS. An area was 
selected randomly and bleached by a laser beam under the confocal microscope. GFP 
intensity in the photobleached area was measured against time. 
 
Graph 3.13 shows that after photobleaching, the green fluorescence intensity in the 
bleached area of ShhN-GFP-His loaded collagen increased gradually, indicating a 
fluorescence recovery of the bleached area by migration of the ShhN-GFP-His from 
the surrounding non-bleached area. Such migration of ShhN-GFP-His in the collagen 
matrix suggested a reversible adsorption of ShhN-GFP-His on collagen, which 
provides a dynamic environment that allows movement of ShhN-GFP-His in the 
matrix. 
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Graph 3.13. Comparison of ShhN-GFP-His motility on surfaces coated with different concentrations 
of collagen. Similar FRAP profiles shown by ShhN-GFP-His (from 500nM solution) 
adsorbed on surfaces coated with different collagen concentrations (from 25 to 240g/ml 
solutions). A circle with diameter of 30m was bleached by a laser irradiation at 
=488nm under the confocal microscope for 3 seconds. The green fluorescence intensity 
in photopbleached area was measured in 1 second intervals after bleaching for 1 minute. 
Initial signals were scaled to 1. 
 
Consistent with the protein intensity measurements, same input concentration of 
ShhN-GFP-His on surfaces coated with different concentrations of collagen gave rise 
to very similar FRAP profiles, indicating that there was no direct relationship of 
fluorescence recovery and the collagen concentrations used. 
 
Stamping of BSA on collagen coated surfaces by microcontact printing (Cp) resulted 
in blockage of ShhN-GFP-His adsorption in collagen. However, it did not affect the 
overall movement of ShhN-GFP-His within the unstamped collagen matrix as 
demonstrated by the FRAP profile (Graph 3.14). The paths for ShhN-GFP-His 
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movement were still connected by the matrix in the unstamped regions. The 
microcontact printed area can be adjusted by using BSA coated stamps of different 
sizes and patterns. In other words, ShhN with a variety of local spatial distributions, 
and hence local concentrations, can be adsorbed on a single collagen coated surface 
with freedom of movement in the matrix. 
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Graph 3.14. Comparison of the motility of ShhN-GFP-His adsorbed on collagen functionalized 
surfaces. Similar FRAP profiles obtained for adsorption of ShhN-GFP-His on collagen 
coated glass surfaces (blue line) and on unstamped area after the collagen coated glass 
surfaces were subjected to Cp with BSA (pink line). Initial signals were scaled to 1. 
 
Concluding from the results of immunofluorescence and FRAP, collagen is a good 
substrate for adsorbing ShhN and yet allows the protein to diffuse within the matrix. 
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3.3.4.3. Adsorption and biological activity analysis of the HEK293 cell 
expressed ShhN-GFP-His on collagen coated glass surfaces 
 
Comparing to other surfaces, preparation of collagen coated glasses was simple and 
required no sophisticated equipment. The surfaces provide a convenient platform for 
preliminary studies of biological activity of adsorbed ShhN-GFP-His. 
 
Since the HEK293 cell expressed ShhN-GFP-His, as shown previously in section 
3.2.6, was biologically active in soluble form, it was selected to adsorb on collagen 
coated glass surfaces to investigate the biological activity of adsorbed ShhN-GFP-His. 
The E. coli expressed RCmShhN purchased from Neuromics (Edina, MN, USA) 
served as positive controls. 
 
100g/ml collagen was used to functionalize the glass surfaces. The collagen surfaces 
were then exposed to RCmShhN solutions with different concentrations. The 
modified surfaces were washed twice in PBS to remove any unbound RCmShhN 
proteins. C3H10T1/2 clone 8 cells, which can express ALP in response to Shh 
signaling, was cultured on the surfaces at 37oC with 5% CO2 for 5 days. Expressed 
ALP was detected with BCIP/NBT substrates in ALP staining solution. 
 
Concentration dependent ALP expression in the C3H10T1/2 clone 8 cells was 
detected, indicating that RCmShhN was adsorbed on the collagen matrix and capable 
of triggering Shh signal transduction (Graph 3.15). The biological activity of the 
adsorbed RCmShhN on collagen surfaces was the highest when 400nM RCmShhN 
were applied. Concentrations of RCmShhN higher than 400nM did not induce ALP 
expression any further, resulting in a level off of the percentage of ALP expressing 
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cells. ShhN-GFP-His adsorption in collagen may have reached the threshold. Increase 
in the input concentration of RCmShhN would not improve the amount of RCmShhN 
adsorbed and thus the cellular responses. 
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Graph 3.15. ALP expression induction in C3H10T1/2 clone 8 cells RCmShhN adsorbed on 
collagen coated surfaces. The percentage of ALP expressing C3H10T1/2 clone 8 
cells increased with an increasing concentration of RCmShhN until a maximum was 
reached with 400nM RCmShhN. After then RCmShhN showed a level off in 
inducing further C3H10T1/2 clone 8 cells to express ALP. 
 
After confirming the biological activity of the adsorbed ShhN in collagen matrix 
using RCmShhN, the HEK293 cell expressed ShhN-GFP-His was tested. After 
coating the glass surfaces with the 100g/ml collagen solution, conditioned medium 
containing ShhN-GFP-His (from HEK293 cells transfected with the ShhN-GFP-His 
construct) in different volume ratios to fresh medium (containing DMEM and 0.5% 
FBS) was added to the surfaces. C3H10T1/2 clone 8 cells were seeded on the surfaces 
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and were incubated at 37oC with 5% CO2 for 5 days. ALP expressing cells were 
counted. Conditioned medium from untransfected HEK293 cells was used as the 
negative control of biological activity analysis. The soluble form of the 
ShhN-GFP-His served as the positive control. This was done by incubating the 
C3H10T1/2 clone 8 cells in the ShhN-GFP-His conditioned medium. 
 
The biological activity of the soluble form of the HEK293 cell expressed 
ShhN-GFP-His is shown in Graph 3.16. The percentage of ALP expressing 
C3H10T1/2 clone 8 cells increased when an increasing volume ratio of the applied 
ShhN-GFP-His conditioned medium was applied. The highest percentage (about 80%) 
of ALP expressing cells was noticed when a conditioned to fresh medium ratio of 
1:1.86 was used. 
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Graph 3.16. Induction of ALP expression in C3H10T1/2 clone 8 cells by the HEK293 cell expressed 
ShhN-GFP-His. The C3H10T1/2 clone 8 cells showed specific ALP expression to the 
soluble form of ShhN-GFP-His (from the conditioned medium collected from HEK293 
cells transfected with the construct of ShhN-GFP-His). Conditioned medium from 
untransfected HEK293 cells served as the negative control. 
 
Graph 3.17 illustrated the biological activity of adsorbed ShhN-GFP-His on collagen 
surfaces. The conditioned medium from HEK293 cells transfected with the construct 
of ShhN-GFP-His with volume ratio to the fresh medium was used for the adsorption 
of the HEK293 cell expressed ShhN-GFP-His in collagen. Any unbound 
ShhN-GFP-His was removed by washing the surfaces twice in PBS. C3H10T1/2 
clone 8 cells were then cultivated on the modified surfaces. Any ALP expressing cells 
were counted. The response curve shown in Graph 3.17 demonstrates the collagen 
adsorbed ShhN-GFP-His was able to induce ALP expressing C3H10T1/2 clone 8 
cells even with small volume ratios. With the conditioned medium to fresh medium 
ratio of 1:9, there was about 43% C3H10T1/2 clone 8 cells expressing ALP. Higher 
1:1.86 
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ratios of the ShhN-GFP-His conditioned medium applied did not result in more ALP 
expressing cells, suggesting that there is a threshold of the amount of ShhN-GFP-His 
adsorbed in collagen matrix, so as the number of cells responding to the protein and 
expressing ALP. 
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Graph 3.17. Induction of ALP expression in C3H10T1/2 clone 8 cells by the HEK293 cell expressed 
ShhN-GFP-His adsorbed on collagen surfaces. The BCIP/NBT staining for ALP 
expression showed that C3H10T1/2 clone 8 cells were specifically responsive to the 
ShhN-GFP-His adsorbed on collagen surfaces. The percentage of ALP expressing cells 
increased in a concentration dependent manner up to about 43% with the volume ratio of 
conditioned medium to fresh medium equals 1:9 and leveled for higher ratios. 
Conditioned medium from untransfected HEK293 cells served as negative control, 
indicating the ALP expression detected was induced by Shh signaling. 
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Though the amount of ShhN-GFP-His in the conditioned medium was under the 
detection limit of Western blot, it did not mean that there was inadequate 
ShhN-GFP-His for biological activity. An undetectable amount of HEK293 cell 
expressed ShhN-GFP-His could still be able to trigger prominent Shh signal 
transduction. 
 
The most significant difference between applications of the soluble and the adsorbed 
form of ShhN-GFP-His was the amount of the protein available for Ptc binding and 
the subsequent cellular response. For the soluble ShhN-GFP-His, the conditioned 
medium concentration applied to the responding cell culture remains constant 
throughout the treatment of cells. In the case of adsorbed ShhN-GFP-His, the 
available amount of the protein depends on the adsorption threshold of the substrate. 
Excess protein molecules in the conditioned medium applied could no longer be 
adsorbed above the threshold. Further increase of the volume ratio of ShhN-GFP-His 
conditioned medium to fresh medium beyond 1:9 did not improve the activity level, 
for 1:9 is the threshold of 100g/ml collagen for ShhN-GFP-His adsorption. 
 
Figure 3.26 showed a positive control image of ALP expression after applying the 
HEK293 cell expressed ShhN-GFP-His to the C3H10T1/2 clone 8 cells. C3H10T1/2 
clone 8 cells were grown on glass chambered slides. The ShhN-GFP-His conditioned 
medium was applied to the cells with the volume ratio of 1:1 to fresh medium. ALP 
expression in response to Shh signaling was detected after 5 days of treatment, 
indicating the biological activity of ShhN-GFP-His. 
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Figure 3.26. Induction of Shh signaling specific ALP expression in C3H10T1/2 clone 8 cells by the 
HEK293 expressed ShhN-GFP-His. ShhN-GFP-His conditioned medium with the volume 
ratio of 1:1 to fresh medium was added to C3H10T1/2 clone 8 cells. ALP expression was 
detected by BCIP/NBT substrate after 5 days. In the negative controls with conditioned 
medium from untransfected HEK293 cells, no ALP expression was detected (A). Soluble 
form of ShhN-GFP-His activated Shh signal transduction and induced ALP expression in 
C3H10T1/2 clone 8 cells (B). Nuclei were stained with Draq 5 (A’ and B’). 
 
When ShhN-GFP-His (from the conditioned medium with the volume ratio of 1:1 to 
fresh medium) was adsorbed on collagen coated surfaces, ALP expression was 
induced in C3H10T1/3 clone 8 cells, demonstrating the biological activity of the 
protein (Figure 3.27). 
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Figure 3.27. Induction of ALP expression in C3H10T1/2 clone 8 cells by the HEK293 cell expressed 
ShhN-GFP-His adsorbed on collagen coated surface. BCIP/NBT staining for Shh 
signaling induced ALP was done after a 5-day ShhN-GFP-His treatment of the 
C3H10T1/2 clone 8 cells on collagen functionalized surfaces. Glass surfaces were first 
exposed to 100g/ml collagen solution. ShhN-GFP-His conditioned medium with the 
volume ratio of 1:1 to fresh medium was then added to the collagen coated surfaces. The 
modified surfaces were incubated with C3H10T1/2 clone 8 cells for 5 days. ALP 
expression was detected by BCIP/NBT substrate. In the negative controls with 
conditioned medium from untransfected HEK293 cells, no ALP expression was detected 
(A). Adsorbed ShhN-GFP-His activated Shh signal transduction and induced ALP 
expression in C3H10T1/2 clone 8 cells (B). Nuclei were stained with Draq 5 (A’ and B’). 
 
Collagen served as a good substrate for adsorbing ShhN-GFP-His. Collagen not only 
allowed freedom of ShhN-GFP-His migration in the matrix, as demonstrated by 
FRAP experiment, but also retained the biological activity of the protein, which was 
shown by the ALP expression detection and cell counting assay. Though the same 
amount of ShhN-GFP-His (from a ShhN-GFP-His containing conditioned medium 
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with the volume ratio of 1:1 to fresh medium) was used in both setups shown in 
figures 3.26 and 3.27, it appears that there were fewer cells expressing ALP in 
response to the Shh signaling. It may be due to the saturation of protein adsorption in 
the collagen matrix, resulting in a limited supply of the protein comparing to the 
soluble one even the same amount of the protein is supplied initially. This argument is 
supported by the findings in graphs 3.16 and 3.17. It can be seen that when the 
ShhN-GFP-His containing medium to fresh medium ration was increased beyond 1:9, 
there was a continuous increase of cellular response when ShhN-GFP-His was applied 
in a soluble form; while a level off of cellular response was observed when the same 
amount of protein was used for surface adsorption. 
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4. Discussion 
 
The project presented the establishment of different immobilization approaches for in 
vitro studies of Shh protein/morphogen. The E. coli expression systems were applied 
for robust expression of ShhN variants with selected modifications for protein 
immobilization and surface analysis; while the eukaryotic HEK293 cells were 
employed for the production of ShhN that was used for biological activity 
determination.  The biological activity of the ShhN variants expressed in the two 
systems was found to be dependent on the analytical assays used. For Shh is an 
important signaling molecule, but the protein activity is complicated to study in vivo, 
the data shown in the thesis may provide a reference for future in vitro assay 
development for the investigation of Shh morphogen function, as well as proteins that 
share similar physicochemical properties. 
 
4.1. Expression and detection systems of ShhN variants 
 
The ALP expression and Gli-luciferase reporter assays are classical analytical 
methods of evaluating the biological activity of Shh in in vitro cell culture systems. In 
this project, it was found that both of these assays were only capable of evaluating the 
biological activity of the HEK293 expressed but not the E. coli expressed ShhN 
variants. By using the chondrocyte differentiation assay, the biological activity of the 
E. coli expressed ShhN variants were detected, indicating the importance of the 
selection of a valid /appropriate system for protein activity analysis. The chondrocyte 
differentiation assay, however, is time consuming and therefore plays a minor role in 
Shh activity detection. 
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Establishment and optimization of protein adsorption or immobilization conditions 
require a rather large amount of the target fusion protein. Therefore the E. coli 
expression system was chosen to guarantee a robust production of the ShhN variants 
for surface analysis; while the HEK293 system was used to produce ShhN variants, 
the biological activity of which was readily detectable with the ALP expression and 
Gli-luciferase reporter assays. 
 
4.2. Immobilization of ShhN on different substrates for 
various in vitro studies of protein activities 
 
There are various substrates and techniques available for in vitro protein adsorption or 
immobilization depending on the applications. 
 
Earlier in 2003, Jarov and colleagues used bovine plasma fibronectin and mouse 
laminin-1 to adsorb different variants and mutants of Shh, and illustrated an example 
of in vitro study of Shh in adsorbed or immobilized conditions. In their work, they 
observed that the extracellular matrix (ECM) adsorbed Shh resembled the Shh 
expressed by neuroepithelial cells. The adsorbed Shh promotes ventral cell type 
differentiation in the neural plate explant from Japanese quail embryos, though not as 
efficiently as the soluble Shh. It was also discovered to profoundly reduce 
cell-substrate adhesion by inactivating the 1-integrins at the cell surface, and in turn 
inhibits cell spreading. Apart from preventing cell-substrate adhesion, the protein 
further modifies N-cadherin mediated cell-cell adhesion and therefore led to cell 
compaction. With reference to the work of Jarov and his group, adsorption of ShhN 
was performed using fibronectin and the other ECM substrate collagen. 
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Recently in 2010, Amadi and colleagues developed a Resistor-Capacitor (RC) device 
and successfully monitored neuronal differentiation of the mouse embryonic stem 
cells by applying a graded concentration of Shh in the hydrogel mimicking the 
architecture of ECM. At the same time, Angeloni et al. (2010) published their findings 
of using peptide amphiphile (PA) nanofibers to encapsulate Shh and deliver the 
protein to the injured cavernous nerves in rats. Regeneration of the penis was detected 
in the treated rats. The erectile function was also found improved. The work of 
Angeloni and colleagues demonstrated that adsorption or immobilization of Shh not 
only is useful in addressing fundamental scientific questions but also has its value in 
clinical practice. 
 
While the above mentioned projects focused on investigating the protein activity 
directly without characterizing the substrate and protein conditions; the adsorption 
efficiency of the substrates, motility and quantity of the adsorbed ShhN were 
considered important and therefore were first evaluated in this project. Any change of 
these parameters can heavily influence the performance of the protein as well as the 
subsequent cellular responses. 
 
The presented project showed that ShhN could be immobilized on functionalized 
surfaces via physisorption on collagen, affinity binding between poly(6)histidine and 
nickel, biotin and streptavidin, and covalent bonding between SNAPTM tag and 
benzylguanine (BG). The immobilization systems tested offered distinct protein 
adsorption strengths, from the weakest: physisorption to the strongest: covalent 
binding. These different immobilization approaches affect the motility of the ShhN 
variants on the surface and the availability of the protein to the responsive cells. 
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4.2.1. Collagen matrix allows motility and availability of ShhN 
 
Collagen differs from other extracellular matrix (ECM) substrates by its ability to 
self-assemble and aggregate to form compact and tough bundle networks. It provided 
an excellent substrate for ShhN adsorption. Adsorption of ShhN-GFP-His on the 
collagen matrix was found to be dependent on the applied protein concentration, and a 
saturated loading of the protein can be reached for possible maximal cellular 
responses (compare graphs 3.16 and 3.17). Collagen coated surface therefore is a 
convenient system for ShhN immobilization.  
 
Previous studies demonstrated a relationship between internalization of morphogens, 
including Shh, and cellular response to the morphogen signals (Gallet and Therond, 
2004; Torroja et al., 2004; Incardona et al., 2000). A number of investigations on the 
subcellular length scale support the idea that ShhN is incorporated in vesicles together 
with its receptor Patched (Ptc) and endocytosed into the cell (Gallet and Therond, 
2004). The collagen/ShhN interactions led to adsorption of ShhN in the matrix, while 
the absence of covalent bonds allowed ShhN to diffuse within the matrix, bind to the 
receptor and be endocytosed (Graphs 3.15, 3.17; Figure 3.27). Collagen would 
therefore be a material of choice for the adsorption of ShhN, and maybe other 
morphogens or signal molecules with similar properties. 
 
4.2.2. Supplement of heparin or BSA in the collagen matrix 
further resembles the in vivo extracellular environment 
 
ShhN possesses a Cardin-Weintraub sequence at the N terminus that can be 
recognized by and is capable of binding to heparin and heparin sulfate proteoglycan 
  
Discussion
189
(HSPG). Such interaction is critical in extracellular transportation and controlling the 
concentration gradient of ShhN in vivo. In the project, more ShhN-GFP-His was 
found to be adsorbed on the heparin supplemented collagen surface as compared to 
the non-supplemented collagen surface (Figure 3.25). 
 
Similarly, BSA was observed to facilitate ShhN-GFP-His adsorption on the collagen 
matrix (Figure 3.25). BSA did not block but largely promoted ShhN adsorption in 
collagen. In the in vivo system, Shh is expressed and transported in the 
microenvironment of ECM. Since there could be a long distance for Shh to travel 
from its source of secretion to the recipient cells, protection of the protein from 
degradation is necessary. BSA is commonly used to protect commercially supplied 
protein containing reagents. It protects other proteins against denaturation and 
digestion (Williams et al., 1996). The presence of BSA in collagen matrix may thus 
favor the protection of ShhN-GFP-His from degradation and offer an advantage of 
facilitating adsorption of ShhN-GFP-His on collagen surfaces. 
 
Taken together, the finding from the supplementation of heparin to the collagen 
matrix went along with the observations by Dierker and colleagues (2009a) that 
heparin contributes to retaining Shh in the ECM. Supplement of BSA prevents 
degradation of Shh before it finally arrives at the responsive cells. The example of 
heparin and BSA also encouraged the use of in vitro systems for studying in vivo 
biomolecule activities by simple modifications. 
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4.2.3. UV irradiated polystyrene surfaces presenting nickel adsorb 
histidine tagged proteins but provide no sufficient selectivity 
 
The increased hydrophilicity of UV irradiated polystyrene advances its usage in cell 
culture and protein adsorption (Welle et al., 2002, 2005). As shown in figure 3.13, UV 
irradiation and nickel functionalization provided a surface modification for the 
immobilization of histidine tagged ShhN. ShhN-GFP-His was bound on the UV 
irradiated and nickel modified regions but not on the remaining non-irradiated areas. 
Additionally, surface sterilization can be achieved by the UV irradiation. High degree 
of surface organization by UV lithography with masks of different patterns favors 
studying ShhN and other morphogens with graded concentrations on a single surface. 
 
Though the nickel head group is selective to the histidine tagged protein, the UV 
irradiated polystyrene surface favors adsorption of all kinds of proteins. The resulting 
UV irradiated and nickel functionalized surface is insufficient to support protein 
immobilization with selectivity. To facilitate immobilization of a specifically tagged 
protein, it is essential to develop substrates with high selectivity to this tagged protein 
and repellent to other proteins. Application of pure passivating thiol EG6OH on gold 
surfaces appeared to be efficient in preventing unspecific adsorption or 
immobilization of proteins (Graph 3.11, Figure 3.22). Combined usage of passivating 
thiols and Ni-NTA head groups can therefore be a solution for the unspecific 
adsorption problem. Indeed, the work of Dr. S. Engin (KIT, Karlsruhe, Germany) has 
demonstrated that EG4OH and EG3OMe are another two alternative passivating 
thiols in minimizing protein adsorption (Graph 4.1; communication with Dr. S. 
Engin); while Ni-NTA thiol was found to selectively immobilize polyhistidine tagged 
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proteins on gold surfaces (Graph 4.1; communication with Dr. S. Engin; Hainfeld et 
al., 1999). 
 
 
Graph 4.1. Immobilization of His-SNAP-GFP on gold surface via the Ni-NTA thiol. The 
polyhistidine-tagged GFP protein is selectively bound to the Ni-NTA head group. 
EG4OH and EG3OMe are passivating thiols that have no selectivity to any protein and 
acted as the negative controls of protein adsorption. (Courtesy of Dr. S. Engin) 
 
4.2.4. ShhN immobilization by dip-pen nanolithography retains 
the motility of the immobilized protein 
 
Similar to UV photolithography, DPN lithography is capable of delivering 
biomaterials with designated patterns of restricted sizes and spacing on a surface. 
Modified phospholipids were deposited on selected surfaces by DPN. The ShhN 
variants were then immobilized via nickel/poly(6)histidine, biotin/streptavidin, and 
BG/SNAPTM interactions with respect to the modifications made to the phospholipids 
(Figures 3.14 – 3.17). Like the collagen matrix and UV irradiated polystyrene, 
(a
.u
.) 
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phospholipids are unselective and can non-specifically absorb other proteins (Nair et 
al., 2011). Blocking of the phospholipid patterns with BSA before the protein binding 
step to the head groups is necessary (Nair et al, 2011). In addition to the flexibility of 
interactions offered for protein immobilization, the phospholipids, being the primary 
component of cell membrane in nature, provide an excellent interface between the cell 
membrane and the adsorbed protein. Even when the protein is immobilized via strong 
bondings between the tags or linkers fused to the peptide and the head groups in the 
phospholipids, it is still mobile and can be endocytosed in the form of a lipid complex 
into the cell body once it is in touch with the cell membrane. 
 
However, because of the lateral diffusibility within the printed lipids, it is impossible 
to generate continuous gradients of the immobilized protein as there is an equilibrium 
formation. DPN can only generate step gradients based on individual spots or areas 
for the immobilized protein, and it would hinder in vitro concentration gradient 
analysis of morphogens, which work in a continuous gradient in vivo. Patterns of 
different protein concentration are therefore compactly organized down to the nano 
scale in order to compensate the need of continuous protein gradient and to minimize 
the possibility of equilibrium formation. As demonstrated in the presented project, 
different amounts of ShhN variants could be adsorbed and organized in subcellular 
scale on the functionalized surfaces (Figures 3.14, 3.16). The remaining limitation is 
the protein binding capacity of the head groups in the phospholipids. Both nickel 
chelating and biotinylated lipids showed a maximum of binding of the ShhN variants 
at certain molar ratios of active and inert lipids in the ink (Figures 3.14, 3.16). The 
saturation was probably due to crowding effect of the head groups printed on the 
surface, leading to ligand structure disruption (Nelson et al., 2001). In addition, a 
mixture of 4% biotinylated lipids in DOPC appeared to show the most conspicuous 
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DPN printed pattern even before the addition of streptavidin and immobilization of 
ShhN-GFP-His-Biotin (Figure 3.16). It indicated that the molar ratio of the lipids is 
another governing factor for biotin head group delivery on a substrate. 
 
Apart from the properties of the phospholipids and technique applied, the substrates 
also play a critical role in effective protein immobilization as well as cell adhesion. 
Both the PEG-g-PLL and polystyrene surfaces used in this project showed good 
performance in phospholipid adsorption (Figures 3.14 – 3.17) but did not support cell 
adhesion (VandeVondele et al., 2002). VandeVondele and colleagues (2002) found 
that pendant functionalization of the PLL grafted PEG by covalent conjugation to the 
peptide motif RGD was an alternative in inducing cell binding, at the same time 
blocking unspecific protein adsorption. Therefore the next step for immobilizing 
ShhN variants via modified phospholipids could be the preparation of surfaces with 
RGD conjugated PEG coating and nanoscaled features produced via DPN allowing 
ShhN binding. The specificity of protein binding to the nickel, biotin and BG head 
groups in the phospholipids would not be interfered; while adhesion of the Shh 
responsive cells could be achieved for biological activity analysis of the protein. 
 
4.2.5. The benzylguanine/SNAPTM system allows for highly 
selective ShhN immobilization 
 
The high selectivity of the BG/SNAPTM system enabled a specific adsorption of 
ShhN-GFP-His-SNAP on patterned BGT SAM on gold surfaces (Figure 3.25). 
Preliminary cell culture tests demonstrated that a variety of cell types showed 
predominant adhesion on the UV modified surfaces where BGT would be used for 
backfilling (data not shown). Taken together, the UV irradiated gold/BGT/SNAPTM 
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system appeared to be good for studying specific protein-cell interactions. In this 
project, the strong protein binding property of the gold/BGT/SNAPTM system offers 
an additional advantage for the investigation of ShhN. The thiol/gold binding is 
semi-covalent and the BG/SNAPTM interaction is covalent. The ShhN adhered strictly 
on the surface. Diffusion of the ShhN protein immobilized in the gold/BGT/SNAPTM 
setup is therefore prohibited compared to the SNAPTM tagged ShhN immobilized via 
the BG terminated lipids deposited by DPN. By comparing with the soluble ShhN, the 
BGT SAM system may give new information for the elucidation of the modes of 
action of Shh. 
 
Apart from covalent binding, the BGT/SNAPTM system can provide a platform for 
immobilizing ShhN with continuous gradient on a single plain. It was demonstrated 
that UV irradiation could effectively introduce patterns on an EG6OH modified gold 
surfaces (Figures 3.21, 3.22). Therefore different amounts of ShhN-GFP-His-SNAP 
could be immobilized via binding with BGT on the UV irradiated EG6OH modified 
gold surface. Because the BGT/gold interaction is semi-covalent and BGT/SNAPTM 
binding is covalent, there is no motility of protein on the surface. A graded pattern of 
ShhN can therefore be established in a highly controlled manner. 
 
4.3. Immobilization of ShhN with the flexibility for 
controlled protein motility 
 
Though there are pros and cons for each of the systems developed in this work, 
information needed for establishing an ideal surface for ShhN immobilization was 
obtained. So far, the BGT/SNAPTM system showed the highest potential for further 
investigation. 
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It has been widely observed that ShhN is internalized together with Ptc after receptor 
binding (Gallet and Therond; 2004; Varjosalo and Taipale, 2007, 2008). Therefore it 
is worth to establish a system to study ShhN as a morphogen by stringently 
immobilizing the protein on a single surface mimicking the in vivo microenvironment, 
and yet allowing the release of the ligand simultaneously after the cells settle down on 
the surface. 
 
Glutathione S transferase (GST) and polyhistidine are commonly used for protein 
purification (Hosfield and Lu, 1999). To remove the tags after purification and obtain 
pure proteins of interest, enteropeptidase can be employed, provided that a (Asp)4-Lys 
site is introduced between the polyhistidine tag and the protein. Therefore, if a 
(Asp)4-Lys site is inserted between the C-terminus of ShhN and the SNAPTM tag, 
immobilized ShhN on BGT SAM could be released from the surface by 
enteropeptidase. In other words, the concentration gradient of ShhN could be 
established and strictly controlled, while endocytosis of the ligand, if needed, is 
permitted for proper signal transduction. The resulting immobilization system would 
mimic the in vivo environment to the closest extent. 
 
4.4. Alternative analytical strategies for determination of the 
biological activity of immobilized ShhN 
 
In this project, cellular responses to the ShhN proteins were investigated by ALP 
colorimetric and Gli-luciferase reporter assays, which require cell lysis. While these 
assays are sensitive and accurate enough in reporting the cell behaviors, the positional 
and morphological information from individual cells on the surface cannot be 
recorded. If ShhN is to be studied as a morphogen and the activity of the protein with 
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graded concentrations on one single surface is to be compared, it is necessary to look 
into individual cells or small populations of cells at different locations on the surface. 
The following methods are introduced to compensate the loss of cell location and 
morphological information from the ALP and luciferase assays. 
 
4.4.1. Investigation of cell migration by time lapse imaging 
 
It has been reported in previous studies that Shh restricted cell migration and played a 
role in cell fate determination in neural tube development (Ericson et al., 1996). It is 
therefore worth to employ the Shh responsive multipotent neuronal stem cell line 
MNS70 (Nakagawa et al., 1996) to look into the migration and behaviors of the stem 
cells in the presence of immobilized Shh. Would the cells show affinity to higher Shh 
concentration, and be able to sense and migrate actively to Shh if the morphogen is 
restricted to certain position instead of diffusing or being transported to the cells? This 
cell migration assay not only helps understand the function of Shh on neuronal 
development but also indicates the requirement of extracellular control in governing 
the availability and concentration of Shh to the responsive cells. 
 
Time lapse imaging could be conducted following the seeding of Shh responsive cells 
on the ShhN protein functionalized surfaces. The speed and direction of cell migration 
would give information for the interaction between the morphogen and the cells. 
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4.4.2. Localized study of signal transduction induced by 
immobilized ShhN with fluorescence labeled Gli reporter 
cell line 
 
Gli is a targeting transcription factor in the Shh pathway. In order to determine Shh 
signal transduction, the Shh LIGHT II cells, which had been stably transfected with 
the Gli responsive firefly luciferase reporter (Sasaki et al., 1997) and respond by 
producing firely luciferase in the presence of Shh signaling, were employed. 
Nevertheless, the cells should be lysed for assay. Schwend and colleagues (2010) 
have generated the Gli-d mcherry reporter construct, which was used as a hedgehog 
pathway reporter to visualize Gli activity in the craniofacial tissues in transgenic 
zebrafish. The sequence structure of the Gli-d mcherry reporter construct is the same 
as the Gli responsive firefly luciferase reporter, except that the firefly luciferase 
reporter sequence is replaced by mcherry. The availability of the Gli-d mcherry 
reporter construct and hence the establishment of a stable transfected cell line would 
be constructive in studying the cellular response of Shh responsive cells in situ at the 
gene transcription level. 
 
4.4.3. Establishment of specific reporter cell lines for investigation 
of the role of Shh in neural cell fate determination 
 
Shh is a renowned modulator of cell differentiation in the developing embryonic 
neural tube (Jarov et al., 2003). The secreting locations and concentrations of the 
morphogen are critical for cell fate determination (Cayuso et al., 2005; Fuccillo et al., 
2006; Monuki, 2007). In in vivo system, the influence of morphogen concentration on 
different gene or protein expressions in specific tissues can be manipulated, for 
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example, via conditional gene knockdown or overexpression,. Nevertheless, 
information obtained in vivo is inadequate to elucidate the significance of localized 
concentrations on individual cells. Establishment of reporter cell lines would therefore 
be essential for investigation of the concentration effects of a morphogen, such as Shh, 
at the subcellular level. 
 
Nakagawa and colleagues (1996) showed that the multipotent neural stem (MNS) cell 
lines from rat were induced by SHH to differentiate into microtubule-associated 
protein 2 (MAP2) and Pax-6 positive neurons, gene glial fibrillary acidic protein 
(GFAP) positive astrocytes and microtubule-associated protein 2 (MAP2), glial 
fibrillary acidic protein (GFAP) and galactocerebroside (GC) positive 
oligodendrocytes. SHH treated MNS-70 was also found to express the ventral 
cell-specific transcription factors Isl-1, Nkx-2.1 and Nkx-2.2, which play crucial roles in 
specification of the ventral phenotype of neuroepithelial cells (Echelard et al., 1993; 
Roelink et al., 1994; Martí et al., 1995; Ericson et al., 1995; Barth and Wilson, 1995). 
With reference to the work of Nakagawa et al. (1996), by cultivating the MNS cells on 
the immobilized biologically active ShhN with different spatial organization and 
concentration gradient, the parameters for the function of Shh on neural cell fate 
determination could be estimated. 
 
The transgenic zebrafish with different Shh responsive neural markers in the KIT fish 
facilities provide a wide source of reporter cell lines for Shh function analysis. They 
offer an alternative for the determination of the capability of Shh to facilitate 
differentiation of certain types of neurons or glial astrocytes. 
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4.5. Conclusions 
 
The immobilization systems for ShhN variants established in the presented project 
offer a variety of choice for studying the biological activity and modes of action of 
Shh. Though there is still room for optimization of each of the methodologies for the 
investigation of specific aspects, however the information obtained from the current 
work provided massive information for surface and assay developement. For instance, 
the supplement of heparin and BSA on collagen coated surfaces suggested the 
possibility of including any extracellular substrates in the immobilization system. This 
would be helpful in studying the protein diffusion from a simple to sophisticated level, 
as well as the contribution of each factor in controlling the diffusion of the protein. To 
take a close observation at the Shh-cell interaction at subcellular length scales, 
deposition of modified phospholipids by DPN and immobilization of ShhN ligands 
can be conducted. A combination of UV lithography and BGT SAMs on gold surfaces 
enabled ordered covalent adsorption of highly selective SNAPTM tagged proteins. 
Table 4.1 summarizes the findings about the different protein immobilization 
approaches obtained in this project. 
 
The above mentioned systems of course are not merely applicable for Shh 
immobilization, the concepts can also be applied for proteins or biomolecules with 
properties comparable to those of Shh. Wnt, transforming growth factor beta (TGFβ), 
epidermal growth factor (EGF) and fibroblast growth factors (FGFs) are morphogens 
like Shh and function with similar mechanisms. They are secreted from a localized 
source and bind as a ligand to the corresponding receptors at the cell membrane, 
thereby activating subsequence signaling pathways. 
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The findings obtained in this project are therefore essential not only in in vitro 
investigating ShhN as a signaling molecule but also in developing suitable platforms 
to control the extracellular spatial distribution of other morphogens of interest. 
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 Collagen, 
without 
patterning 
 
Cp 
 
Ni-NTA 
on UV irradiated 
PS 
DPN of functionalized lipids BGT& MT 
SAM on gold, 
lithographic 
patterning 
BSA 
on collagen 
 
BGT& MT SAM 
on gold 
Ni head group 
on PEG 
Biotin 
head group 
on PEG 
BG 
on PS 
ShhN variant binding 
 
Yes,  
label free 
Yes,  
label free 
Yes,  
SNAPTM tag. 
Aggregates due 
to drying of BGT 
Yes,  
His tag 
Yes, His tag Yes, biotinylated Yes,  
SNAPTM tag 
Yes,  
SNAPTM tag 
Unspecific adsorption 
of other proteins 
 
Yes, 
by physisorption 
Yes, 
by physisorption 
by collagen 
No, 
passivation by 
EG6OH 
Yes, 
physisorption on 
UV irradiated PS 
Yes, due to 
non-selectivity 
of phospholipids 
Yes, due to 
non-selectivity 
of phospholipids 
Yes, due to 
non-selectivity 
of phospholipids 
No, passivation 
by EG6OH 
 
Methods for 
reduction of 
unspecific protein 
adsorption 
Not available, 
dependent on 
high purity of 
protein solution 
 
Not available, 
dependent on 
high purity of 
protein solution 
Not necessary Not available, 
dependent on 
high purity of 
protein solution 
Dependent on 
high purity of 
protein solution, 
and BSA 
blocking 
Dependent on 
high purity of 
protein solution, 
and BSA 
blocking 
Dependent on 
high purity of 
protein solution, 
and BSA 
blocking 
Not necessary 
Cell adhesion 
 
Yes Yes No,  
passivation by 
EG6OH 
Yes No,  
passivation by 
PEG 
No,  
passivation by 
PEG 
No, 
self passivation 
(BSA) of native 
PS 
No,  
passivation by 
EG6OH 
Possible 
functionalization for 
cell controlled 
adhesion 
Not applicable Not applicable Application of 
RGD in 
BGT/EG6OH 
solution 
Not applicable Application of 
RGD conjugated 
PEG or lipids 
Application of 
RGD conjugated 
PEG or lipids 
Application of 
RGD conjugated 
lipids 
Application of 
RGD in 
BGT/EG6OH 
solution 
Continuous gradient 
 
No, 
Shh is diffusive 
No,  
but step gradient with stamp of 
different feature and pitch sizes 
Yes, 
dependent on 
proximity gap 
and irradiation 
time 
No,  
but step gradient with lipid patterns with different amount 
of head groups, and pattern and pitch sizes 
 
No,  
but step gradient  
ShhN motility 
 
Yes,  
Shh 
physisorption 
 
Yes, 
on the 
unstamped 
collagen surface 
No, BG/SNAPTM 
binding is 
covalent 
Possible, 
Ni-ShhN binding 
strong but not 
covalent 
Yes,  
within each individual lipid deposit due to the diffusive 
property of phospholipids 
No, BG/SNAPTM 
binding is 
covalent 
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ShhN internalization 
 
Yes,  
Shh physisorption 
 
 
No, BG/SNAPTM 
binding is 
covalent 
Possible, 
Ni-protein 
binding due to 
strong affinity 
but not covalent 
Yes,  
due to the dynamicity property of phospholipids. 
However, internalization is strongly affected in case of 
BGT lipid/SNAPTM-ShhN system. 
No, BG/SNAPTM 
binding is 
covalent 
Lateral resolution 
 
Not applicable m m m nm nm nm m 
Diversity of 
application 
 
No Yes,  
direct stamping 
or backfilling of 
protein 
 
Yes,  
direct stamping 
or backfilling of 
BGT 
No Yes,  
dependent on the 
head group 
conjugated 
phospholipids 
Yes,  
dependent on the 
head group 
conjugated 
phospholipids 
Yes,  
dependent on the 
head group 
conjugated 
phospholipids 
No 
Sterility 
 
No,  
aseptic 
precaution 
needed 
 
No,  
aseptic 
precaution 
needed 
 
No,  
aseptic 
precaution 
needed 
 
Yes,  
due to UV 
irradiation and 
sterile substrates 
No,  
aseptic 
precaution 
needed 
 
No,  
aseptic 
precaution 
needed 
 
No,  
aseptic 
precaution 
needed 
 
No,  
aseptic 
precaution 
needed 
 
Transparency 
 
Yes Yes No Yes Yes Yes Yes No 
Time 
 
Short Short Short Moderate Long Long Long Long, 
upscaling 
possible 
New pattern layout Not applicable Slow 
(master for stamp casting) 
Slow 
(lithography 
mask) 
Fast, 
no master needed 
Slow 
(lithography 
mask) 
Instrumentation / 
Cost 
 
Cheap Moderate 
(masters, stamps) 
Moderate 
(masks, lamp) 
Expensive 
(DPN setup) 
Moderate 
(masks, lamp) 
Table 4.1. Summary of different approaches used for ShhN immobilization. The substrate properties and characteristics of each immobilization system are listed and 
compared. Immobilization of ShhN and other proteins can be achieved by specific approach according to the investigation aspect. 
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